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ABSTRACT:
Phosphorylation is an important mechanism for the modulation of ligand- 
gated ion channel function. CaMK-II dependent modulation of GABAa receptors 
was investigated through analysis of GABAa receptor mediated currents recorded by 
whole-cell patch clamp from non-neuronal and neuronal cell lines and from primary 
neurones in culture.
Application of pre-activated a-CaMK-II had no effect on recombinant 
receptors expressed in HEK293 cells. Whole-cell currents recorded from cerebellar 
granule cells were significantly increased in peak amplitude on application of pre­
activated a-CaMK-II. Analysis of spontaneous (s)IPSCs recorded from cerebellar 
granule cells in culture in the presence of pre-activated 0 CaMK-II revealed an 
increase in sIPSC amplitude and decay time constants. Expression of recombinant 
GABAa receptors in the neuronal cell line NG108-15 allowed the functional effect of 
CaMK-II to be studied in a recombinant system. CaMK-II was able to up-regulate 
the function of cd/Sl^S and g:1/33y2S GABAa receptors but not alfil'il receptors. 
This modification of function occurred through phosphorylation of Ser on the /33 
subunit and through a downstream activation of a tyrosine kinase and subsequent 
phosphorylation of the y2 S subunit at previously identified sites of tyrosine kinase 
phosphorylation, Tyr357 and Tyr359. Tyrosine kinase phosphorylation of 7 2S occurred 
when co-expressed with cd/31 or cd/33 but not with cd/32. Transfection of different 
GABAa receptor subunits into cerebellar granule cells was carried out to confirm the 
importance of these sites in a neuronal environment. Analysis of sEPSCs recorded 
from cerebellar granule cell cultures prepared from /52 subunit knockout mice 
revealed a-CaMK-II modification of /32 subunit-containing receptors at the synapse, 
resulting in an increase in sIPSC amplitude with no change in decay times. This was 
in contrast to the lack of any functional modulation of 0'1/52y2S receptors observed in 
NG108-15 cells.
These findings are potentially important for understanding the mechanisms of 
CaMK-II dependent modulation of the GABAa receptor and may also have 
significant implications for the understanding of inhibitory synaptic plasticity.
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Chapter One: General Introduction: 
Modulation of the GABAa receptor bv phosphorylation.
1.1 INTRODUCTION
The y-aminobutyric acid type A (GABAa) receptor is a pentameric ligand-
gated ion channel responsible for the majority of fast synaptic inhibition in the brain. 
It is related in structure to the cys-loop family of ligand-gated ion channels including 
the serotonin (5 -HT3) receptors, nicotinic acetylcholine receptors (nAChR) and 
glycine receptors (Nayeem et al., 1994; Rothlin et al., 1999; Cromer et al., 2002; 
Korpi et al., 2002). It is formed from five subunits that form a C1‘ permeable ion 
channel (Jenson et al., 2002) that is opened after binding of the amino acid 
neurotransmitter GABA (Smith and Olsen, 1995; Moss and Smart, 1996; Mehta and 
Ticku, 1999; Moss and Smart, 2001; Connolly and Wafford, 2004).
1.1.1 Receptor structure.
Numerous different subunits of the GABAa receptor have been identified 
which can be divided into subunit families based on sequence homology. These 
consist of al-6, 01-3, yl-3, 8, t, e, 6 and p (Barnard et al., 1998; Whiting et al., 1999; 
Korpi et al., 2002). There is typically 30-40 % homology between subunit families 
and 70-90 % between subunit isoforms (Smith and Olsen, 1995; Korpi et al., 2002). 
In addition, some of these subunits have multiple splice variants the most commonly 
expressed being the y2S and y2L forms of the y2 subunit in which the y2L variant 
has an additional eight amino acids at position 338-345 (Moss and Smart, 1996). 
This heterogeneity of GABAa receptors allows for a large amount of spatial and 
temporal diversity with different cells expressing different subunit combinations at
18
different times (McKeman and Whiting, 1996; Whiting et al., 1999; Sieghart et al., 
1999).
Each GABAa receptor subunit contains a large extracellular domain, four 
transmembrane domains (TM) and a large intracellular loop between TM 3 and 4 
(Smith and Olsen, 1995; Moss and Smart, 1996). The TM2 domain lines the channel 
pore (Xu and Akabas, 1996). The TM3-4 intracellular loop can account for up to 
20 % of the total mass of a subunit and is known to contain multiple sites of 
phosphorylation (Smith and Olsen, 1995; Moss and Smart, 1996; See Fig 1.1).
The subunit stoichiometry of GABAa receptors in the brain is thought to 
consist of 2cE2/3:ly (Nayeem et al., 1994; Chang et al., 1996; Tretter et al., 1997; 
Farrar et al., 1999). In recombinant systems, it has been determined that the /31 and 
/33 subunits can form functional homomeric channels, although this doesn’t appear to 
be the case for /32 subunits (Krishek et al., 1996; Connolly et al., 1996a; Connolly et 
al., 1996b; Wooltorton et al., 1997; Taylor et al., 1999). For the formation of a 
robust GABA gated CT channel it appears that co-expression of an a  and a subunit 
is required (Connolly et al., 1996a; Taylor et al., 1999). However aj3 channels have 
different single channel conductance and gating properties than afiy channels and 
they are not modulated by benzodiazepines (Angelotti and Macdonald, 1993; 
Angelotti et al., 1993a). The inclusion of the y subunit increases the amplitude of 
whole-cell currents recorded in a recombinant system and results in an increase in the 
EC50 for GABA (Angelotti et al., 1993a). The inclusion of y2 in the receptor 
complex has also been reported to alter the kinetic properties of GABAa receptors 
(Boileau et al., 2003). For modulation by benzodiazepines, an a  and y subunit are 
required (Sigel et al., 1990; Angelotti et al., 1993a).
19
Fig 1.1:
c i -
HCO
Fig 1.1: Illustration of the proposed structure of the GABAa receptor.
(A) The GABAa receptor is thought to be pentameric consisting of 2a, 2/3 and I7 
subunit. The channel opens in response to GABA binding and is permeable to CT 
and HCO3" ions.
(B) Each subunit is proposed to consist of an N-terminal extracellular domain, four 
trans-membrane domains (TM), a large intracellular loop between TM3-4 and an 
extracellular N-terminus in which the cys-loop is situated. The large intracellular 
loop is thought to contain multiple potential sites of phosphorylation. A small 
external C-terminus is also evident.
(C) The TM2 region of each subunit is thought to line the channel pore.
Adapted from Moss and Smart (1996).
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1.1.2 GABAa receptor trafficking.
GABAa receptors have been identified in various intracellular compartments 
within neurones, as well as at the plasma membrane, and it appears that receptors can 
dynamically shuttle between these locations (Brandon et al., 2002a; Kittler and 
Moss, 2003). The removal of receptors from the cell surface is mediated by clathrin- 
dependent endocytosis (See Fig 1.2). In this context, interaction between ft and y  
subunits and the adaptin complex, AP2, has been identified. AP2 is critical for the 
recruitment of receptors into clathrin-coated pits (Kittler et al., 2000). These 
processes can be modulated by phosphorylation, for example, PKC dependent down- 
regulation of GABAa receptor function can be partly mediated by a loss of receptors 
at the cell surface through a block of recycling of receptors back to the cell surface 
(Connolly et al., 1999). Plic-1 is a GABAa receptor-associated protein which 
enhances receptor insertion into the membrane. A block of its interaction with the 
GABAa receptor results in a rapid decrease in GABAa receptor-mediated currents 
implying that Plic-1 is required for the replacement of receptors lost by 
internalisation (Bedford et al., 2001). Alteration in trafficking through perturbation 
of these pathways results in significant effects on GABAa receptor-mediated currents 
and inhibitory synaptic transmission (Kittler and Moss, 2003).
The correct targeting of assembled receptors to synaptic sites is crucial for the 
proper functioning of inhibitory synaptic transmission. It is thought that an 
interaction between the ^2 subunit and the scaffolding protein gephyrin may be 
involved in receptor targeting and clustering at the synapse (See Fig 1.2). The loss of 
the *y2 subunit results in a large decrease in the number of receptors at synapses 
despite the fact that aft receptors are capable of trafficking to the cell surface. The 
loss of *{l also results in a subsequent loss of gephyrin, suggesting an important link
21
between the two proteins (Essrich et al., 1998). Disruption of gephyrin results in the 
disruption of o£/3 subunit-containing GABAa receptor clustering and synaptic 
targeting of *y2 subunit-containing receptors. However, in gephyrin knockout mice, 
some GABAa receptor subtypes are unaffected. Gephyrin is thought to act as a 
scaffolding molecule important for receptor clustering of certain subtypes of GABAa 
receptor, but evidence suggests there must be additional proteins involved in 
clustering and trafficking (Kneussel et al., 1999; Kneussel et al.t 2001).
The GABAa receptor associated protein GABARAP has been identified to 
associate with the *y2 subunit and is thought to play a role in intracellular transport 
and cell surface targeting of the receptor (Chen et al., 2000; Kittler et al., 2001; 
Kneussel, 2002; Kanematsu et al., 2002; Leil et al., 2004). The correct targeting of 
receptors to synapses is significant given the large amount of heterogeneity of 
GABAa receptors and the apparent precise control of GABAa receptor subtype 
expression and localisation (Koulen et al., 1996; Briinig et al., 2002).
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Fig 1.2:
lCK-
ephyri
ActinMicrotubules
GABARAP
AP2
Fig 1.2: Trafficking of the GABAa receptor and interactions at the plasma 
membrane.
(A) GABAa receptor clustering in some cases is thought to be mediated by the 
protein gephyrin. Associations between gephyrin, the GABAa receptor and the 
cytoskeleton have been proposed to anchor and cluster GABAa receptors at the 
synapse.
Anchoring proteins can target protein kinases to the GABAa receptor and can 
modulate, or be critical for kinase function (e.g. PKC and RACK-1).
(B) GABARAP has been implicated in the trafficking of GABAa receptors to the 
plasma membrane through an interaction with the y subunit of the GABAa receptor, 
microtubules and N-ethylmaleimide sensitive factor (NSF). NSF is key protein 
involved in membrane fusion and is critical for intracellular transport.
(C) GABAa receptors at synaptic sites undergo constitutive endocytosis via clathrin- 
mediated endocytosis. This is mediated by an interaction between /3 and y subunits 
and adaptor proteins (e.g. AP2) essential for the recruitment of protein cargo into 
clathrin-coated pits.
Adapted from Moss and Smart (2001).
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1.1.3 GABAa receptor localisation.
Immimocytochemistry and in situ hybridisation have allowed the temporal 
and spatial heterogeneity of GABAa receptors within the brain to be revealed. There 
are distinct patterns of GABAa receptor subunit expression in different regions of the 
brain at different points in development (Persohn et al., 1992; Wisden et al., 1992; 
Laurie et al., 1992a; Laurie et al., 1992b). Different cell types often express a 
particular subset of the many subunits. Even within the same cell it appears that 
different subunits are targeted to precise locations (Koulen et al., 1996; Connolly et 
al., 1996b; Briinig et al., 2002). There is also evidence that certain subunits are 
preferentially expressed together (Benke et al., 1994). Certainly the number of 
receptor subtypes in the brain is believed to be significantly less than the theoretical 
number of possible combinations (McKeman and Whiting, 1996). The (32 subunit is 
widely expressed and accounts for 60 % o f all (3 subunits with a relatively smaller 
contribution of /31/3 (Benke et al., 1994). However, recent evidence suggests that 
al/32 subunits prefer to co-assemble and that cd!3(33 subunits also preferentially co- 
assemble (Benke et al., 1994; Ramadan et al., 2003; Ortinski et al., 2004; Vicini and 
Ortinski, 2004). The 04/32^2 receptor and the 02/33^2 receptor together account for 
75-85 % of the diazepam-sensitive receptors in the brain (Benke et al., 1994). 
Although these associations are not mutually exclusive, they suggest a broad division 
between these two receptor subtypes with each form being targeted to specific 
cellular locations (Whiting et al., 1999; Vicini and Ortinski, 2004).
1.1.4 Physiological role and pathology.
Activation of GABAa receptors in the adult brain causes the rapid influx of 
C f ions which results in a hyperpolarisation of the cell. As a consequence they are
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critical in the control of neuronal excitability (Moss and Smart, 1996). In immature 
neurones, GABA is excitatory resulting in cell depolarisation and the generation of 
action potential firing. Independent of the net flow of Cl" ions, the opening of 
GABAa receptors is often enough to shunt excitatory synaptic currents (Ruiz et al., 
2003). The shift from excitation to inhibition occurs when the KCC2, K+ / Cl" co­
transporter is expressed changing the electrochemical gradient for Cl" (Ben-Ari, 
2002).
The GABAa receptor is also the site of action of a number of important, 
clinically relevant drug families. The most widely used and characterised of these is 
the benzodiazepine family, which acts as an allosteric modulator of GABAa 
receptors enhancing their function in response to GABA. Disruptions to the normal 
function of GABAa receptors have been linked to many pathological conditions 
(Mehta and Ticku, 1999). The clinical use of benzodiazepines is particularly 
widespread in anxiety and epilepsy (Liiddens et al., 1995; Basile et al., 2004). One 
of the most widely studied pathological conditions associated with GABAa receptors 
is epilepsy in which disruption or alteration of normal GABAergic synaptic 
transmission has been observed in a number of different experimental models 
(Kardos, 1999; Jones-Davis and Macdonald, 2003). Analysis of familial epilepsy 
has revealed mutations in GABAa receptor subunit genes which result in altered 
functional behaviour o f these receptors (Bianchi et al., 2002; Buhr et al., 2002; 
Fisher, 2004; Macdonald et al., 2004). GABAa receptors are also thought to play an 
important role in alcohol dependence (Young et al., 2004) and alterations in the 
normal physiology of inhibitory synaptic transmission has been linked to 
schizophrenia (Lewis et al., 2005), Alzheimer’s disease (Armstrong et al., 2003) and 
a number of anxiety disorders (Nemeroff, 2003; Basile et al., 2004).
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GABAa receptors have been demonstrated to be critical for the formation of 
network oscillations crucial to behaviour (Nusser et al., 2001; Gaiarsa et al., 2002). 
The function of GABAa receptors is critical to the development and maintenance of 
normal neuronal network activity. As a result it is of great importance to understand 
how GABAa receptor function is regulated within the cell. The cellular signalling 
mechanism of phosphorylation has been shown to modulate the function of many 
ligand-gated ion channels including the GABAa receptor. There is a substantial 
amount of evidence that phosphorylation can modulate GABAa receptor function in 
physiologically relevant ways, however, there is not yet a full understanding of the 
mechanisms and the significance of this form of cellular signalling and modification.
1.2 Phosphorylation of the GABAa receptor: recombinant 
systems.
The process of phosphorylation involves the covalent modification of 
receptor structure through the transfer of a highly charged phosphate group from 
adenosine triphosphate (ATP) to a serine, threonine or tyrosine residue within a 
substrate. This covalent modification is catalyzed by a series of enzymes known as 
protein kinases. The subsequent cleavage of the phosphate group from a substrate 
(dephosphorylation) is catalysed by protein phosphatases (Moss and Smart, 1996). 
The phosphorylation state of a given substrate is often bi-directionally regulated and 
the functional consequences are determined by a balance between kinase and 
phosphatase activities. The most common class of protein kinases are the 
serine/threonine second messenger dependent kinases such as cAMP-dependent 
protein kinase A (PKA) and protein kinase C (PKC). The second major class of
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kinases are those that specifically phosphorylate tyrosine residues (Moss and Smart, 
1996; Smart, 1997).
1.2.1 Phosphorylation in vitro.
Protein kinases catalyse phosphorylation acting at specific sites that can be 
recognised by the sequence surrounding the site of phosphorylation, which is often 
specific to a particular kinase. Consensus sites for a number of different kinases 
have been identified on GABAa receptor subunits, most commonly on the TM3-4 
intracellular loop. However, consensus sites do not act as a guarantee that 
phosphorylation will actually occur in a living cell. Phosphorylation can occur at 
sites that do not conform to consensus sequences. As a result consensus sites can 
only be used as a rough guide for the potential targets and sites of phosphorylation 
(Moss and Smart, 1996; Sedelnikova and Weiss, 2002).
Consensus sites for a number of Ser/Thr kinases, such as PKA / PKC / 
cGMP-dependent protein kinase (PKG) and calcium/calmodulin dependent protein 
kinase II (CaMK-II) have been identified on the large intracellular loop between TM 
3 and 4 in a range of GABAa receptor subunits (Moss and Smart, 1996). These sites, 
to date, have all been identified on the /3 and y subunits. The intracellular domains of 
GABAa receptor subunits have been expressed as glutathione-S-transferase (GST) 
fusion proteins in E-coli which have been used to identify the individual sites of 
phosphorylation in vitro (See Table 1.1). The /31 fusion protein can be 
phosphorylated by PKC/PKG/PKA/CaMK-II at Ser409 (Moss et al., 1992a; 
McDonald and Moss, 1994). The /32 fusion protein can be phosphorylated at the 
corresponding site, Ser410, by the same kinases (Moss et al., 1992a; McDonald and 
Moss, 1997) and the /33 fusion protein can be phosphorylated at Ser408 and Ser409 by
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PKA/PKC/PKG/CaMK-II (McDonald and Moss, 1997). CaMK-II can also 
phosphorylate additional sites in the /31 and /33 fusion proteins at Ser384 and Ser383, 
respectively (McDonald and Moss, 1994; McDonald and Moss, 1997). Both splice 
variants of y2 can be phosphorylated by CaMK-II at Ser348 and Thr350, and PKC can 
phosphorylate y2S/L at Ser327 (Moss et al., 1992a; McDonald and Moss, 1994). The 
y2L subunit can also be phosphorylated by PKC and CaMK-II at Ser343 within the 8
amino acid insertion (Machu et al., 1993; McDonald and Moss, 1994).
T a b le  1.1:
Subunit Residue Kinase Reference
P1 Ser384
Ser409
CaMK-II
PKA/PKC/PKG/CaMK-ll
McDonald and Moss 
(1994)
Moss eta l. ,  (1992)
P2 Ser410 PKA/PKG/PKC/CaMK-ll Moss e ta l. ,  (1992)
(33 Ser383
Ser408
Ser409
CaMK-II
PKC
PKA/PKG/PKC/CaMK-ll
McDonald and Moss 
(1997)
y2S Ser327
Ser348
Thr350
PKC
CaMK-II
CaMK-II
McDonald and Moss 
(1994)
y2L Ser327
Ser343
Ser348
Thr350
PKC
PKC/CaMK-ll
CaMK-II
CaMK-II
McDonald and Moss 
(1994)
Moss e ta l. ,  (1992) 
Machu e t  al., (1993)
l/C Loop TM3-4
Table 1.1: A summary of the main sites of phosphorylation identified on the 
TM3-4 loop of the 3  and y  subunits of the GABAa receptor.
Each of these potential sites of phosphorylation was identified by expression of 
GST-fusion proteins of the TM3-4 intracellular loop for different GABAa receptor 
subunits and co-incubation, in vitro, with various protein kinases. Specific residues 
that were phosphorylated were identified by site-specific mutagenesis.
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1.2.2 Phosphorylation of recombinant GABAa receptors: PKC
The study of phosphorylation in neurones has been hampered by the 
heterogeneity of GABAa receptors between cell types and within the same cell. As a 
result phosphorylation of GABAa receptors has been studied in a number of different 
recombinant systems to attempt to determine the functional consequence of 
phosphorylation of different receptor subunits. Transfection of relevant subunit 
cDNA’s into a recombinant cell line with no endogenous GABAa receptor subunits 
allows the precise subunit combination of the receptor to be controlled within 
reasonable limits. However, even within recombinant systems there is a considerable 
degree of variation in the reported effects of phosphorylation (Song and Messing, 
2005).
Phosphorylation of the recombinant subunit combination al/3272S expressed 
in Xenopus oocytes by PKC has been reported to decrease the amplitude of whole­
cell currents recorded. This modification was abolished by the site-specific mutation 
of the residues Ser410 site on /32 and Ser327 on the i2S  subunit to alanine 
(Kellenberger et al., 1992). Both sites were thought to be required for a full 
functional effect. A similar functional result of PKC activation on a lp l'fiS  
receptors expressed in Xenopus oocytes was also reported that was not mediated by 
phosphorylation of /32 Ser410. In this case it was thought that PKC dependent 
phosphorylation resulted in a decrease in the number of GABAa receptors at the cell 
surface (Chapell et al., 1998). PKC activity has also been reported to block receptor 
recycling of a lf& il  receptors expressed in HEK293 cells back to the cell surface 
thereby reducing receptor number at the cell surface (Connolly et al., 1999).
PKC dependent phosphorylation of cd/31T2S expressed in HEK293 cells and 
in Xenopus oocytes results in a decrease of the amplitude of whole-cell currents
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recorded that was found to be dependent on phosphorylation of Ser409 in the 01 
subunit, Ser327 in the t2S subunit and Ser343 in ^2L (Leidenheimer et al., 1992; 
Krishek et al., 1994). However, phosphorylation of similar residues in the 01 and 
*y2L subunits has also been shown to mediate a PKC dependent enhancement of the 
amplitude of whole-cell currents recorded from L929 fibroblasts transfected with 
a ljS l^ L  receptors (Lin et al., 1994; Lin et al., 1996).
The discrepancies between these different effects may be in part due to the 
mechanism of activation of PKC. It is difficult to rule out the possibility that 
activation through different mechanisms may activate different signalling pathways. 
It is always possible that another downstream kinase or signalling pathway is 
involved in, or masks an apparent effect of, phosphorylation. In addition, the cell 
type may alter the response to phosphorylation as different cell lines may contain 
different endogenous phosphatases and kinases that may alter the basal 
phosphorylation state o f the receptor.
Many kinases have multiple substrates within a cell and play a role in many 
different cellular processes. There is increasing evidence that the localisation of a 
kinase, possibly through specific kinase anchoring proteins, has a profound effect on 
the functional effects of phosphorylation (Pawson and Scott, 1997). Some 
differences in the response to phosphorylation between cell lines may therefore 
reflect differences in the anchoring proteins present. The receptor for activated C 
kinase-1 (RACK-1) has been shown to facilitate phosphorylation and functional 
modulation of GABAa receptors in HEK293 cells. In this case PKC dependent 
phosphorylation of 01 Ser409 resulted in a depression of whole-cell currents. 
Blocking the binding of RACK-1 to the 01 subunit (with a dominant negative 
peptide) abolished this PKC dependent effect (Brandon et al., 2002b).
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1.2.3 Phosphorylation of recombinant GABAa receptors: PKA
One further factor that is important concerns the receptor subunit 
composition. PKA dependent phosphorylation of recombinant receptors has been 
demonstrated to be dependent on the /3 subunit present. Within HEK293 cells, PKA 
increased the amplitude of whole-cell currents recorded from a\(33'fi.S receptors 
through phosphorylation of Ser408,409. PKA dependent phosphorylation of /31 at 
Ser409 resulted in a depression of whole-cell currents recorded from HEK293 cells 
expressing cd/31'y2S (Moss et al., 1992b). The mutation of Ser408 on the /33 subunit 
converted the observed enhancement into a depression similar to that seen for /31 as 
well as reproducing the phosphorylation profile of the /31 subunit. The /32 subunit- 
containing receptors were not functionally modulated at all by PKA in this study 
(McDonald et al., 1998). Chronic activation of PKA in Cod 2 fibroblast cells (L929 
cell line over-expressing the active catalytic subunit of PKA) led to an enhancement 
of crij3l72S, receptors, in contrast to the depression observed after acute activation of 
PKA (McDonald et al., 1998). This enhancement was also dependent on Ser409 but 
in this case was also dependent on the presence of the t2S subunit (Angelotti et al., 
1993b). This implied that acute transient activation of a protein kinase may have a 
different functional effect to that of chronic activation. In addition over-expression 
of this catalytically active form of PKA (cAMP-independent) in this cell line could 
be expected to produce levels of PKA activity that far exceeded the levels reached 
using other protocols.
The effects of PKA dependent phosphorylation on desensitisation have also 
been studied in a recombinant system through rapid application of GABA to 
HEK293 cells expressing alpl'fi.L  and The residues Ser408 in /31 and
Ser409 in /33 were again identified as critical for PKA dependent modulation. In this
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case PKA phosphorylation of both /31 and /33 resulted in alterations in desensitisation 
and deactivation that prolonged the duration of inhibitory postsynaptic current 
(EPSC)-like currents (Hinkle and Macdonald, 2003) suggesting that phosphorylation 
may be capable of modulating IPSC duration in neurones. The relatively less well 
studied protein kinase B (PKB/Akt), has also been demonstrated to phosphorylate the 
/52 residue Ser410 in HEK293 cells. This appeared to increase the number of GABAa 
receptors at the cell surface (Wang et al., 2003b).
1.2.4 Phosphorylation of recombinant GABAa receptors: tyrosine kinases.
In addition to Ser/Thr kinases, tyrosine kinases are capable of 
phosphorylating and modulating the function of ligand-gated ion channels (Boxall 
and Lancaster, 1998). Tyrosine kinase phosphorylation of both /? and y  subunits of 
GABAa receptors has been reported (Moss et al., 1995; Valenzuela et al., 1995; Wan 
et al., 1997). Tyrosine phosphorylation of (3 subunits has been reported to increase 
the amplitude of whole-cell currents in HEK293 cells (Wan et al., 1997). However, 
Moss et a l (1995) originally reported that the (3 subunit phosphorylation was 
functionally silent and that phosphorylation of Tyr365:367 on the t2L subunit alone 
was responsible for the increase in whole-cell currents. Valenzuela and colleagues 
(1995) determined that /32 and *y2 GABAa receptor subunits purified from bovine 
brain could be phosphorylated by Src as well as the intracellular loop of /31 and *y2L 
in vitro. They also observed in Xenopus oocytes expressing al/31 and CL\(3\*fiL 
receptors an inhibition of GABA currents on bath application of genistein suggesting 
in this case (31 phosphorylation had a functional effect (Valenzuela et al., 1995). 
However, genistein can have a direct effect on GABAa receptor function (Dunne et 
al., 1998). Tyrosine phosphorylation may maintain GABAa receptor activity and a
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loss of basal tyrosine kinase activity may be responsible for the phenomenon of “run­
down” (Huang and Dillon, 1998).
The a  subunit of the GABAa receptor is not thought to be a good substrate for 
phosphorylation. There is a lack of suitable consensus sites within the TM3-4 
intracellular loop and the a l  GST-fiision protein cannot be phosphorylated in vitro 
(Moss et al., 1992a; Moss and Smart, 1996). However, CaMK-II dependent 
phosphorylation of the a l  subunit has been reported using synaptosomal membrane 
fractions (Chum et al., 2002). In addition, phosphorylation of the a l  TM3-4 
intracellular loop, that supports GABAa receptor activity and prevents receptor run­
down during electrophysiological recording, has been observed in acutely dissociated 
rat neocortical neurones (Laschet et al., 2004).
1.3 Phosphorylation of the GABAa receptor: neuronal systems.
There is a wide range of evidence that phosphorylation of the GABAa receptor 
can modulate function in a neurone in a physiologically significant way. However, 
there has been a wide range of different functional effects reported. Part of this 
variation in response to phosphorylation between different cell-types and culture 
conditions may reflect differences in the GABAa receptor subunits that are 
expressed. However, even taking this into account there are still discrepancies 
between reported effects of phosphorylation in recombinant systems and neurones.
1.3.1 PKC dependent effects in neuronal preparations.
The effects of PKA and PKC dependent phosphorylation have been the most 
widely studied. Activation of PKC in cultured sympathetic neurones results in a 
decrease in whole-cell currents recorded, similar to that seen in HEK293 cells
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expressing a lfil 'fl  receptors (Krishek et al., 1994). PKC activity has been reported 
to have different effects in different cell types. In CA1 pyramidal neurones, PKC 
was without effect (Poisbeau et al., 1999); however in dentate gyrus granule cells, 
PKC increased the peak amplitude of spontaneous (s)IPSCs (Poisbeau et al., 1999). 
Dentate gyrus cells express pre-dominantly /53 subunits (Miralles et al., 1999; Pirker 
et al., 2000) and the increase in amplitude is consistent with /53 subunit mediated 
increases in GABAa receptor function observed in other neuronal cell types 
(Jovanovic et al., 2004). However, in cortical neurones, constitutive phosphorylation 
of j83 Ser408,409 by PKC has been reported to decrease the amplitude of whole-cell 
currents (Brandon et al., 2000).
The anchoring protein RACK-1 has been shown to form complexes with 
PKC and GABAa receptors in the adult rat brain. In rat superior cervical ganglion 
neurones activation of PKC led to a decrease in the amplitude of GABA-mediated 
currents. Inclusion of a peptide that competes with RACK-1 for binding to the /31 
subunit reduced the effect of PKC on these GABAa receptors (Brandon et al., 
2002b). The absence or presence of RACK-1 or other similar proteins within a cell- 
type could significantly alter the apparent effect of phosphorylation and may explain 
some of the differences reported for PKC modulation within cells that express 
similar GABAa receptor subtypes.
Brain-Derived Neurotrophic factor (BDNF) can modulate GABAa receptor 
mediated mIPSCs through the activation of PKC, followed by protein phosphatase 
(PP2A) mediated dephosphorylation of the receptor. There was differential 
recruitment of PKC, RACK-1 and PP2A according to the phosphorylation state of 
the (33 subunit. Phosphorylation of (33 at Ser408 409 was associated with an increase in
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miniature (m)IPSC amplitude, with no change in the decay time (Jovanovic et al., 
2004).
Recombinant studies highlighted potential phosphorylation sites on the ~{l 
subunit for PKC at Ser327 and Ser343 within the eight amino acid insert that forms the 
*y2L splice variant. Within neurones the role of PKC phosphorylation of Ser327 is 
unknown. However, phosphorylation o f Ser343 has been reported in neurones to 
facilitate the trafficking of t2S to the synapse (Meier and Grantyn, 2004). Activation 
of PKC has also been reported to increase receptor internalisation in cultured cortical 
neurones and promotes receptor endocytosis in HEK293 cells. This appears to occur 
via a dynamin endocytic pathway that is dependent on a dileucine motif in the /32 
subunit and also requires the presence of the ^2 subunit (Herring et al., 2005).
1.3.2 PKA dependent effects in neuronal preparations.
Modulation of GABAa receptors by PKA in neurones has also revealed 
different functional effects in different cell-types (Porter et al., 1990; Kano and 
Konnerth, 1992; Moss et al., 1992b; Kapur and Macdonald, 1996). Again, some of 
this may be related to differential effects on different subunits. There is however, 
some discrepancy between reported effects in a recombinant system and that seen in 
neurones.
Inclusion of the catalytic domain of PKA in the patch pipette was reported to 
reduce the amplitude of whole-cell currents recorded from mouse spinal neurones. 
This reduction was reported to be mediated by a reduction in channel opening 
frequency (Porter et al., 1990). It has also been reported that in CA1 hippocampal 
pyramidal cells PKA reduced the amplitudes of IPSCs and altered the fraction of 
events with a double exponential decay. However, in hippocampal dentate gyrus .
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granule cells PKA was without effect (Poisbeau et al., 1999). In granule cells of the 
olfactory bulb which express predominantly the (33 subunit, constitutively-active 
PKA resulted in an increase in BPSC amplitudes with no change in decay (Nusser et 
al., 1999). An increase in amplitude would correlate with the up-regulation of 
function seen in HEK293 cells expressing (33 subunit-containing receptors 
(McDonald et al., 1998). The lack of a reported effect of PKA on dentate gyrus cells 
is surprising given this cell-type also expresses predominantly /33 subunit-containing 
receptors (Miralles et al., 1999; Pirker et al., 2000). However a PKA dependent 
increase in whole-cell currents recorded from hippocampal dentate granule cells has 
been reported by another group (Kapur and Macdonald, 1996). Therefore, even 
within the same cell type, variations in response to phosphorylation occurs possibly 
as a result of differences in tissue preparation or experimental method of kinase 
activation. Addition of PKA to cerebellar stellate and basket cells that express 
predominantly /?2 subunit-containing receptors prolonged the time-course of IPSCs 
without changing the peak amplitude (Nusser et al., 1999). This is in contrast to the 
lack of any functional modulation observed on /52 subunit-containing receptors in 
HEK293 cells (McDonald et al., 1998).
Phosphorylation of (33 Ser408,409 by PKA can be counteracted by protein 
phosphatase 1 (PP1). This interaction can also be regulated by additional binding 
proteins. For instance, phospholipase C (PLC)-related inactive protein type 1 (PRIP- 
1) binds and inactivates protein phosphatase (PP)1 allowing PKA phosphorylation to 
occur (Terunuma et al., 2004). The A-kinase anchoring protein (AKAP) 79/150 has 
been identified which allows PKA to be selectively targeted to /51/3 subunit- 
containing receptors. This protein binds to /31 and /33 only and is critical for PKA 
mediated phosphorylation (Brandon et al., 2003). PKA dependent effects on
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GABAa receptors in neurones have been observed in cell-types thought to express 
predominantly /32 subunit-containing receptors (Kano and Konnerth, 1992; Nusser et 
al., 1999). It may be that other, as yet unidentified, kinase anchoring proteins exist 
that are able to allow PKA dependent phosphorylation of the /32 subunit. Or 
alternatively, the activation of PKA or PKC in neurones might activate secondary 
pathways downstream or in parallel which influence GABAa receptor function. 
PKA or PKC might be able to phosphorylate proteins associated with the GABAa 
receptor which may have different effects to direct phosphorylation of the receptor 
itself. The considerable variation in response to activation of these kinases in 
neuronal systems implies that phosphorylation dependent modulation of GABAa 
receptors is complex and may well involve multiple kinase anchoring proteins and/or 
different mechanisms of phosphorylation mediated effects.
1.3.3 PKB and Src.
In addition to PKA and PKC the Ser/Thr kinase PKB has also been 
demonstrated to phosphorylate the GABAa receptor in neurones at Ser410 in the /32 
subunit. PKB activity leads to an increase in the number of functional GABAa 
receptors at the cell surface, increasing IPSC amplitudes with no change in decay 
times. The tyrosine kinase Src has also been demonstrated to alter GABAa receptor 
function in neurones. Src mediated phosphorylation of Tyr365 367 on iZL  leads to an 
increase in the whole-cell GABA current amplitude recorded from superior cervical 
ganglion neurones in culture. Single channel recordings revealed an increase in 
mean open time and probability of opening of the channel after activation of Src 
(Moss et al., 1995). Src is capable of interacting with /? and *y2 subunits. The
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residues Xyr365,367 on 72  have also been shown to be phosphorylated in the adult rat 
brain (Brandon et al., 2001).
1.3.4 Mechanisms of phosphorylation dependent changes in receptor function.
The process of phosphorylation appears to be more complex than a simple 
covalent modification of receptor structure. There are a number of potential 
mechanisms for phosphorylation-dependent effects. The simplest mechanism is 
direct phosphorylation of the receptor followed by a structural change which alters 
the ion channel properties. For instance tyrosine kinase dependent changes in mean 
open time and probability of opening (Moss et al., 1995). These types of changes 
could also alter the amplitude or decay phase of whole-cell currents or IPSCs. One 
particular mechanism that has been identified is phosphorylation-dependent 
modulation of desensitisation (Jones and Westbrook, 1996). This could alter the 
apparent decay times of IPSCs, a phenomenon that has been observed in response to 
phosphorylation. Phosphorylation dependent changes in desensitisation of the 
GABAa receptor have been demonstrated in response to application of the protein 
phosphatase calcineurin (Jones and Westbrook, 1997).
Another potential mechanism of phosphorylation-dependent changes is 
through modulation of receptor trafficking which could occur through direct 
phosphorylation o f the receptor or indirectly through phosphorylation of other 
proteins involved in the correct targeting and insertion of receptors at the synapse. 
For instance, PKC can alter the trafficking of GABAa receptors by blocking receptor 
recycling to the cell surface thereby reducing the number of functional receptors at 
the plasma membrane (Connolly et al., 1999). It has also been proposed that PKC 
activity can induce receptor internalisation through a dynamin-dependent endocytic
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pathway (Herring et al., 2005). In addition, PKC phosphorylation of Ser343 has been 
linked to the correct targeting of *y2L subunits to the synapse (Meier and Grantyn, 
2004).
Phosphorylation dependent changes to receptor trafficking may also allow the 
insertion of new receptors in order to potentiate inhibitory synapses. There is 
evidence that PKB phosphorylation may function in this way (Wang et al., 2003b). 
The modulation of excitatory AMPA receptors by phosphorylation has been shown 
to occur by both mechanisms (Lisman et al., 2002). Phosphorylation can directly 
change the properties of the AMPA channel (Barria et al., 1997; Benke et al., 1998); 
however, synaptic plasticity driven by phosphorylation can result in the insertion of 
new AMPA receptors at the synapse (Hayashi et al., 2000; Malinow and Malenka, 
2002; Bredt and Nicoll, 2003; Ju et al., 2004).
1.3.5 Perturbation of normal phosphorylation pathways in disease states.
The abnormal function of protein kinases or perturbation of specific 
signalling pathways can be linked to particular disease states. Mice lacking the y 
isoform of PKC have been shown to exhibit decreased anxiety (Bowers et al., 2000). 
The mutant tottering (tg) mouse, displays seizures similar to human petit-mal 
epilepsy. It has been reported that there is an abnormal elevation of PKA activity in 
these mice and a reduction in GABAa receptor function, indicating that this may 
contribute to the induction of seizures (Tehrani and Barnes, 1995). Cell membranes 
isolated from patients with drug-resistant temporal lobe epilepsy were injected into 
Xenopus oocytes and the response of GABAa receptors to BDNF was determined. 
BDNF potentiated the epileptic GABAa receptors probably through activation of 
tyrosine kinase receptor B and both PLC and PKC. Recombinant cd/32y2 receptors
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and GABAa receptors transplanted from a non-epileptic brain were unaffected by 
BDNF (Palma et al., 2005). The onset of epilepsy appears to induce changes in the 
GABAa receptor in terms of its response to signalling pathways and 
phosphorylation.
1.4 Calcium/calmodulin-dependent protein kinase II: structure 
and function.
Calcium/calmodulin dependent protein kinase II is a serine/threonine 2nd 
messenger dependent protein kinase that responds to increases in intracellular Ca2+ 
concentration (Fink and Meyer, 2002; Hudmon and Schulman, 2002; Soderling et 
al., 2002). It is a multifunctional protein that phosphorylates a large number of 
different substrates and is involved in many different cellular processes (Schulman, 
2004; Colbran, 2004b). There are four main families of CaMK-II subunits (a, /?, y, 5) 
and around 28 different isoforms. The a  and /3 subunits are most prominent in the 
brain(obere they are highly expressed (Hudmon and Schulman, 2002). CaMK-II is 
known to phosphorylate a number of proteins involved in synaptic transmission and 
is thought to play a key role in synaptic plasticity (Lisman et al., 2002; Colbran and 
Brown, 2004).
1.4.1 CaMK-II structure and function: autophosphorylation at Thr286.
CaMK-II has a unique complex structure containing self-regulatory 
properties. Each subunit consists of an N-terminal catalytic domain, a central 
regulatory domain (containing within it an auto-inhibitory domain), a Ca2+/CaM 
binding motif and a C-terminal association domain (Shen and Meyer, 1998; Hudmon 
and Schulman, 2002; Lisman et al., 2002). Subunits can associate together in groups
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of 10-12 to form a holoenzyme arranged as two stacked rings (See Fig 1.3, 1.4) with 
the association domains in the centre and the catalytic domains facing outwards 
(Kolodziej et al., 2000; Hoelz et al., 2003).
In the absence of Ca2+/CaM, CaMK-II remains relatively inactive. The auto- 
inhibitory domain (AID) acts as a pseudo-substrate which binds with the catalytic 
region of the same subunit acting as a gate that inhibits enzyme activity (Mukheiji et 
al., 1994; Mukheiji and Soderling, 1994). The AID makes multiple interactions with 
the catalytic domain. Part of the AID occupies the substrate binding site or the S-site 
of the kinase whereas a more N-terminal portion of the AID makes an additional 
interaction on the C-terminal lobe of the catalytic domain (T-site). The interaction at 
the T-site is thought to induce conformational changes that interfere with ATP 
binding to the kinase. In this way the kinase remains inactive in the absence of 
Ca2+/CaM (Hudmon and Schulman, 2002; Lisman et al., 2002; Colbran, 2004b). 
The Ca2+/CaM binding motif overlaps the AID, so Ca2+/CaM binding is thought to 
disrupt the interaction between the AID and the catalytic domain allowing the kinase 
to become active (See Fig 1.4).
After binding of Ca2+/CaM and subsequent activation of the kinase, 
autophosphorylation can occur at Thr286 (of-subunit, Thr287 - /3-subunit) within the 
AID. This occurs between adjacent subunits that have bound Ca2+/CaM (Hanson et
I
al., 1994). Autophosphorylation causes the dissociation rate for Ca /CaM to fall 
significantly so that it is effectively bound to the kinase. Even after Ca /CaM
s y i
dissociates the kinase retains partial Ca /CaM independent activity (Colbran et al., 
1988; Fong et al., 1989), until it is dephosphorylated by a protein phosphatase 
(Hashimoto et al., 1987). Autophosphorylation at Thr286 allows CaMK-II to remain 
persistently active after the initial stimulus and Ca2+ signal has dissipated. Thus, a
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transient rise in Ca2+ can stimulate long-term kinase activation (See Fig 1.3 and 1.4). 
It also allows CaMK-II to respond to the frequency of Ca2+ oscillations (Hanson et 
al., 1994; De Koninck and Schulman, 1998). The extent of CaMK-H activity is also 
dependent on the rate at which subunits are de-phosphorylated. Evidence suggests 
that in the PSD this dephosphorylation is primarily mediated by PP1 (Hudmon and 
Schulman, 2002; Lisman et al., 2002).
Fig 1.3:
Ca2+ independent Protein Phosphatase 
(60% Activity) Inactive
t o  ^Calmodulin I
Autophosphorylation .
O
Activated .___ Activated
Catalytic Domain
rf Association Domain
T286
Autolnhibitory Domain 
Fig 1.3: A schematic representation of the cycle of activation and deactivation 
of CaMK-II.
The binding of Ca2+/CaM activates CaMK-II and enables it to phosphorylate 
substrates. It also allows autophosphorylation to occur at Thr286 between adjacent
 ^i
subunits that have bound Ca /CaM.
■*> j ^  i
Autophosphorylation reduces the rate of Ca /CaM dissociation, trapping Ca /CaM 
to the kinase. When Ca2+/CaM eventually dissociates the kinase retains some 
Ca2+/CaM independent activity until Thr286 is dephosphorylated by a protein 
phosphatase and the kinase becomes inactive again.
CaMK-II forms holoenzymes of 10-12 subunits. Each subunit consists of three 
functional domains, a catalytic domain, an autoinhibitory domain and an association 
domain. Thr286 autophosphorylation and Ca2+/CaM binding occurs within the 
autoinhibitory domain.
Adapted from Molecular Biology of the Cell (1994), Garland Publishing.
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Fig 1.4: 
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CaMK-II activated  
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/ T Site Active S Site\
CaMK-II persistently  activated by 
the NMDA receptor.
CaMK-II persistently activated by 
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NR2B
Active S Site
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T S ite
Fig 1.4: Proposed 3D structure of CaM K-II and schematic representation of 
the interaction between the catalytic and autoinhibitory domains.
(A) Three-dimensional structure of CaMK-II holoenzyme, showing a hexameric ring 
from a plan-view perspective.
(B) The autoinhibitory domain acts as a gate to regulate catalytic activity. The 
enzyme is inhibited when the autoinhibitory domain binds at the S and T sites. The
94 -binding of Ca /CaM disrupts the association and the enzyme becomes active. A 
site on the NR2B subunit of the NMDA receptor can bind the T site, disrupting the 
association of the autoinhibitory domain and keeping the enzyme active in the 
absence of Ca2+/CaM. Autophosphorylation at Thr286 is also sufficient to disrupt the 
association between the catalytic domain and the autoinhibitory domain and to allow 
CaMK-II to be active after the dissociation of Ca2+/CaM.
Adapted from Lisman et a l (2002) and Kolodziej et al (2000).
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1.4.2 CaMK-II structure and function: autophosphorylation at Thr30576.
CaMK-II can also undergo autophosphorylation at other sites. This can occur
as a slow intra-subunit autophosphorylation that occurs when CaMK-II is in its basal 
state leading to phosphorylation of Thr305/6. This has the effect of blocking 
subsequent Ca2+/CaM binding and so locks the kinase in an inactive state. Following 
autophosphorylation at Thr286 removal of Ca2+/CaM can induce a burst of inhibitory 
autophosphorylation at Thr305 and/or Thr306, either of which is sufficient to block 
further Ca2+/CaM binding. In this case the kinase retains partial activity due to prior 
phsophorylation at Thr286 (Hanson and Schulman, 1992; Colbran, 2004b).
Phosphorylation of these sites is strongly opposed by phosphatase activity 
and it has been difficult to observe their phosphorylation in vivo. However, 
formation of knock-out mice has revealed that these sites may be important in 
regulating sub-cellular localisation of CaMK-II as well as regulating CaMK-II 
activity. Phosphorylation of these sites is elevated in a mouse model of the 
neurodevelopmental disorder Angelman syndrome (Elgersma et al., 2002; Weeber et 
al., 2003).
1.4.3 Regulation of CaMK-II by protein phosphatases.
It is important to consider how the activity of protein phosphatases regulates 
CaMK-II activity in the brain (Colbran, 2004a). It has been known for a number of 
years that PP1, PP2A and PP2C can dephosphorylate Thr286 and that in some cell 
types autophosphorylation of CaMK-II is strongly opposed by phosphatase activity 
(Fukunaga et al., 1989; Molloy and Kennedy, 1991; Fukunaga et al., 1993). It is 
thought that PP1 acts to dephosphorylate Thr286 at the PSD, whereas PP2A might 
dephosphorylate CaMK-II in the cytosol (Strack et al., 1997). Therefore the
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localisation of the kinase may alter which phosphatase is the more physiologically 
relevant for dephosphorylation (Strack et al., 1997; Colbran, 2004a). The presence 
of phosphatases may alter CaMK-II function, as the presence of PP1 results in an 
ultra-sensitive kinase activation within a tighter range of Ca concentrations than 
that observed for the kinase alone (Bradshaw et al., 2003). The opposing actions of 
CaMK-II and PP1 have been suggested to be such that the CaMK-II/PPl system 
could function as an energy efficient bi-stable switch (Lisman and Zhabotinsky, 
2001). Phosphatase activity against CaMK-II has also been shown to be 
physiologically and pathologically relevant in that PP1 activity modulates LTP 
induction (Brown et al., 2000) and decreased PP1/PP2A activity has been shown to 
be involved in the alterations in CaMK-II inhibitory autophosphorylation associated 
with the mouse model of Angelman syndrome (Weeber et al., 2003; Elgersma et al., 
2004).
The binding of Ca2+ to CaM and recruitment of the Ca2+/CaM complex to a 
CaMK-II enzyme is not simply a diffusion of Ca2+ and CaM in solution but is a
24-regulated process in itself involving multiple cellular protems and processes. Ca 
influx to a cell can occur via voltage-gated Ca channels or ligand-gated channels 
(e.g., NMDA receptors). Within the cell release of Ca2+ in stores can also provide a 
stimulus to activate CaMK-II. There are a large number of proteins present in 
neurones that can bind CaM. Increases in Ca2+ cause the release of this stored CaM 
and phosphorylation of some CaM binding proteins can cause CaM to dissociate, 
allowing it to participate in other signalling events (Gnegy, 2000; Meldolesi, 2001; 
Xia and Storm, 2005). As well as activating CaMK-II, CaM is involved in several 
other cellular signalling cascades and can have direct effects on ligand-gated ion 
channel function. For example, CaM has been shown to bind to the NR1 subunit of
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the NMDA receptor and cause a four-fold reduction in channel open probability 
(Ehlers et al., 1996; Zhang et al., 1998; Rycroft and Gibb, 2002). It can also activate 
the phosphatase calcineurin (PP2B). PP2B is not thought to directly dephosphorylate 
Thr286 like PP1/PP2A but could act indirectly through dephosphorylation of DARPP- 
32 which inhibits PP1 activity. Therefore PP2B activity against DARPP-32 might 
indirectly increase PP1 activity against CaMK-II (Kawaguchi and Hirano, 2002; 
Svenningsson et al., 2004; Colbran, 2004a). In addition, activation of 
PP2B/calcineurin is thought to be involved in some forms of LTD at both excitatory 
and inhibitory synapses (Winder and Sweatt, 2001; Wang et al., 2003a).
1.5 CaMK-II localisation and role in synaptic plasticity.
CaMK-II is an abundant enzyme in the nervous system with multiple 
substrates that responds to changes in intracellular Ca2+ (Bayer and Schulman, 2001; 
Hudmon and Schulman, 2002; Griffith et al., 2003; Colbran, 2004b). Calcium itself 
is a ubiquitous signalling molecule which plays a role in multiple cellular processes. 
Ca2+ signalling is tightly controlled both temporally and spatially (Berridge et al., 
1998). Increases in Ca2+ usually occur within discrete microdomains, small local 
regions of Ca2+ influx and localisation of Ca2+-sensitive effector proteins to these 
regions of Ca2+ influx is often crucial for the proper function of Ca2+-dependent 
signalling pathways (Franks and Sejnowski, 2002; Augustine et al., 2003). The 
localisation of CaMK-II to sites of action and an ability to translocate on stimulation 
to specific sites of action is thought to be crucial for the proper function of the kinase 
(Bayer and Schulman, 2001; Griffith et al., 2003; Schulman, 2004; Colbran, 2004b).
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1.5.1 The role of a  and 0 subunits of CaMK-II.
Examination of different forms of CaMK-II has revealed the importance of 
the different subunits of CaMK-II. The a  and /3 isoforms can exist as homomers or 
can form heteromers with varying amounts of a : ft subunits. Within the cerebellum 
there is a high ratio of /3-CaMK-II to Of-CaMK-II but within the forebrain Of-CaMK-II 
is dominant (Miller and Kennedy, 1985). The physical properties of these two 
isoforms of CaMK-II are identical in that homomers of a  or 0 subunits possess the 
same substrate specificity. However, /3-CaMK-II appears to be more sensitive to 
Ca2+ and becomes autophosphorylated at Thr287 at much lower Ca2+/CaM levels 
(Miller and Kennedy, 1985). Half-maximal autophosphorylation of the a  subunit 
occurs at 130 nM CaM whereas the same level of autophosphorylation of /3 subunits 
occurs at 15 nM CaM (Brocke et al., 1999).
The /? subunit is expressed earlier in development, within the embryo, 
whereas the a  subunit is only expressed postnatally and the ratio of a  to increases 
throughout synaptogenesis (Burgin et al., 1990; Vallano, 1990; Griffith et al., 2003). 
The localisation o f a  and 13 subunits also appears to differ and it is thought that the 
proportion of a  to /3 subunits within a heteromer may determine kinase localisation. 
The a  subunit is often found to be cytosolic whereas the /3 subunit is thought to be 
more closely localised to the cytoskeleton. The /? subunit can bind F-actin whereas 
the Of subunit does not and the presence of a small number of 13 subunits is enough to 
localise CaMK-II to the cytoskeleton (Shen et al., 1998; Bayer and Schulman, 2001; 
Fink et al., 2003; Griffith et al., 2003). The mRNA for Of-CaMK-II but not /3-CaMK- 
II can be found at dendrites and an increase in mRNA and de novo synthesis of this 
subunit has been reported in response to synaptic plasticity (Ouyang et al., 1997; 
Ouyang et al., 1999).
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The proportion of a  to /3 subunits is known to change in response to 
stimulation. The a-subunit increases in expression during increased activity and the 
/3-subunit increases in expression during decreased activity. Over-expression of a- 
CaMK-II or /3-CaMK-II can have opposite effects on synaptic strength. Over­
expression of o«-CaMK-II leads to an increase in miniature excitatory postsynaptic 
current (mEPSC) amplitudes and a lengthening of decay times and over-expression 
of the /3-subunit has no effect on amplitude whilst decay time is reduced. Overall, 
increased expression of a-CaMK-II increased charge transfer of mEPSCs whilst 
over-expression of /3-CaMK-II decreased charge transfer (Thiagarajan et al., 2002). 
Despite similar substrate specificity (Miller and Kennedy, 1985), a  and /3 isoforms in 
heteromers may alter cellular localisation and translocation rates (Griffith et al., 
2003; Colbran, 2004b) and so differences in the relative access to specific substrates 
may mediate this differential effect on EPSC synaptic strength. Therefore the ratio 
of a  to subunits within a cell can play an important role in synaptic transmission 
and plasticity. In addition, the /3 subunit appears to be involved in morphological and 
structural changes associated with synaptogenesis in line with its close association 
with the cytoskeleton, whereas the a  subunit has no morphogenic activity (Fink et 
a l , 2003).
1.5.2 Translocation of CaMK-II to the PSD.
CaMK-II is capable of rapid translocation in response to a stimulus in time 
scales of seconds / minutes (Gleason et al., 2003). Expression of GFP-tagged a- 
CaMK-II and /3-CaMK-II has revealed that these subunits differ in terms of their 
translocation in response to a stimulus. NMDA receptor stimulation can cause 
reversible CaMK-II translocation from an F-actin bound to a postsynaptic density
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(PSD) bound state. The time taken for translocation to occur is controlled by the 
ratio of a : (3 subunits expressed. F-actin dissociation, PSD translocation and 
localisation at the PSD can be controlled by Ca2+/CaM binding and 
autophosphorylation (Shen and Meyer, 1999). Early reports estimated that CaMK-II 
constituted 20-50 % of the total protein isolated in PSDs. Subsequently it has 
become clear that in some cases there can be a post-mortem accumulation of CaMK- 
II at the PSD (Suzuki et al., 1994; Lengyel et al., 2001). In addition, in certain 
pathological conditions such as during ischemic episodes CaMK-II can translocate 
and form clusters of CaMK-II within the cytoplasm (Dosemeci et al., 2000; Tao- 
Cheng et al., 2002).
Association of CaMK-II with the PSD can be dynamically regulated in an 
activity-dependent way (Griffith et al., 2003; Schulman, 2004; Colbran, 2004b). The 
a. subunit of CaMK-II appears to be cytosolic but can co-localise with the PSD in 
puncta within 20 s of glutamate addition (Shen and Meyer, 1999). The /? subunit can 
associate with F-actin under basal conditions, but after stimulation slowly dissociates 
and accumulates at the PSD (Shen and Meyer, 1999). Autophosphorylation at Thr286 
stabilises the association of CaMK-II with the PSD and PP1 activity encourages 
dissociation (Strack et al., 1997; Shen and Meyer, 1999; Shen et al., 2000). 
Autophosphorylation at Thr305 and/or Thr306 also modulates the interaction of 
CaMK-II with the PSD. It appears that phosphorylation of these sites leads to 
CaMK-II dissociation from the PSD (Shen et al., 2000; Elgersma et al., 2002; 
Weeber et al., 2003).
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1.5.3 CaMK-II targeting and/or anchoring proteins.
The importance of kinase anchoring proteins in localising a kinase to its 
substrate and controlling phosphorylation-dependent signalling has been revealed in 
recent years (Pawson and Scott, 1997). As a result there has been a great deal of 
interest in identifying potential CaMK-II anchoring proteins. A number of proteins 
located at the synapse have been found to bind CaMK-II and may play a role in 
localistion of the kinase. In some cases these interactions can alter the function of 
the kinase itself (Bayer and Schulman, 2001; Colbran, 2004b).
The NMDA receptor is capable of binding to CaMK-II (See Fig 1.4). This 
association is thought to localise CaMK-II to the site of Ca2+ entry. In addition, the 
association of CaMK-II with the NR2B subunit may alter the function of the kinase 
itself (See Fig 1.4) acting to disrupt the AID and allow Ca2+-independent activity 
(Strack et al., 2000a; Bayer et al., 2001).
As well as a known association between F-actin and /3-CaMK-II (Shen et al., 
1998) both a  and /3 CaMK-II can interact with a-actinin at a region within the 
catalytic domain (Walikonis et al., 2001; Dhavan et al., 2002). CaMK-II also 
interacts with another synaptic protein, densin-180, which can also interact with ct- 
actinin, suggesting a possible ternary complex at the synapse (Walikonis et al., 
2001). a-actinin can bind a number of receptors and ion channels and so this 
association may act to localise CaMK-II and target its activities to specific sites. 
Densin-180 is capable of directing CaMK-II localisation within HEK293 cells and a- 
CaMK-II and densin-180 can be co-immunoprecipitated from brain extracts (Strack 
et al., 2000b; Walikonis et al., 2001). As densin-180 can interact with other synaptic 
proteins it is also a strong candidate for a protein that can determine CaMK-II 
localisation and therefore function (Colbran, 2004b).
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Another identified CaMK-II binding protein is a membrane associated 
guanylate kinase (MAGUK) found in Drosophila called Camguk. Camguk is similar 
to the mammalian CASK protein which is part of a subfamily of MAGUKs which 
are defined by an N-terminal CaMK-II like domain. In mammalian neurones, CASK 
has been shown to be localised at synapses both pre- and postsynaptically (Hata et 
al., 1996). In Drosophila, Camguk, associates with CaMK-II in the absence of 
Ca2+/CaM and Thr286 autophosphorylation and promotes phosphorylation of Thr30576 
and subsequent inactivation of the kinase. In the presence of Ca2+/CaM, CaMK-II 
associated with camguk can autophosphorylate at Thr286 and became constitutively- 
active. Camguk in the presence of Ca2+/CaM provides a local source of active 
CaMK-II but when synaptic activity is low and levels of Ca2+/CaM are low, Camguk 
promotes autophosphorylation at inhibitory sites that then requires phosphatase 
activity to dephosphorylate these inhibitory phosphorylation sites and allow 
subsequent activation of the kinase (Griffith et al., 2003; Lu et al., 2003). This kind 
of interaction may provide a mechanism for the local control of CaMK-II activity at 
active and inactive synapses.
1.5.4 CaMK-II and synaptic plasticity.
The most well studied role for CaMK-II at the synapse is in the induction of 
long-term potentiation (LTP) of AMPA receptor-mediated synaptic currents. This is 
a process by which a repetitive stimuli at a synapse leads to an increase in the 
strength of AMPA receptor mediated transmission at that synapse for hours after the 
initial stimulus has dissipated (Lisman et al., 2002; Rongo, 2002; Collingridge et al., 
2004). CaMK-II activity is now known to be crucial for this process to occur. For a 
number of years the ability of CaMK-II to maintain activity after a Ca stimulus
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through autophosphorylation at Thr286 led to the hypothesis that CaMK-II was a
“memory molecule” capable of maintaining long-term changes in synaptic function.
0 -1  1
CaMK-II was found to phosphorylate the AMPA receptor directly at Ser on the 
GluRl subunit (Barria et al., 1997; Derkach et al., 1999; Lee et al., 2000). This 
phosphorylation led to an up-regulation of receptor function through a change in the 
properties of the channel, by increasing the single channel conductance (Benke et al., 
1998; Derkach et al., 1999).
Recently it has been demonstrated that CaMK-II dependent changes 
associated with LTP can also occur through another separate mechanism. CaMK-II 
dependent activation of a Ras/Rap GTPase pathway (Zhu et al., 2002) and a 
subsequent insertion of receptors (Lledo et al., 1998) into the synapse is thought to 
up-regulate AMPA receptor function during LTP. This process does not require 
direct phosphorylation of the AMPA receptor (Hayashi et al., 2000). However, 
receptor insertion is thought to be subunit dependent as GluRl/4 subunits are thought 
to be inserted into the membrane during LTP and this process is dependent on the 
GluRl subunit, whereas the maintenance of receptor number through recycling is 
thought to involve GluR2/3 subunits (Shi et al., 2001; Malinow and Malenka, 2002; 
Bredt and Nicoll, 2003; Ju et al., 2004). In this way receptor number is increased 
and then maintained (See Fig 1.5).
1.5.5 CaMK-II, LTP and behaviour.
It is clear that CaMK-II is crucial for certain forms of LTP and that disruption 
of CaMK-II and subsequently LTP prevents proper memory formation and alters 
animal behaviour (Lisman et al., 2002; Elgersma et al., 2004; Ehrlich and Malinow, 
2004). Mice devoid of a-CaMK-II have been generated which revealed the
importance of this subunit for the generation of NMDA receptor-dependent LTP at 
the CA1 pyramidal neurone in the hippocampus. In addition these mice exhibited 
specific spatial learning impairments strengthening the view that LTP forms the 
cellular basis of spatial learning (Silva et al., 1992a; Silva et al., 1992b). In T286A 
O'-CaMK-II mutant mice, in which the a  subunit cannot undergo autophosphorylation 
and therefore display Ca2+-independent activity, CA1-LTP is completely absent 
(Giese et al., 1998). These mice also displayed deficits in spatial learning. This 
illustrated the importance of autophosphorylation for LTP and the subsequent effects 
on physiology and behaviour.
Within mice which contain the a-CaMK-II T305D mutation (mimicking 
inhibitory autophosphorylation), CaMK-II activation and autophosphorylation at 
Thr286 is blocked as is subsequent translocation to the PSD (Hanson and Schulman, 
1992; Elgersma et al., 2002). In this case a stimulus which has no effect in wild-type 
mice can induce LTD. Mice which express a-CaMK-II which cannot be 
phosphorylated at Thr305,306; show a marked LTP in response to the same stimulus 
demonstrating that these sites are important in the regulation of CaMK-II activity and 
can control the threshold for LTP induction (Elgersma et al., 2002). Alteration in 
LTP seems to correlate with cognitive impairment. For instance T305D and T286D 
mice, which lack any LTP at CA1 synapses and show no evidence of /3-CaMK-II 
compensation, have severely impaired spatial learning (Elgersma et al., 2002). A 
reduction in the level of CaMK-II at the PSD, and in CaMK-II activity as well as 
impairment of LTP and deficits in context-dependent learning, have been observed 
within a mouse model of Angelman syndrome (Weeber et al., 2003). The human 
form of this disease is characterised by severe mental retardation and epilepsy. This 
forms a clear link between alterations in the normal function of CaMK-II, changes in
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hippocampal LTP and subsequent alterations in memory learning and behaviour 
(Elgersma et al., 2004).
1.6 CaMK-II and GABAa receptor function.
1.6.1 Ca2+-dependent depression of GABAa receptor function.
There have been a number of studies that have demonstrated Ca dependent 
modulation of GABAa receptor function. Increases in intracellular calcium levels 
have been reported to depress GABA currents in sensory neurones of the bullfrog. In 
this case, Ca2+ influx led to a rapid decrease in the affinity of the GABAa receptor to 
GABA (Inoue et al., 1986). In CA1 hippocampal pyramidal cells Ca2+ entry through 
NMDA receptors was reported to depress the amplitude of whole-cell currents. This 
effect was prevented by the addition of a specific protein phosphatase 2B (PP2B) / 
Calcineurin (CaN) inhibitor (Stelzer and Shi, 1994). Ca2+-dependent phosphatases 
have been reported to depress GABAa receptor currents in a number of different cell- 
types (Akopian et al., 1998; Huang and Dillon, 1998; Mozrzymas and Cherubini, 
1998; Wang et al., 2003a; Sanchez et al., 2005). Calcineurin has also been reported 
to alter desensitisation, acting to alter the decay phase of IPSCs (Martina et al., 1996; 
Jones and Westbrook, 1997; Mozrzymas and Cherubini, 1998; Sanchez et al., 2005) 
as well as playing a pivotal role in the process of long-term depression (LTD) of 
CA1 inhibitory synapses in the hippocampus (Wang et al., 2003a).
1.6.2 Bidirectional plasticity.
At excitatory synapses long-term plasticity is thought to be mediated through 
phosphorylation (Soderling and Derkach, 2000; Lee et al., 2000; Lisman et al., 2002; 
Collingridge et al., 2004). The protein phosphatase, CaN, and the protein kinase,
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CaMK-II, may act in opposition to each other in response to Ca2+ signals that vary in 
magnitude (Yang et al., 1999; Cormier et al., 2001; Winder and Sweatt, 2001; 
Collingridge et al., 2004; Xia and Storm, 2005). It is possible that a similar situation 
exists at inhibitory synapses. Indeed it has been demonstrated that long-term 
plasticity at inhibitory synapses can be bi-directional (potentiation or depression) and 
that this is also mediated by Ca2+ signals of different magnitudes (McLean et al., 
1996; Aizenman et al., 1998).
1.6.3 CaMK-II mediated potentiation of GABAa receptor function.
As well as depression in response to Ca2+ influx there are also a number of 
studies which have identified up-regulation of GABAa receptor function which is 
dependent on Ca2+ (See Table 1.2). For instance, Aguayo et al (1998) demonstrated 
that increases in intracellular Ca2+ in mouse cortical neurones could induce a 
transient increase in the amplitude of whole-cell GABAa receptor-mediated currents. 
The addition of CaM and CaMK-II specific inhibitors blocked this potentiating effect 
suggesting that CaMK-II was a necessary part of the signal cascade.
There are several studies which have reported a CaMK-II dependent 
modulation of GABAa receptor function. Wang et al. (1995) intracellularly-applied 
pre-activated (autophosphorylated at Thr286) a-CaMK-II to acutely isolated rat spinal 
dorsal horn neurones and observed a significant increase in the peak amplitude of 
whole-cell currents induced by a fixed dose of GABA. They found a similar effect 
when recording IPSCs from CA1 neurones in a hippocampal slice preparation. As 
well as an increase in amplitude they also reported a slight change in desensitisation 
acting to prolong the decay of the currents they recorded. A Ca2+ dependent increase 
in the decay of IPSCs has also been reported in response to amputation of the
55
dendrites of dentate gyrus granule cells in central neurones (Soltesz and Mody, 
1995).
Chum et al. (1998) examined how CaMK-II activity towards endogenous 
substrates in a synaptosomal membrane fraction altered GABAa receptor agonist 
binding. Activation of endogenous CaMK-II led to an increase in muscimol binding, 
without altering binding affinity. The results suggested that the increase in binding 
was due to an increase in the number of functional GABAa receptors (Chum and 
DeLorenzo, 1998). In an additional study they used a similar protocol to 
demonstrate that CaMK-II activity increased allosteric-modulator binding (Chum et 
al., 2002). Again this was thought to be due to an increase in the apparent number of 
receptors available for binding. In this study, CaMK-II was reported to 
phosphorylate the a l  subunit (Chum et al., 2002).
Alix et al. (2002) characterised a Ca2+ sensitive GABA mediated chloride 
(Cl') current in cockroach dorsal unpaired median neurones. This current could be 
potentiated by increases in intracellular Ca2+ and the potentiation could be blocked 
by addition of specific CaMK-II and CaM inhibitors (KN-62 and W7 respectively). 
Insect GABA-stimulated Cl' channels are pharmacologically and structurally distinct 
from vertebrate GABAa receptors (Alix et al., 2002), but it appears they may be 
regulated by phosphorylation in a similar way to the vertebrate GABAa receptors.
During the development of the hippocampus BDNF has been reported to have 
a potentiating action on GABA currents recorded from CA1 pyramidal neurones 
isolated from P6 rats. This was prevented by the addition of the CaMK-II inhibitor 
KN-62 (Mizoguchi et al., 2003). Potentiation of GABA currents has also been 
reported after mechanical injury of cortical neurones. This potentiation took the
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form of an increase in peak current density (pA/pF) that could be blocked by the
CaMK-II inhibitor KN-93 (Kao et al., 2004).
It appears possible that GABAa receptors can be modulated by Ca2+-
dependent phosphorylation processes and that in some cases Ca2+-dependent
activation of CaMK-II results in a potentiation of GABAa receptor mediated
currents. CaMK-II dependent phosphorylation is critical for excitatory synaptic
plasticity, like long-term potentiation (LTP). There is also evidence that CaMK-II
may also play a role in inhibitory synaptic plasticity.
Table 1.2:
Cell-Type Method Response Reference
Rat dorsal horn 
neurones 
Hippocampal 
CA1 pyramidal
i/c pre-activated 
(^CaMK-II
t Peak w-c amplitude 
iDesensitisation
t IPSC amplitude
Wang etal., (1995)
Mouse cortical 
neurones.
t i/c Ca2+ t Peak w-c amplitude 
Blocked by KN-93
Aguayo etal., 
(1998)
Rat forebrain 
synaptosomal 
membrane 
fractions.
i/c Ca27CaM 
i/ca-CaMK-ll
t Agonist binding 
t Allosteric modulator 
binding 
al subunit 
phosphorylation
Churn and 
DeLorenzo (1998) 
Churn et al., (2002)
Cerebellar
purkinje
neurones
ti/c Ca2+ via 
VGCCs
i/c pre-activated 
oe-CaMK-ll
t Peak w-c Amplitude 
t sIPSCs amplitude 
No change in decay. 
(Rebound Potentiation)
Kano etal., (1996)
Hippocampal 
CA1 pyramidal 
neurones
BDNF
application
t Peak w-c Amplitude (P6 
not P14)
Blocked by BAPTA and 
KN-62
Mizoguchi et al., 
(2003)
Cockroach 
dorsal unpaired 
median 
neurones
t i/c Ca2+ via 
depolarisation
t w-c amplitude 
Blocked by calmodulin 
blocker (W7) and KN-62
Mix etal., (2002)
CA1
hippocampal
neurones
t Ca2+/CaM t IPSC amplitude. 
Blocked by CaMK 
autoinhibitory peptide.
Weiefa/., (2004)
Table 1.2: A summary of the published evidence for CaMK-II modulation of the 
GABAa receptor.
In a number of neuronal preparations increases in Ca /CaM and activation of CaMK- 
II or inclusion of exogenous pre-activated CaMK-II in the patch pipette has been 
demonstrated to up-regulate GABAa receptor function, 
i/c = intracellular; w-c = whole-cell GABA current.
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1.7 Inhibitory Synaptic Plasticity
A number of Ca2+ dependent forms of inhibitory synaptic plasticity have been 
reported (Komatsu and Iwakiri, 1993; Komatsu, 1994; McLean et al., 1996; Caillard 
et al., 1999; Gaiarsa et al., 2002; Patenaude et al., 2003; Bauer and LeDoux, 2004). 
The mechanisms behind plasticity vary with some reports of a presynaptic effect on 
frequency (Caillard et al., 1999; Ouardouz and Sastry, 2000) and others suggesting a 
purely postsynaptic effect mediated by an up-regulation of GABAa receptor function 
(Patenaude et al., 2003; Bauer and LeDoux, 2004).
1.7.1 Activity and development dependent plasticity.
One of the first forms of inhibitory plasticity to be identified occurs within 
the visual cortex. High frequency stimulation could induce a long-term increase in 
the amplitude of IPSPs recorded. This form of LTP of inhibitory synapses shared 
many of the features of excitatory LTP recorded from CA1 hippocampal neurones 
(Komatsu and Iwakiri, 1993; Komatsu, 1994). One of the interesting features of this 
form of plasticity was that LTP was more easily inducible in developing rats rather 
than mature. A similar form of activity-dependent plasticity of IPSCs mediated by 
GABAa receptors has been reported in rat hippocampal slices. Stimulation induced 
a long-lasting change in both the frequency and amplitude of IPSCs recorded, 
however, this plasticity could only be induced within a restricted period of 
development (Gubellini et al., 2001).
Some of these reported forms of inhibitory plasticity are bi-directional 
(McLean et al., 1996; Aizenman et al., 1998) and rely on differences in magnitude of 
Ca2+ signals in a similar way to the plasticity of excitatory synapses (Yang et al., 
1999; Cormier et al., 2001). In the same way that CaMK-II and CaN can bi­
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directionally regulate excitatory synaptic transmission it has been proposed that 
CaMK-II may potentiate inhibitory synapses and CaN may depress them (Morishita 
and Sastry, 1996; Wang et al., 2003a; Sanchez et al., 2005). Aizenman et al. (1998) 
found that at GABAergic synapses onto deep cerebellar nuclei neurones, a long-term 
potentiation of IPSC amplitudes could be induced by a strong stimulation and large 
Ca2+ influx into the postsynaptic cell whereas a more moderate stimulation and Ca2+ 
influx resulted in a long-term depression of the IPSC amplitudes.
In neurones of the deep cerebellar nuclei (DCN) long-term potentiation (LTP) 
of inhibitory GABAa receptor mediated currents can be evoked by high frequency 
stimulation of the white matter surrounding the DCN. This potentiation is dependent 
on NMDA receptor activation and Ca2+ influx and is blocked by an NMDA receptor 
antagonist (APV) and the Ca2+ chelator BAPTA, suggesting that Ca2+ influx via 
NMDA receptors stimulated the potentiation. Intracellular application of tetanus 
toxin, a blocker of exocytosis, also prevented the induction of LTP of inhibitory 
currents. Suggesting a role for exocytosis and receptor trafficking in this form of 
Ca2+ stimulated inhibitory plasticity (Ouardouz and Sastry, 2000).
Another form of long-term inhibitory plasticity has been identified at 
inhibitory synapses onto CA1 hippocampal pyramidal neurones (Wei et al., 2004). 
In this case a Ca /CaM dependent increase in the amplitude of IPSCs was prevented 
by postsynaptic dialysis of an auto-inhibitory peptide of CaM-dependent kinases, 
suggesting the enhancement observed was CaMK-II dependent. In addition, 
inhibition of tubulin or actin polymerization attenuated this effect implying an intact 
cytoskeleton was required for this to occur.
Modelling and functional studies of GABAergic synapses suggests that if 
GABA is saturating at a given synapse, the most effective mechanism to potentiate
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GABA mediated currents would be to increase receptor number at the synapse, as 
alterations in transmitter concentration and the probability of channel opening would 
have no impact on the amplitude of the inhibitory currents (Otis et al., 1994; Nusser 
et al., 1998). In this regard, it is now thought AMPA receptor insertion may be the 
predominant mechanism operating during excitatory LTP (Hayashi et al., 2000; Zhu 
et al., 2 0 0 2 ).
Experimental models of epilepsy in which chronic epilepsy is induced 
through a process known as kindling have revealed inhibitory synaptic plasticity in 
response to the induction of epilepsy. This increase in inhibitory synaptic 
transmission is thought to be associated with an increase in the number of GABAa 
receptors at inhibitory synapses (Otis et al., 1994; Nusser et al., 1998). These kinds 
of alterations in inhibitory synaptic transmission have been suggested to function as 
homeostatic plasticity (Turrigiano and Nelson, 2004). Blockade of activity in 
cortical neuronal cultures by TTX leads to a decrease in the amplitude of IPSCs 
recorded. This is also accompanied by a reduction in the number of channels at the 
cell surface (Kilman et al., 2002). A similar treatment caused an increase in the 
amplitude of mEPSCs, suggesting that the balance between excitatory and inhibitory 
synaptic currents could be dynamically modulated (Turrigiano et al., 1998).
1.7.2 Rebound potentiation
Kano et a l (1992; 1996) characterised a phenomenon known as rebound 
potentiation in which stimulation of climbing fibre synapses onto cerebellar Purkinje 
cells could produce a long term potentiation of GABAa receptor mediated currents 
(in the same cell). The Ca2+ chelator BAPTA can block this rebound potentiation 
suggesting the process is Ca2+ dependent. Calmodulin binding domain (CBD)
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synthetic peptide inhibits binding of Ca2+/CaM to CaMK-II and blocks the activation 
of the kinase. Its introduction into Purkinje cells blocked the potentiation of GABA- 
mediated currents. The CaM antagonist, calmidazolium, and the selective CaMK-II 
antagonist, KN-62, had a similar effect. Moreover, the intracellular introduction of 
purified pre-activated CaMK-II increased the amplitude of whole-cell GABA 
currents recorded. Addition of CaMK-II inhibitors five minutes after the initial 
stimulus (Ca2+ rise) failed to block the effect, suggesting that CaMK-II activation is 
involved in the induction not the maintenance of rebound potentiation.
Further investigation has elucidated some of the molecular pathways involved 
in rebound potentiation. It has been demonstrated that multiple kinase pathways 
interact to modulate GABAa receptors in Purkinje cells. Kawaguchi and Hirano 
(2002) confirmed that inhibition of CaMK-II reduces or blocks rebound potentiation 
and observed that inhibition of PKA has a similar effect. Inhibition of PP1 or CaN 
impairs the suppression of potentiation caused by PKA inhibition, but not that caused 
by CaMK-II inhibition. The substrate of PKA and CaN, DARPP-32, inhibits PP1 
when phosphorylated by PKA (Svenningsson et al., 2004). PP1 inhibits CaMK-II, 
which alters GABAa receptor function more directly by a mechanism that is yet to be 
determined (Fig 1.5B).
In ionotropic glutamate receptor subunit 62 (GluR62) knockout mice 
GABAergic synaptic transmission is enhanced and it is not possible to stimulate 
rebound potentiation suggesting that rebound potentiation occurs in vivo, potentially 
as a form of homeostatic plasticity (Ohtsuki et al., 2004). Stimulation of 
metabotropic P2Y purinoceptors and subsequent G-Protein-coupled stimulation of 
Ca2+ release from intracellular stores can induce a long-term enhancement of 
GABAa receptor mediated currents recorded from Purkinje cells. This process
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appears similar to rebound potentiation in that it is dependent on postsynaptic 
calcium increases. However, the time course is much slower and does not require 
Ca2+ influx through voltage gated calcium channels indicating that different 
pathways may be involved (Saitow et al., 2005).
There are a number of similarities between long-term plasticity of excitatory 
and inhibitory synaptic transmission in that both kinds of synapse can be modified 
bi-directionally, dependent upon the magnitude of the Ca2+ signal. Under certain 
circumstances Ca2+-dependent potentiation of GABAa receptor function has been 
linked to activation of CaMK-II. It appears, therefore, that CaMK-II may be capable 
of mediating some forms of long-term inhibitory plasticity and as a result CaMK-II 
dependent modulation of the GABAa receptor may have important functional 
consequences for understanding network behaviour.
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Fig 1.5: Schematic representation of signalling pathways involved in excitatory 
and inhibitory forms of long-term synaptic plasticity.
(A) Schematic representation of the signalling pathways thought to be involved in 
excitatory LTP. CaMK-II is able to directly phosphorylate the AMPA receptor and 
can also drive AMPA receptor insertion into the plasma membrane. GluRl/4 
receptors are inserted into the synapse during LTP. GluR2/3 receptors are 
continuously recycled to and from the plasma membrane and maintain a constant 
level of receptors at the surface. LTD may involve Ca2+-dependent phosphatase 
activity directly against the AMPA receptor but may also involve removal of 
receptors from the plasma membrane. Plasticity is bi-directional in response to Ca2+ 
signals of differing magnitude.
Adapted from Zhu et al. (2002).
(B) Schematic representation of the signalling pathways involved in rebound 
potentiation, a form of inhibitory long-term potentiation.
In a similar way to excitatory LTP pathways, activation of CaMK-II is thought to 
induce a long-term potentiation of GABAa receptor function, and activation of a 
protein phosphatase (CaN) is thought to counteract that process. PKA is able to 
induce rebound potentiation through an interaction with DARPP-32 and a 
subsequent downstream activation of CaMK-II through inhibition of PP1.
The process or events downstream of CaMK-II activation that result in modification 
of G A B A a receptor function, are at present unknown.
Adapted from Kawaguchi and Hirano (2002).
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1.8 CONCLUSIONS
The process of phosphorylation is known to regulate GABAa receptor 
function through direct changes to the properties of the channel and through changes 
in cell surface trafficking in ways that have been shown to be physiologically 
relevant (Moss and Smart, 1996; Brandon et al., 2002a; Kittler and Moss, 2003; 
Luscher and Keller, 2004). CaMK-II can phosphorylate GST-fusion proteins of the 
TM3-4 intracellular loop of /3 and y  subunits (McDonald and Moss, 1994; McDonald 
and Moss, 1997). CaMK-II has also been shown to potentiate GABAa receptor 
mediated currents in several neuronal cell types and has been implicated in the 
induction of certain forms of inhibitory synaptic plasticity (Wang et al., 1995; Kano 
et al., 1996; Wei et al., 2004). It is important to determine the mechanism of CaMK- 
II dependent modulation of GABAa receptors as the processes involved may play 
important physiological roles. For instance, up-regulation of inhibitory synaptic 
strength may be important in forms of homeostatic plasticity and in the proper 
formation of inhibitory networks during development.
At present it is unclear whether CaMK-II dependent modulation of GABAa 
receptors occurs through direct phosphorylation or through indirect downstream 
processes. In addition, given the heterogeneity of GABAa receptors and the 
differential effects of other kinases on different GABAa receptor subtypes, it is 
unknown whether CaMK-II shows any subunit-dependent effects on GABAa 
receptors.
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1.9 AIMS
• To establish whether CaMK-II dependent modulation of GABAa receptors 
occurs through direct phosphorylation of the receptor.
• To determine if CaMK-II dependent modulation of the GABAa receptor has 
differential effects on different GABAa receptor subtypes.
• To establish which specific subunits are required for CaMK-II modulation, 
and if possible, which specific residues might be phosphorylated.
• To understand more about the possible mechanism(s) of CaMK-II dependent 
functional modulation of the GABAa receptor.
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Chapter Two:
Materials and Methods
2.1 MOLECULAR BIOLOGY
All molecular biology was carried out in collaboration with Dr A.M Hosie and Ms 
H.M.A da Silva. In brief the methods were as follows:
2.1.1 Site-directed mutageneis.
Murine a l ,  /32/3, y2S GABAa receptor cDNAs were cloned into the plasmid 
vector pRK5 (Moss et al., 1991; Connolly et al., 1996). Expression of heterologous 
subunits in this vector is under the control of the cytomegalovirus promoter. Site- 
directed mutagenesis was carried out using the Quikchange method (Stratagene). 
This involved:
• The design of appropriate oligonucleotides containing the desired mutation
flanked by an unmodified nucleotide sequence; to be used as mutagenic 
primers.
• The amplification of the relevant product by polymerase chain reaction
(PCR); electrophoresis to check for amplification of the desired product and 
digestion of unmutated DNA.
• Transformation into E.Coli.
• Purification and sequencing of plasmid DNA.
Complementary olignucleotides containing the desired mutation were used as 
primers for PCR (See Appendix A 1.1). The PCR reaction contained 5 pi of 10X 
reaction buffer, 10-100 ng of dsDNA template (cloned into pRK5), 125 ng primer 1 
(Invitrogen) and 125 ng of primer 2 (Invitrogen), 1 pi of deoxynucleotide
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triphosphate (dNTP) mix (10 mM of each dNTP), 2.5U of Pfu turbo DNA 
polymerase and double distilled water to a final volume of 50 jil.
The PCR reaction mix underwent thermocycling with the following 
parameters: 99°C for 30 s, followed by 18 cycles of 95°C for 30 s (denaturation), 55 
to 65°C for 30 s to 60 s (annealing), and 72°C for 2 min/kb of plasmid length 
(extension). The PCR mix was then electrophoresed on a 1 % w/v agarose gel, to 
check for the formation of a product. The PCR product was then digested with Dpn I  
restriction enzyme (lOU-New England Biolabs) to cut the methylated template DNA, 
leaving only mutated PCR product DNA (1 hr at 37°C).
After digestion, the PCR product was transformed into E-Coli using TOP 10 
one shot Kit (Invitrogen -  See Appendix A 1.2). Top 10 competent cells (Invitrogen) 
were grown on LB Agar (Sigma) containing 50 pg/ml ampicillin. Bacterial colonies 
containing the mutated DNA were selected and grown overnight in Lennox L broth 
base (LB) medium (Sigma) to allow the transformed bacteria to multiply. The 
plasmid was then purified using the QIAprep Spin Miniprep Kit (Qiagen -  See 
Appendix Al .3).
The sequence of the entire coding region of the cDNA was then determined 
to ensure the mutation had been correctly incorporated into the template DNA 
sequence without any ectopic mutations (DNA sequencing service -  The Wolfson 
Institute for Biomedical Research, Cruciform Building, UCL). The analysis of the 
base sequence was performed by Sequencher 3.1.2 software. If the mutation had 
been successfully incorporated into the base sequence the bacterial stock was grown 
to increase the amount of the mutated cDNA using a large volume of LB media (100 
ml midi prep; 250 ml, maxi prep Qiagen; grown overnight). As before, cDNA was
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purified but this time at higher concentrations (1 pg/pl) that could then be used for 
transfection of cell lines or neurones.
2.2 CELL CULTURE
2.2.1 HEK293 cells.
HEK293 cells (Graham et al., 1977) were grown in 10 cm diameter culture 
dishes (Nunc) in media containing Dulbecco’s modified Eagle’s medium (DMEM - 
Gibco) supplemented with 10 % v/v foetal calf serum (FCS), 2 mM glutamine, 100 
U/ml penicillin G, 100 pg/ml streptomycin and incubated at 37°C, in 95 % air / 5 % 
CO2. Cells were passaged when they reached approximately 70 % confluency, 
usually every 2-3 days. Cells requiring passaging were washed once with 5 ml 
Hank’s balanced salt solution (HBSS) and then incubated in 2 ml trypsin (0.25 % 
w/v) until the cells floated free off the dish. DMEM (10 ml) was then added to 
quench the trypsin and the cells were transferred to a 50 ml conical tube for 
centrifugation at 1000 rpm for 2 min. The supernatant was then removed and cells 
were re-suspended in 5 ml of media and re-plated at a dilution factor of 1:10 / 1:20 
cell-containing media to fresh media (Krishek et al., 1994; Dunne et al., 1998; 
Thomas and Smart, 2002; Thomas and Smart, 2005). Cells used for transfection by 
electroporation or calcium phosphate were subsequently triturated to ensure a single­
cell suspension and were re-suspended in OPTIMEM (Gibco) at this point.
2.2.2 NG108-15 cells.
NG108-15 cells (Klee and Nirenberg, 1974; Daniels and Hamprecht, 1974; 
Docherty et al., 1991) were grown in 50 ml culture flasks (Nunc) in DMEM (4.5 g/L 
glucose - Gibco) supplemented with 10 % v/v FCS, 2 mM glutamine, 100 pM
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hypoxanthine, 0.4 pM aminopterin, 16 pM thymidine (Sigma) and 20 U/ml 
penicillin G and 20 mg/ml streptomycin and incubated at 37°C, 90 % air /10 % CO2. 
Cells were passaged when they reached approximately 70 % confluency every two- 
three days at a ratio of 1:3 or 1:6 cell-containing media to fresh media. Cells were 
detached from the bottom of the flask by a gentle wash and spun at 900 rpm for 5 
min; they were then re-suspended in fresh media and re-plated to continue the 
culture. At this point cells for transfection were further diluted (1:2-3) and drops of 
cell-containing media were dropped onto pre-prepared (2.2.3) glass coverslips in 35 
mm dishes to allow the cells to adhere (Nunc, See Fig 2.1 A).
2.2.3 Primary cell culture -  rat/mouse cerebellar granule cells.
The cerebella of postnatal day 1 (PI) Sprague-Dawley rats were removed 
after decapitation and placed in ice-cold dissection media (DM = HBSS -  without 
Ca2+/Mg2+ (Gibco) + Gentomycin 10 pg/ml (Sigma). The meninges were then 
carefully removed and the cerebella transferred to DM that had been heated to 37°C 
and CO2 saturated in the incubator. They were then centrifuged at 1000 rpm for 1.5 
min; the supernatant was removed and another 10 ml DM added and the tissue 
centrifuged again. The supernatant was removed and the cerebella were then 
incubated in trypsin (0.1 % w/v, Sigma) at 37°C for 10 min. The trypsin was 
removed and the cerebella washed with 10 ml DM. They were centrifuged again for 
3 min at 1000 rpm followed by a second wash in DM and centrifuged at 1000 rpm 
for 1.5 min.
The DM was removed virtually completely using a 200 pi Gilson pipette. 
Then, 1 ml DNase (0.05 % w/v in 12 mM MgSC>4, Sigma) was added and the 
cerebella were triturated with two glass pipettes that had been fire-polished to small
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bore diameters. The final trituration step was carried out with a 200 pi pipette tip until 
a single-cell suspension had formed. Another 9 ml DM was added and the mixture 
centrifuged at 1200 rpm for 5 min. Care was taken to remove all the supernatant at 
this point with a 2 0 0  pi pipette and the cells were re-suspended in 1 ml of seeding 
media (Basal Medium Eagle -  BME (Gibco) + 10 % v/v FCS). An aliquot (15 pi) 
of the suspension were then transferred to a haemocytometer and an estimate of cell 
number made. Cells were diluted to give approximately 5 x 106 cells/ml; 90 pi of 
this suspension was then placed onto the pre-prepared glass coverslips coated in 
poly-L-omithine (Sigma). Coverslips were washed in 100 % v/v ethanol and flamed, 
twice and coated in 500 pg/ml poly-L-omithine in borate buffer (50 mM Boric acid, 
12.5 mM sodium tetraborate), 0.5 ml per coverslip, overnight at 4°C, then washed 
three times with sterile water and finally left to air dry before use. Dishes were left 
in the incubator for 3 hrs to allow cells to adhere to the glass after which the 
appropriate growth media was added.
[1] Serum free media -  20 mM KC1.
BME (Gibco) supplemented with 0.5 % w/v glucose, 5 mg/L insulin, 5 mg/L 
transferrin, 5 mg/L selenium (Sigma), 20 U/ml pencillin-G and 20 pg/ml 
streptomycin, 0.14 mM glutamine, 1.4 mM N aC l, 0.01 mg/ml Bovine 
Serum Albumin (BSA, Sigma) and 20 mM KC1 (See Fig 2.IB).
[2] Serum-containing media -  5 mM KC1.
BME (containing 5mM KC1) supplemented with 0.5 % w/v glucose, 20 U/ml
penicillin-G, 20 pg/ml streptomycin, 0.2 mM glutamine, 5 % v/v FCS, 1.2
mM NaCl and 5 mg/ml insulin, 5 mg/ml transferrin and 5 mg/ml selenium
(Sigma, See Fig 2.IB).
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Cells maintained in serum-containing media were treated with 1-2 pM 
cytosine arabinoside (Sigma) at 4-5 DIV to control the growth of non-neuronal cells, 
which otherwise threatened to overwhelm the culture. Serum-free media maintained 
cells had 1 ml of media replaced every 7-10 days. Cells for transfection were chosen 
and transfected at 3-4 DIV (Furuya et al., 1998; Leao et a/., 2000; Tabata et al., 
2000; Ives et al., 2002).
2.2.4 Embryonic cortical neuronal culture.
The cortical neuronal cultures (See Chapter 4, Fig 4.1) were prepared by Dr 
J.N Jovanovic and Ms K McAinsh as follows:
Cortices were dissected from embryonic day 19 rats and the tissue incubated 
in 0.25 % w/v trypsin in HBSS for 15 min followed by 3 x 5 min washes in HBSS. 
The tissue was then dissociated by titration with a fire-polished pipette. Cells were 
plated on 0.5 mg/ml poly-L-omithine-coated glass coverslips at a density of 105 
cells/cm2 and incubated at 37°C, 95 % air / 5 % CO2 for 6 days before use (Brandon 
etal., 1999).
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Fig 2.1: Images of NG108-15 cells and cerebellar granule cells in culture.
(A) NG108-15 cells transfected with cDNAs for al/?3'y2S GABAa receptor subunits 
and EGFP (Enhanced Green Florescent Protein). Cells were then stained with a /33 
specific antibody (red fluorescence - See table 2.1) 48 hrs after transfection.
(B) Differential interference contrast (DIC) images of cerebellar granule cells 
maintained in culture in 20 mM KCI and 5 mM KCI. Cells in 5 mM KCI tended to 
form clusters whereas cells in 20 mM KCI had a more uniform distribution.
Images acquired on a Zeiss laser scanning confocal microscope (LSM 510 Meta; See 
2 .6.2).
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2.3 TRANSFECTION
2.3.1 Electroporation -  HEK293 cells.
For the production of a large number of dishes expressing the same receptor 
subunits the following method was used (Wooltorton et al., 1997; Dunne et al., 
1998). A 10 cm dish of HEK293 cells at 70 % confluency was used for each 
transfection. Cells were dissociated from the dish with trypsin (See 2.2.1) and re­
suspended in 25 ml OPTIMEM in a 50 ml conical tube and centrifuged for 2 min at 
1000 rpm. The supernatant was removed and the cells re-suspended in 0.5 ml 
OPTIMEM for electroporation and 0.3 ml for continuation of the culture. The cells 
were triturated with a flame-polished pipette to form a single-cell suspension. 
Electroporation cuvettes were washed twice with sterile water and twice with 
OPTIMEM before use. The appropriate cDNA suspension was then placed in the 
bottom of the cuvette, e.g, al:p3:y2S:EGFP at a ratio of 1:1:1:1 (Stock solutions of 
DNA at 1 pg/pl, 1 pi of each cDNA was used per dish).
Then, 0.5 ml of the cell suspension was added to the cDNA in the cuvette and 
mixed gently. The cuvette contents were mixed before, in-between and after 
electroporation with the Biorad Gene pulser II. Settings were “infinite resistance”, 
voltage 0.4 kV and capacitance 0.125 mF. The time constant for the electric field 
used for electroporation generally fell between 3-4 ms.
Cells were allowed to stand for 10 min after electroporation. Then, 8-10 ml 
of media (See 2.2.1) was then placed in a 10 ml tube and with a glass pipette the 
contents of the cuvette were added and the suspension inverted to mix well. After 
checking the cell density, 0.5 ml of media was placed onto pre-prepared glass 
coverslips in 35 mm dishes (Nunc) and a suitable number of drops of the cell 
suspension were added to this. Coverslips were prepared by washing in 100 % v/v
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ethanol and flaming, then adding 0.5 ml of poly-L-lysine (100 pg/ml) for 1 hour, 
followed by three washes with sterile water and then left to dry before use.
Coverslips with cells added were left in the incubator for 10 min at 37°C to 
allow the cells to adhere to the substratum. Then 1-2 ml of media (DMEM) was 
added to each dish and they were placed into the incubator (37°C / 95 % air / 5 % 
CO2) for at least 24 hrs. These cells could be recorded from for 24-48 hrs after 
transfection.
2.3.2 Calcium phosphate -  HEK293 and NG108-15 cells.
This procedure was used when a number of different cDNAs were to be 
transfected into different dishes for recording on the same day (Krishek et al., 1994). 
To 1 pi of cDNA stock solution (1000 ng//ul) per dish per subunit (+ EGFP), 340 
mM CaCl2 (20 pi per dish to be transfected) was added. This was left for 20 min to 
allow a precipitate to form. This suspension was then mixed with double-strength 
HBSS (24 pi per dish to be transfected; 2 x HBSS = 280 mM NaCl , 2.8 mM 
Na2HP0 4 , 50 mM HEPES, NaOH to pH 7.2). Once mixed, 45 pi was then applied to 
each 35 mm dish of cells. Dishes of cells were prepared by dissociating cells from 
the stock dish they were growing in (when at 70 % confluency) and re-suspending 
them in their normal media (See 2.2.1 and 2.2.2). Pre-prepared coverslips in 35 mm 
dishes (Nunc), already coated with poly-L-lysine for HEK293 cells (See 2.3.1) and 
poly-L-omithine (See 2.2.3, 1 hr incubation only) for NG108-15 cells, were coated 
with 0.5 ml of normal media, prior to seeding with drops of cell suspension to obtain 
the appropriate cell density for recording.
After seeding the cells, the coverslips were left for 10-15 min to allow the 
cells to adhere. After this, 1.5 ml of fresh media was applied to each dish. At this
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point the cells were ready for calcium phosphate transfection. After transfection 
cells were left overnight and the media changed in the morning. Cells could be 
recorded from 24 hr after transfection (See Fig 2.1 A).
2.3.3 Effectene transfection - NG108-15 cells and cerebellar granule cells.
Both NG108-15 and cerebellar granule cell cultures were transfected using 
the Effectene transfection reagent (Qiagen, See Fig 2.1 A and Fig 7.6-7).
On the day of transfection, NG108-15 cells were seeded onto glass coverslips 
(See 2.3.2) and left for 10 min in the incubator for cells to adhere. Cerebellar granule 
cell cultures were transfected at 3-4 DIV. A total of 0.4 pg DNA per dish (0.3 pg for 
granule cells) was prepared (containing an equal ratio of each subunit and enhanced 
GFP, 1:1:1:1) and added to EC Buffer (DNA-condensation buffer, 75 pi per 35 mm 
dish -  supplied with reagent). Then, 8 pl Enhancer (supplied with reagent) was then 
added per 1 pg of total DNA. The mixture was then vortexed and allowed to stand 
for 5 min. Then, 10 pi of Effectene reagent was added per dish for the transfection 
and the mixture vortexed and allowed to stand for a further 10 min to allow the DNA 
transfection-complex to form. Finally 0.5 ml of the appropriate media was added for 
each dish and mixed. The DNA suspension was then added immediately to the 
previously prepared cells. Cells were left in the transfection reagent containing 
media for 3-4 hrs and then the media was replaced. NG108-15 cells could be 
recorded from 24 hrs later (See Fig 2.1 A). Cerebellar granule cells were left for a 
further 3-5 days and recorded from at 7-12 DIV.
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2.4 ELECTROPHYSIOLOGY
2.4.1 The equipment
The cells to be recorded from were identified under a Nikon Eclipse TE300 
microscope at 200-400X magnification, with additional X5 magnification, as 
required sometimes for cerebellar granule cells. Transfected NG108-15 and 
HEK293 cells could be identified by GFP fluorescence observed using the Nikon 
epifluorescence unit (See Fig 2.2). Drugs were applied to cells using a fast perfusion 
system based on a modified Y-tube (Wooltorton et al., 1997) controlled with 
solenoid valves (Lee products ltd, Buckinghamshire) operated electronically (See Fig 
2.4). Cells were voltage-clamped using an Axopatch 1C patch clamp amplifier 
(Axon Instruments) with a CV-3 headstage (Axon Instruments) at -50mV (HEK293 
or NG108-15 cells) or -60mV (cerebellar granule cells). Membrane currents were 
filtered at 3kHz (8  pole Bessel filter) and digitised via a Digidata 1200 (Axon 
Instruments) and viewed with a PC (Dell -  Optiplex GX260) using the software 
programme Clampex 8.2 (Axon Instruments - See Fig 2.3).
2.4.2 Whole-cell patch clamp recording.
Cells were cultured on glass coverslips that could be transferred to the 
recording chamber and anchored in place in the bath. Cells were continuously 
perfused with Krebs solution at room temperature containing: 140 mM NaCl, 4.7 
mM KC1, 1.2 mM MgCl2, 2.52 mM CaCl2, 11 mM glucose and 5 mM HEPES, pH 
adjusted to 7.4 with NaOH and filtered through Whatman paper. Osmolarity was 
confirmed as 300 ± 10 mOsm with an Osmometer (Automatic -  CAMLAB).
Patch pipettes were pulled from thick-walled borosilicate glass (Harvard, 
GC150-10) and filled with an internal patch pipette solution containing: 120 mM
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KC1, 1 mM MgCl2, 11 mM EGTA, 10 mM HEPES, ImM CaCl2 and 4mM Na2ATP, 
pH adjusted to 7.2 with NaOH (osmolarity confirmed as 280-300 mOsm). This 
solution was used to record from HEK293 cells in Figs 3.2-4. At all other times the 
patch pipette solution contained: 150 mM CsCl, 1 mM MgCl2, 10 mM HEPES, 4 
mM Na2ATP, 0.1 mM CaCl2 and 1.1 mM EGTA, pH adjusted to 7.2 with CsOH 
(osmolarity confirmed as 280-300 mOsm). Free [Ca2+] <100nM . 1
The resistance of patch electrodes was monitored using the seal-test option in 
Clampex 8.2. The resistance of electrodes used to record from HEK293 and NG1 OS- 
15 cells was 5-6 MQ, and for cerebellar granule cells, 8-9 MQ. Electrodes were 
manoeuvred into position onto the surface of the cell using a Sutter MP-285 
micromanipulator.
The seal-test option and the membrane test option in Clampex 8.2 were used 
to monitor the fidelity of the whole-cell recording (See Fig 2.3B and C). The seal 
test measured the seal resistance between pipette and ground by repetitive application 
of -5mV voltage pulses and measuring the current response. This was then used to 
set the capacitance compensation on the patch clamp amplifier. Series resistance and 
whole-cell capacitance were optimised before the start of experiments using the 
shape of the waveform in the seal-test as a guide (See Fig 2.3C).
During patch clamp recording a proportion of the command potential is 
expected to be lost as it passes across the patch electrode and cell membrane in series 
(series resistance). Voltage clamp errors are expected to be low if the cell is healthy 
and the membrane seal around the electrode is high (GQ). Voltage clamp errors 
were further reduced by compensating for series resistance by using the patch clamp 
amplifier to inject current into the cell to compensate what is lost due to series 
resistance. Voltage clamp errors unavoidably increase for larger membrane currents
1 Calculated using Mathcad 2000i.
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(Thomas and Smart, 2002). Thus as a result, membrane currents of over 4 nA, 
usually recorded from larger NG108-15 cells, were discarded from the analysis.
The stability of the connection between cell and electrode was monitored 
throughout the course of the experiment using the seal-test and membrane test 
options to continuously monitor seal resistance, access resistance (Ra) and series 
resistance (Rs). Series resistance can also vary as access resistance alters which 
tends to occur as the electrode tip becomes occluded with cellular contents. Cells 
showing changes in access resistance or series resistance of over 15 % were 
discarded from the analysis.
The cell’s current response after application of GABA was recorded, in the 
gap-free mode (Clampex 8.2) and stored on the PC for further analysis. Typical 
values for series resistance were <1MQ, and for capacitance, 21.7 ± 3.6 pF (n = 6 , 
HEK293), 56.5 ± 7.6 pF (n = 6 , NG108-15), 11.1 ± 0.6 pF (n = 15, CGCs -  20mM 
KC1) and 8.3 ± 0.5 pF (n = 15, CGCs -  5mM KC1). The resting membrane 
potentials of cells immediately after achieving the whole-cell configuration were 
recorded as a good approximation of cell health. HEK293 cells and NG108-15 
cells generally had typical values -33.5 ± 5.6 mV (n = 6 , HEK293 cells), -39.5 ± 4 
mV (n = 6 , NG108-15). CGCs maintained in depolarising conditions had slightly 
lower resting potentials on average (-39.2 ± 2.5 mV) as compared to CGCs 
maintained under physiological conditions (-47.5 ± 5.9 mV; comparable to that 
reported by Mellor etal., 1998).
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Fig 2.3
m am ! WE5E5S3M
pClamp gap-free recording
B Membrane test
Capacitance
Access resistance
Seal test
Seal resistance
Fig 2.3: Software used for data acquisition: pClamp 8.2.
(A) Whole cell currents were recorded in the gap-free mode.
(B/C) Membrane test and seal test in pClamp were used throughout the experiment 
to monitor Ra and Rs. The seal test waveform was used as a guide for compensation 
of series resistance on the amplifier.
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2.5 D R U G  A P P L IC A T IO N  AND S O L U T IO N S
2.5.1 Drug application.
Drugs were rapidly-applied to cells via a Y-tube positioned approximately 
400 pm away from the recorded cell. Cells were continuously superfused by a 
gravity-fed Krebs solution (See Fig 2.4) whilst solenoid 1 was open. Water (to save 
drug solutions) was perfused around the Y-tube whilst solenoid 2 was open, powered 
by the vacuum pump. Just before the drug was added water was replaced by the 
appropriate drug solution dissolved in Krebs solution. Both solenoids were closed 
simultaneously allowing the drug solution to flow rapidly over the cell whilst 
stopping the normal Krebs from flowing. When both solenoids were opened again 
(after a fixed amount of time), the normal Krebs could wash-off the drug solution 
from the exposed cell (Wooltorton et al., 1997).
Fig 2.4:
Drug Krebs
Sol 1
Pum p
V acuum Sol 2
Fig 2.4: Schematic representation of the rapid perfusion Y-tube system.
The flow of a drug was controlled by two solenoids which acted as gates to allow 
or stop drug application and wash. The solenoids were controlled electronically. 
The typical rise time (10-90 %) of the 10 pM GAB A response in NG108-15 cells 
was 276.2 ± 28.9 ms (n = 6).
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2.5.2 Drug solutions (intracellular ligands).
• KN-93 (Sigma), an inhibitor of CaMK-II activity (Sumi et al., 1991) was 
dissolved in DMSO to form a stock concentration of 2.4 mM. KN-93 was 
added to the pipette solution at a dilution factor of 1 in 4800 to ensure DMSO 
did not interfere with the stability of recordings.
• KN-92 (Sigma), an inactive analogue of KN-93 was dissolved in DMSO to 
form a stock concentration of 1 mM and was dissolved in the pipette solution 
at a dilution of 1 in 2 0 0 0 .
• Genistein a specific inhibitor of tyrosine kinase activity (Akiyama et al., 
1987) was dissolved in DMSO to give a final stock solution of 100 mM and 
diluted 1 in 1000 in the patch pipette solution.
• Okadaic acid sodium salt (Sigma), an inhibitor of protein phosphatase 
activity (Bialojan and Takai, 1988) was dissolved in internal pipette solution 
to form a stock solution of 100-120 pM. This was further diluted at a ratio of 
1:100-120 (1 pM final concentration) or 1:10-12 (10 pM final concentration) 
okadaic acid-containing pipette solution to normal pipette solution.
2.5.3 Pre-activation of CaMK-II (Upstate) and in vitro phosphorylation assay.
Purified rat forebrain CaMK-II (50 ng/pl in 50 mM HEPES, pH 7.5, 50 % v/v 
glycerol, 10 % v/v ethylene glycol, 2.5 mM EDTA and 1 mM dithiothreitol) 
consisted of a mixture of CaMK-II isoforms (a, ft y, 5), 50-60 kDa/isoform and was 
pre-activated by incubation with 10 mM MgCl2, 1 pM CaM, 0.2 mM EGTA, 0.3 
mM CaCb for 15 min at 25°C. The pre-activation buffer containing CaMK-II was 
then diluted in the patch pipette solution to give a final concentration of 60-100 nM 
CaMK-II.
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In vitro phosphorylation of /33 TM3-4 loop GST-fusion proteins by CaMK-II 
(See Fig 3.4) was carried out in collaboration with Dr J.N Jovanovic as follows:
Purified CaMK-II (Upstate -  10 ng/pl final concentration in pre-activation 
buffer), was pre-activated (10 min) and incubated with GST-P3 (1.6 pg/pl) and 32P- 
ATP (0.4mM) at 25°C or 5°C, with or without 150 mM KC1. The reaction was 
stopped (t = 10 min) by addition of an equal volume of SDS-PAGE (sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis) sample buffer. Phosphorylation was 
analysed by SDS-PAGE and visualized by autoradiography. KC1 (150 mM) was 
added to the pre-activation/autophosphorylation buffer to simulate addition to the 
patch pipette solution. CaMK-II was pre-activated by incubation in 10 mM MgCl2, 1 
pM CaM, 0.2 mM EGTA, 0.3 mM CaCl2 (McDonald and Moss, 1994; McDonald 
and Moss, 1997).
2.5.4 Pre-activation of recombinant a-CaMK-II (New England Biolabs).
In all other experiments a truncated monomer of rat a-CaMK-II (1-325 amino 
acid residues) with a molecular weight of 33 kDa (New England Biolabs) obtained 
from Spodoptera frugiperda (Sf9) cells infected with recombinant baculovirus 
carrying the recombinant O'-CaMK-II cDNA (Brickey et al., 1990; Suzuki-Takeuchi 
et al., 1992) was used. This had a specific activity of *5,000,000 units/mg, supplied 
at 500 units/p 1 (100 ng/pl). One unit is defined as the amount of activated CaMK-II 
required to catalyze the transfer of 1 pmol of phosphate to Autocamtide-2 (CaMK-II 
peptide substrate) KKALRRQETVDAL (NEB -  50 pM) in 1 min at 30°C in a total 
reaction volume of 30 pi.
a-CaMK-II was supplied in 100 mM N aC l, 50 mM Tris-HCl (pH 7.5 @ 
25°C), 0.1 mM Na2EDTA, 1 mM dithiothreitol, 0.02 % v/v Tween-20 and 50 % v/v
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glycerol. Glycerol at this concentration was detrimental to the health of the cells so 
a-CaMK-II was dialysed with the Slide-A-Lyzer MINI Dialysis unit to reduce the 
glycerol concentration. Dialysis units were soaked in de-ionised water for 15 min. 
The dialysis unit was then placed in the microtube supplied, filled with 1.3 ml of 
dialysate containing 100 mM N aC l, 50 mM Tris-HCl (pH 7.5 @ 25°C), 0.1 mM 
EDTA and 1 mM dithiothreitol. The a-CaMK-11 as supplied was then added just 
above the membrane and allowed to sink. The dialysis unit was then capped and 
placed on a shaker at 4°C. CaMK-II and the microtube were kept on ice throughout 
the procedure. After 1-2 hrs the sample was collected from the dialysis unit and 
aliquots ready for use in patch clamp recordings were frozen and kept at -70°C. The 
dilution factor generally fell between 2-2.5 fold giving a final concentration of 1200- 
1500 nM (40-50 ng/pl). Stocks were defrosted just before use and incubated in a 
pre-activation/autophosphorylation buffer as suggested by the manufacturers: 8-10  pi 
CaMK-II stock (40-50 ng/pl = 1200-1500 nM) diluted into CaMK-II buffer as 
supplied (50 mM Tris-HCl, 10 mM MgCb, 2 mM dithiothreitol, 0.1 mM Na2EDTA, 
pH 7.5 @ 25°C) in a total volume of 16-20 pi supplemented with 1.2 pM calmodulin 
(CaM), 1.5 mM CaCb, 0.4 mM ATP-7-S incubated at 25°C for 15 min (McGlade- 
McCulloh et al., 1993).
The CaMK-II pre-activation buffer was then diluted into the patch pipette 
solution (McGlade-McCulloh et al., 1993; Lledo et al., 1995; Barria et al., 1997; 
Nelson et al., 2005) to give a final CaMK-II concentration of 35 nM (1.16 ng/pl), 60 
nM (2 ng/pl), 85 nM (2.85 ng/pl) or 100 nM (3.33 ng/pl). At the highest 
concentration the dilution factor was approximately 1:12 a-CaMK-II stock solution 
to patch pipette solution. Control recordings were made with the pre-activation 
mixture without CaMK-II diluted into the patch pipette solution at the same ratio, in
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order to ensure there were no non-specific effects on the stability of recordings 
caused by residual CaM and CaCh from the pre-activation buffer or that the buffer 
diluted into the patch pipette solution did not activate endogenous Ca /CaM 
dependent kinases or phosphatases.
2.6 IMMUNOCYTOCHEMISTRY
2.6.1 Procedure for immunolabelling of cell cultures.
Cells cultured on glass coverslips (See 2.2.3) were washed gently twice with 
ice-cold phosphate buffered saline (PBS). They were then fixed in 4 % 
paraformaldehyde (Sigma) in PBS, for 15 min at room temperature. The fixative 
was then washed with PBS twice and quenched with 50 mM NH4CI (in PBS) twice 
for 5 min. Cells were then washed again with PBS (twice). At this point the fixed 
cells were kept until required at 4°C.
If the desired antigen was intracellular (anti-/33) the cells were then 
permeabilised by incubation at room temperature with 0.05 % v/v Triton-X-100, 10 
% v/v FCS, 0.5 % w/v BSA (in PBS) for 10 min. Followed by a further two washes 
in PBS. If the desired antigen was extracellular (anti-myc) this stage was omitted as 
only cell-surface labelling was required.
Prior to antibody incubation, cells were washed in 10 % v/v FCS, 0.5 % w/v 
BSA (in PBS). The appropriate antibody was then diluted (See Table 2.1) in the 
same buffer. Then, 50 pi of the diluted antibody was placed onto a parafilm 
segment, the coverslip was removed from solution and the edge briefly dried on a 
tissue before inverting over the drop. Coverslips were covered with the dish lid to 
prevent drying and left for 45 min at room temperature.
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After the primary antibody incubation cells were placed back into 35 mm 
dishes and washed three times with 10 % v/v FCS, 0.5 % w/v BSA in PBS. The 
secondary antibody was diluted into the same buffer at the appropriate concentration 
(See Table 2.1) and again coverslips were inverted over 50 pi of the diluted antibody 
mixture dropped onto parafilm. Coverslips were covered with the lid of the dish to 
prevent drying and covered with foil to protect from the light. Cells were incubated 
in the secondary antibody for 45 min at room temperature.
After incubation, the coverslips were returned to the 35 mm dishes and 
washed three times in 10 % v/v FCS, 0.5 % w/v BSA (in PBS) and then three times 
in PBS. Coverslips were fixed to microscope slides using glycerol. The coverslips 
were lifted from the dish and excess fluid was removed by dipping the edge on a 
tissue. A drop of (pre-heated) glycerol (30 pi) was placed on the slide and the 
coverslip was inverted onto it and left to dry (Duguid and Smart, 2004).
Table 2.1:
Antibody Species Epitope Dilution Source
Anti-myc (1 °) Polyclonal 
Raised in 
Rabbit
C-teminus of 
c-Myc of 
human origin.
1:250 Santa Cruz 
Biotechnology
Anti-p3 (1°) Polyclonal
Raised in 
Rabbit
TM3-4 Loop 
of the [33 
subunit.
1:200 Gift from Prof. 
W. Sieghart 
(Vienna)
Anti-rabbit 
TRITC (2°)
Raised in 
Goat
IgG pooled 
rabbit serum
1:250 Sigma
Table 2.1: Primary and secondary antibodies used in immunocvtochemistrv.
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2.6.2 Image acquisition.
Images were acquired using a Zeiss laser-scanning confocal microscope 
(LSM 510 Meta). An oil-immersion objective lens (x 40 Plan-Neofluar or x 63 Plan- 
Apochromat) was used to visualise individual cells. Multi-track images were 
obtained with an Argon laser (488 nM) to visualise EGFP fluorescence and a 
Krypton (568 nM) laser to visualise tetramethyl rhodamine isothiocyanate (TRITC) 
fluorescence. Optical sections (z series) of intervals of 0.3-0.4 pm were taken 
through cells and 8-10 images were reconstructed to yield the final projection image. 
The precise settings can be seen in Fig 2.5.
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Fig 2.5: Settings of Zeiss LSM 510 Meta laser scanning confocal microscope.
Optimal settings are shown. Detector gain and amplifier offset can be altered to 
increase the signal to noise ratio for each channel. The pinhole size was set at 1 Airy 
unit with an optical slice of <1 pm. A series of optical slices (Z series) can be taken 
through the cell to form a projected image.
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2.7 KNOCKOUT MICE
The /32 knockout mouse strain (from Merck Sharp and Dohme, UK) was 
created by deleting exons 6 and 7 of the /32 subunit gene by homologous 
recombination (Sur et al., 2001). Heterozygous F3 generation mice were cross-bred 
to produce /32 -/- and wild-type (wt) strains. The offspring of breeding pairs of the 
F5-6 generation of wt and 02 -/- mice were taken at PO-2 to prepare cerebellar 
granule cell cultures (See 2.2.3).
The tails of offspring were removed after dissection for genotyping to 
confirm that the /32 subunit was missing from the /32 -/- cultures. DNA was extracted 
from the mouse tails of every pup (See appendix A1.4) in a litter used for each 
culture and this genomic DNA was included in a PCR reaction using primers 
complimentary to the /52 subunit gene and a primer complimentary to the neomycin 
cassette, to act as a positive control for homologous recombination in /32 -/- cultures 
(Sur et al., 2001).
2.8 ANALYSIS
2.8.1 Whole-cell currents.
Whole-cell currents were analysed in Clampfit 8.2 (See Fig 2.3A) by 
measuring the peak amplitude and subtracting the baseline. Cells were chosen for 
analysis if  access resistance and series resistance remained stable throughout the 
period of recording (See 2.5.2). If traces had deflections in their rising phase that 
current was discarded from the analysis. The peak amplitude recorded at 2 min 
intervals was normalised to the peak amplitude of the response obtained 3-4 min 
after achieving the whole-cell configuration.
The peak amplitude of the response to different concentrations of GABA was 
used to construct a concentration-response curve (See Fig 4.2). The peak amplitudes 
were normalised to the capacitance of the cell (pA/pF). These values were then 
plotted against GABA concentration. At least 5 different GABA concentrations 
were used to define the threshold or heel of the curve, the linear portion, and the 
clear saturating maximum. These data were then fitted by the Hill equation (shown 
below) within the program Origin 6.0 (Microcal):
I = 1 / ( 1 +  (EC50/[GABA]n)
where, I = the current activated by GABA (normalised to membrane 
capacitance). EC50 = the concentration of GABA to activate a current that is 
50 % of the amplitude of current induced by a maximal dose of GABA and n 
= the Hill coefficient.
2.8.2 MiniAnalysis
The software program MiniAnalysis (Synaptosoft) was used to analyse 
synaptic currents. Recordings were captured in Clampex 8.2 over 2 min or 5-6 min 
epochs starting 4-5 min after achieving the whole-cell configuration. Within 
MiniAnalyis a period of recording could be displayed and synaptic currents were 
detected automatically with an amplitude threshold of 6 -10  pA, depending on the 
level of baseline noise, which was typically around 5 pA. After automatic detection, 
each event was manually checked and verified by eye. The program could then 
analyse and display a mean value for the frequency, the peak amplitude and the half­
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width (the time taken to decay to 50 % of the peak amplitude) over that period of 
recording (See Fig 2.6A).
Events could also be grouped manually and these groups could be used to 
analyse the decay time constants of each period of recording. Synaptic events were 
chosen for analysis if  there were no deflections in the rising or decaying phases and 
they decayed back to the baseline. Events of low amplitude (<5 pA) were discarded 
from this analysis as they were thought to represent events occurring at the most 
distant synapses and therefore more affected by dendritic filtering or cabling. All the 
events chosen were grouped together for a given recording and aligned by their mean 
rise-times (50 %) for analyses of decay time constants. The program calculated an 
average current from the group. From this the 10-90 % rise-time could be calculated. 
The average current can then be fitted with a sum of one, two or three exponentials. 
The best fit could be identified visually but the program also allowed the best fit to 
be determined by regression analysis.
The resulting best fit curve was described by the following equation: 
y = Al*exp (-x/xl) + A2* exp (-x / t2) + baseline,
where, A l and A2 are the fractions of the fast (1) and slow (2) components 
and xl and x2 are their respective decay time constants.
A decay time constant is defined as the time taken for each component to 
decay to 37 % of its original amplitude. From this, values for the decay time 
constant of each component could be recorded as well as the relative area of each
90
component. When several cells had been analysed in this way, mean values could
then be determined (See Fig 2.6B).
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Fig 2.6: Software used for analysis of synaptic currents: MiniAnalysis.
(A) In the main display window the green x indicates the location of the baseline. 
The yellow dot ( ) indicates the starting time of the rising phase of the peak. The 
red x indicates the maximum point of the peak. The purple dot (•  ) indicates the 
decay of the peak (50 %).
(B) 10-90 % rise time is indicated by two yellow dots ( ). 90-37 % decay is shown 
by two purple dots ( •  , indicated by the arrows). The red x is where the peak is 
located. The green x and green horizontal line are where the baseline average is 
located. The peak amplitude is calculated as peak minus baseline average. The 
area under the curve is calculated from the whole trace with respect to the green 
line. The equation describing the curve is shown in 2.€.2.
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2.8.3 Gaussian fits
Raw current data could be transferred from MiniAnalysis into Origin 6.0 for 
analysis of distributions. If the data was formed from populations described by a 
Gaussian distribution this program fitted the data (with multiple Gaussian 
distributions if necessary) to identify separate populations. The best fit was 
determined visually.
2.8.4 Statistics
For comparison of two values, statistical analyses were carried out using the 
unpaired Student’s t-test (with a Welch correction if the difference in standard 
deviations between groups was large). When analysing multiple means, statistical 
analyses were carried out using ANOVA, with a Bonferroni post-test to compare 
selected groups. With all statistical tests, two means were considered significantly 
different if the P value was less than 0.05. All statistical tests were carried out using 
the software program GraphPad Instat 3.01 (GraphPad, USA).
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Chapter Three:
CaMK-II modulation of recombinant GABA+ Receptors 
expressed in HEK293 cells.
3.1 INTRODUCTION
The HEK293 cell line is endothelial in origin so is generally not thought to 
express any functional neuronal ligand-gated ion channels (Graham et al., 1977). 
These cells are suitable for whole-cell patch clamp, which allows 
electrophysiological recordings to be made of membrane currents following 
activation of recombinant ion channels that are expressed after transfection. In this 
way the exact isoform/s or combinations of subunits making up a given receptor/ion 
channel can be largely controlled, allowing functional dissection of the roles of 
different subunit isoforms, and the signalling processes that alter their function.
Expression of GABAa receptor subunits in HEK293 cells has been used 
previously to investigate the role of PKA-induced phosphorylation, revealing 
functional heterogeneity between different /? subunits (McDonald et al., 1998). 
Similar approaches have been used to investigate PKC-dependent phosphorylation of 
GABAa receptors (Brandon et al., 2002b) and tyrosine kinase-Src dependent 
modulation (Moss et al., 1995).
It has been shown that CaMK-II can phosphorylate GST-fusion proteins 
formed from the intracellular loop between transmembrane (TM) domains 3 and 4 of 
/? and 7  subunits of GABAa receptors in vitro (Machu et al., 1993; McDonald and 
Moss, 1994; McDonald and Moss, 1997). In neuronal preparations intracellular 
addition of pre-activated CaMK-II, through inclusion in the patch pipette, led to a 
significant increase in the peak amplitude of GABAa mediated currents (Wang et al.,
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1995; Kano et al., 1996). Synaptosomal membrane fractions have also been used to 
show CaMK-II dependent modulation of agonist binding to GABAa receptors and 
alterations in benzodiazepine binding to these receptors possibly through 
phosphorylation of the a l  subunit (Chum and DeLorenzo, 1998; Chum et al., 2002).
However, as yet, no attempt has been made to study the functional effects of 
CaMK-II dependent phosphorylation of GABAa receptors in a controlled 
environment such as the HEK293 cell. Such HEK293 cells have been used to 
successfully demonstrate CaMK-II dependent functional modulation of AMPA 
receptors (Barria et al., 1997; Derkach et al., 1999). The advantages of using such a 
system are that any potential differences in effect caused by phosphorylation on 
different GABAa receptor subunits may be determined. This is especially important 
in the case of GABAergic signalling mechanisms as the GABAa receptor displays 
considerable heterogeneity in subunit combinations and variable functional effects 
depending on the different subunits present in a particular recombinant system or 
neuronal cell type (Moss and Smart, 1996; Nusser et al., 1999; Brandon et al., 
2002a). It is also possible, through site-directed mutagenesis, to dismpt 
phosphorylation of specific residues within subunits and determine the specific sites 
of phosphorylation and their relative importance. Using these advantages, the initial 
aim of these experiments was to express different subunit combinations of the 
GABAa receptor in HEK293 cells and to induce CaMK-II dependent 
phosphorylation to study the functional consequences (See Fig 3.1).
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Fig 3.1: Studying CaMK-II dependent effects on GABAa receptors using 
HEK293 cells.
The cDNAs of various GABAa receptor subunits are transfected into HEK293 
cells by electroporation (See Chapter 2) along with the plasmid encoding for 
enhanced GFP to allow identification of transfected cells.
The cells are left for 24 hours to allow expression of the recombinant GABAa 
receptors at the cell surface.
Whole-cell currents can then be recorded in response to applied GABA, over time, 
as pre-activated CaMK-II within the patch pipette dialyses into the cell and 
modulates the response (dotted lines).
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3.2 RESULTS
In order to characterise the effect of CaMK-II on GABAa receptor mediated 
currents recombinant GABAa receptors were expressed in HEK293 cells. The cells 
were transfected by electroporation with cDNAs for specific GABAa receptor 
subunits in equal ratio (1:1:1) and enhanced GFP to allow easy identification of 
transfected cells (See Chapter 2). The GABAa receptor a  and j(3 subunits, when 
expressed together, are known to form robust functional channels that respond to 
GABA (Levitan et al., 1988a; Levitan et al., 1988b; Sigel et al., 1990; Connolly et 
al., 1996). To simplify the search for the effect(s) of CaMK-II on GABAa receptors, 
initial experiments involved HEK cells expressing od/32 and cd/33 alone, as the y2 
subunit also possesses potential phosphorylation sites for this kinase (Machu et al., 
1993; McDonald and Moss, 1994).
Whole-cell patch clamp recordings were conducted to measure GABA 
mediated currents. To assess the stability of these currents over time, a fixed 
concentration of GABA (10 pM) was applied every 2 min for 20-30 min. The peak 
amplitude was then normalised to the peak amplitude recorded 3-4 min after 
achieving the whole cell configuration. Under control conditions, the peak amplitude 
of the GABA-activated current remained at a relatively constant level for the time of 
recording with only a slight decrease of about 10-20 % apparent over 30 min (Fig 
3.2-3.4). This “run-down” of GABAa receptor currents has been observed in 
neurones and in recombinant expression systems and is thought to be associated with 
a disruption of the phosphorylation state(s) of the receptor. This is possibly through
94-depletion of ATP or an alteration in the concentration of unbuffered Ca caused by 
differences between the internal pipette solution and the normal intracellular milieu
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(Stelzer et al., 1988; Chen et al., 1990; Huang and Dillon, 1998; Laschet et al., 
2004).
3.2.1 Recombinant al/32 receptors and Of-CaMK-II.
Purified recombinant Of-CaMK-II (Brickey et al., 1990; Suzuki-Takeuchi et 
al., 1992) was pre-incubated in 1.2 pM Calmodulin (CaM), 10 mM MgCl2, 2 mM 
CaCl2 and 0.4 mM ATP-y-S to promote autophosphorylation at Thr286 (McGlade- 
McCulloh et al., 1993; Lledo et al., 1995; Wang et al., 1995; Barria et al., 1997; 
Nelson et al., 2005). This recombinant form of a-CaMK-II represents a structurally 
simplified form of the kinase that cannot form a holoenzyme but which is capable of 
phosphorylating the same substrates as the full length form of the kinase (Suzuki- 
Takeuchi et al., 1992). This recombinant form of a-CaMK-II can be extracted and 
purified after being expressed at high levels in an appropriate cell line, avoiding the 
difficulties associated with obtaining purified CaMK-II from whole-brain extracts. 
In addition this monomeric form of the kinase has a molecular weight of 33 kDa as 
opposed to the full holoenzyme with a molecular weight of 600 kDa thereby 
avoiding problems associated with diffusion of such a large molecule out of the patch 
pipette and into the cell.
ATP-y-S was used rather than ATP in the pre-activation/autophosphorylation 
reaction, as thiophosphorylated proteins are less subject to dephosphorylation by the 
endogenous protein phosphatases that might be present in the HEK cell. The a- 
CaMK-II and the pre-activation buffer were then diluted into the pipette solution 
immediately before recording and then maintained on ice (See Chapter 2). To 
determine that the pre-activation buffer had no effect on GABA mediated currents,
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all controls included a mock pre-activation buffer (lacking a-CaMK-II) diluted into 
the pipette solution at the same ratio.
In previous experiments using a similar form of recombinant a-CaMK-II, 
200 nM a-CaMK-II significantly potentiated GABA mediated currents in rat dorsal 
hom and hippocampal neurones (Wang et al., 1995). Since HEK293 cells are more 
compact without the large processes of neurones to diffuse through, the 
concentration of a-CaMK-II was reduced to 100 nM (3.33 ng/pl, See Chapter 2). 
This concentration should be sufficient to allow phosphorylation of the GABAa 
receptor without compromising the quality of recordings. In HEK cells expressing 
cd/32 subunits, the addition of 100 nM pre-activated a-CaMK-II in the patch pipette 
induced no significant differences from control GABA currents over a recording 
period of 30 min. Control currents recorded in response to application of 10 pM 
GABA at t = 10 min was 88.5 ± 2.3 % (Fig 3.2A, n = 13) and in the presence of a- 
CaMK-II at t = 10 min was 87.5 ±3.1 % (Fig 3.2A, n = 5).
In addition, purified rat forebrain CaMK-II (full-length, consisting of a 
mixture of a, (3, y  and 5 subunits) was also used and pre-activated in a similar way 
(co-incubation with 10 mM MgCl2, 1 pM CaM, 0.2 mM EGTA, 0.3 mM CaCl2, 0.4 
mM ATP-y-S; See Chapter 2). This form of CaMK-II (60-100 nM) also had no 
significant effects on GABA mediated currents which attained 87.8 ± 1 . 8 % a t t = 1 0  
min (n = 4, Fig 3.4A) as compared to control (88.5 ± 2.3 %, n = 13; Fig 3.2A). This 
form of CaMK-II was tested biochemically and shown to be capable of 
phosphorylating the /33 subunit intracellular domain in vitro, after the pre-activation 
reaction and in the presence of 150 mM KC1, used to simulate conditions in the patch 
pipette solution (in collaboration with Dr. J. Jovanovic; Fig 3.4B).
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As an alternative method, HEK cells were transfected with al/32 cDNA and 
with cDNA for a-CaMK-II in equal ratio. Inclusion of a relatively high CaM 
(600 nM) concentration in an internal solution with a higher free Ca2+ (10 pM) 
concentration may be expected to activate a-CaMK-II expressed in the HEK cells 
and thereby modulate GABA mediated currents. However no significant differences 
were seen between control recordings without CaMK-II co-transfection, CaMK-II 
co-transfection with normal patch pipette solution, and CaMK-II co-transfection with 
a high CaM and high free Ca2+ patch pipette solution. The free Ca2+ concentration in 
the pipette solution was altered by changing the ratio between EGTA : CaCl2 from 
10:1 (10 nM free Ca2+) in the normal pipette solution to 1:1 (10 pM free Ca2+- 
(Aguayo et al., 1998). After 10 minutes recording, GABA current amplitudes were: 
Control, 88.5 ± 2.3 % (n = 13); CaMK-II co-transfection, 92.9 ± 5 % (n = 5); and 
CaMK-II co-transfection with additional Ca2+/CaM, 96.4 ± 6.2 % (n = 9, Fig 3.2B).
Previously, it has been demonstrated that CaM itself can have a functional 
effect on some ion channels including ligand-gated ion channels like GABAa 
receptors. For instance it can have a direct inhibitory effect on NMDA receptor 
function (Ehlers et al., 1996; Zhang et al., 1998; Rycroft and Gibb, 2002). It can 
also activate CaM dependent phosphatases such as PP2B/Calcineurin, which may 
have a direct effect on the GABAa receptor (Jones and Westbrook, 1997; Wang et 
al., 2003). In order to determine whether CaM itself was modulating GABAa 
receptor function and occluding CaMK-II dependent effects, GABA currents were 
recorded in the presence of higher concentrations of CaM (1.5 pM) alone. However 
there were no significant differences observed between control GABA current 
amplitudes, 88.5 ± 2.3 % (Fig 3.2C, n = 13), and those in the presence of CaM, 90.5 
% ± 4.2 % (Fig 3.2C, n = 6 ) at t = 10 min.
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Taken together it appeared that CaMK-II had no functional effect on al/32 
subunit-containing GABAa receptors expressed in HEK293 cells. Interestingly, 
cAMP-dependent kinase (PKA) was also unable to functionally modulate cd/32 
subunit-containing receptors in HEK cells but had a significant effect on whole-cell 
currents recorded from cd/?3 subunit-containing receptors (McDonald et al., 1998). 
Therefore the same series of experiments with CaMK-II were repeated in HEK293 
cells expressing al/53 subunits.
Fig 3.2:
250 t
A
c  200-
Id  150^
<
GO
< 100  ^
"OJ 50-i
CD
E
•  100nM aCaMK-ll
#  C o n tr o l- a lp 2
D a-CaMK-ll in patch pipette 
10pM GABA
—i   r
0 5 10 15 20 25 30
200pA [_  
1s
Tim e (mins) t = 2 min t = 10 min
250 n
c  2 0 0 -
IIE
0  150H 
<CO
g  100H 
"5
50H
CD
1 0
g  •  C o - t r a n s f e c t io n  a C a M K -l l  c D N A
High C a 2+ p ip e t te  so lu t io n  + 6 0 0 n M  C aM
•  C o - tr a n s f e c t io n  a C a M K -l l  c D N A
•  C o n t r o l - a i p 2  
- • = • = 1= ^ 1= ; ; ^ = ,
5 10 15
T im e  (m in s )
20
250 n
c  2 0 0 -
E 
1—
o  150H 
<CO
§  10CH
T3 0^
 5 0 -j
CD
E
o 0
•  1 .5pM  C a M
#  C o n t r o l - a i p 2
5 10 15
T im e  ( m in s )
20
100
Fig 3.2: o?-CaMK-II modulation of whole-cell currents recorded from HEK293 
cells expressing alff2 subunits.
Peak amplitudes of GABA-mediated currents recorded following the application of 
10 pM GABA to transfected HEK293 cells expressing cd/32 GABAa receptors. 
GABA was re-applied at 2 min intervals for up to 30 min. All currents were 
normalised to the peak amplitude of the response measured during the first 3-4 min 
(= 100 %) after achieving the whole-cell configuration (t = 0 min). Control 
recordings were made with normal patch pipette solution supplemented with the pre­
activation buffer without a-CaMK-II.
(A) GABA currents recorded in the absence (Control, n = 13) and presence of 
100 nM pre-activated a-CaMK-II, which was introduced into the cells via the patch 
pipette solution (n = 5).
(B) Using HEK293 cells now also transfected with a-CaMK-II cDNA, GABA 
currents were recorded using two different patch pipette solutions, containing: 
normal Ca2+ buffered patch pipette solution (EGTA 10:1 CaCl2, free Ca2+ 10 nM; 
n = 5); and a solution supplemented with CaM (600 nM) and high Ca (EGTA 1:1 
CaCl2, free Ca2+ 10 pM; n = 9). The control cells were transfected with cDNA for 
al/32 only (Taken from 3.2A, n = 13).
(C) GABA currents recorded from HEK293 cells expressing only cd/32 GABAa 
receptors using either a normal patch pipette solution (Taken from 3.2A, Control, 
n = 13) or one supplemented with 1.5 pM CaM (n = 6).
(D) Representative 10 pM GABA-activated currents recorded at t = 2 and 10 min 
following internal dialysis with 100 nM O'-CaMK-II in the patch pipette solution.
All points represent the mean ± s.e.
In A, B and C, the exposure to a-CaMK-II or CaM did not significantly affect the 
GABA currents recorded.
P < 0.05, t-test, ANOVA.
101
3.2.2 Recombinant al/33 GABAa receptors and CaMK-II
The addition of autophosphorylated a-CaMK-II to the pipette solution also 
had no significant effects on GABA mediated currents compared to control in cells 
expressing al/33 (Control = 92 ± 3.3 %, n = 11; + CaMK-II = 81.7 ± 4.5 %, n = 6; 
Fig 3.3A, t = 10 min). Furthermore, the co-transfection with a-CaMK-II cDNA and 
the addition of CaM to a high Ca2+ containing patch pipette solution had no 
significant effects on GABA (10 pM) currents compared to control (Control = 92 ±
3.3 %, n = 11, a-CaMK-II transfection + CaM = 85.2 ± 2.9 %, n = 4, t = 10 min, Fig 
3.3A). Finally the addition of 1.5 pM CaM alone to the pipette solution also had no 
significant effects on the al/33 GABAa receptors (Control = 92 ± 3.3 %, n = 11, + 
CaM = 92.2 ± 3.5 %, n = 6, t = 10 min, Fig 3.3C).
Pre-activated CaMK-II purified from rat forebrain also had no significant 
effect on GABA mediated currents recorded from HEK293 cells expressing al/33 
(84.4 ± 11.3 %, n = 5, t = 10 min, Fig 3.4A). Taken overall CaMK-II was unable to 
modulate al/33 subunit-containing receptors in HEK cells.
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Fig 3.3: a-CaMK-II modulation of whole-cell currents recorded from HEK293 
cells expressing al/33 subunits.
Peak amplitudes o f  G ABA-m ediated currents recorded follow ing the application o f  
10 pM  G A B A  to transfected HEK293 cells expressing al/33 G A B A a receptors. 
G A B A  w as re-applied at 2 min intervals for up to 30 min. A ll currents were 
normalised to the peak amplitude o f  the response measured during the first 3-4 min  
(= 100 %) after achieving the w hole-cell configuration (t =  0 min). Control 
recordings were made with normal patch pipette solution supplemented with the pre­
activation buffer without a-CaMK-II.
(A) G A B A  currents recorded in the absence (Control, n =  11) and presence o f  100 
nM pre-activated a-CaM K-II, which was introduced into the cells via the patch 
pipette solution (n =  6).
(B) U sing HEK293 cells now also transfected with a-CaM K-II cD N A , G A B A  
currents were recorded using normal patch pipette solution supplemented with CaM  
(600 nM ) and high Ca2+ (EGTA 1:1 CaCl2: free Ca2+ * 1 0  nM; n =  4). The control 
cells were transfected with G A B A a receptor cD N A s only (Taken from 3.3A, 
Control, n =  11).
(C) G A B A  currents recorded from HEK293 cells expressing only al/33 G A B A a 
receptors using either a normal patch pipette solution (Taken from 3.3A, Control, n 
=  11) or one supplemented with 1.5 pM  CaM (n =  6).
A ll points =  mean ±  s.e.
In A, B and C, the exposure to a-CaM K-II or CaM did not significantly affect the 
G A B A  currents recorded.
P <  0.05, t-test.
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Fig 3.4: Purified ra t forebrain CaMK-II phosphorylation of the #3 subunit in 
vitro and modulation of GABA currents in HEK293 cells.
(A) GABA currents recorded with patch pipette solution supplemented with 
purified pre-activated CaMK-II (60-100 nM) from HEK293 cells expressing cd/32 
(n = 4) and al/33 (n = 5). All points are mean ± s.e.
(B) Purified pre-activated CaMK-II incubated with GST-P3 and 32P-ATP at 25°C 
or 5°C with or without 150 mM KCI, visualized by autoradiography. 
Phosphorylation reaction was carried out in collaboration with Dr J. Jovanovic 
(See Chapter 2).
104
3.2.3 Recombinant aljff2/372  GABAa receptors and CaMK-II.
The y2 subunit also contains potential phosphorylation sites for CaMK-II as 
identified by studies involving GST-fusion proteins in vitro (Machu et al., 1993; 
McDonald and Moss, 1994). It is also thought that GABAa receptors require a y 
subunit to form functional synaptic receptors (Essrich et al., 1998; Brickley et al., 
1999; Studler et al., 2002). Therefore the possibility remained that CaMK-II 
dependent modulation may be solely dependent upon the y2  subunit, which would 
explain why the modulation was not observed on aft heteromers. Recordings were 
made from HEK cells expressing cd/32y2S and cd/33y2S with 100 nM a-CaMK-II in 
the patch pipette. As for the aft heteromers again no significant differences in the 
10 pM GABA currents were observed from control in either case (Fig 3.5A, 3.5B). 
Given that the proposed stoichiometry for an afty subunit-containing receptor is 
thought to be 2:2:1 (Chang et al., 1996; Tretter et al., 1997) transfection of HEK 
cells with cDNA for each subunit in a ratio of 1:1:1 should ensure an overabundance 
of y2 cDNA and a preference for afty subunit-containing receptors at the cell surface. 
There remains a possibility that some aft subunit-containing GABAa receptors may 
have been present and there is evidence that this can occur in HEK cells (Boileau et 
al., 2003). There is also, however, evidence that when aft and y  subunits are 
expressed together within a cell line afty channels are formed preferentially (Farrar et 
al., 1999) and that the ratio of cDNA has to be increased to afty 1:4:1 before aft 
receptors can be detected alongside afty (Angelotti et al., 1993; Angelotti and 
Macdonald, 1993). Angelotti et al, (2004) also observed that incorporation of the y2 
subunit increased the peak amplitudes of the currents recorded. This was also 
observed in the current study (Fig 3.2D, Fig 3.5C). For the purposes of this 
experiment there should have been sufficient expression of y2S subunit-containing
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receptors at the cell surface to determine if CaMK-II can functionally modulate these 
receptors.
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Fig 3.5: a-CaMK-II modulation of whole-cell currents recorded from HEK293 
cells expressing a l# 272S and criff3V2S subunits.
Peak amplitudes of GABA-mediated currents recorded following the application of 
10 pM GABA to transfected HEK293 cells expressing al(32y2S and al/33 t2S 
GABAa receptors. GABA was re-applied at 2 min intervals for up to 30 min. All 
currents were normalised to the peak amplitude of the response measured during the 
first 3-4 min (= 100 %) after achieving the whole-cell configuration (t = 0 min). 
Control recordings were made with normal patch pipette solution supplemented with 
the pre-activation buffer without a-CaMK-II.
(A) GABA currents recorded from HEK293 cells expressing al/3272S in the absence 
(Control, n = 6) or presence of 100 nM a-CaMK-II (n = 6).
(B) GABA currents recorded from HEK293 cells expressing a l ^ ^ S  in the absence 
(Control, n = 5) or presence of 100 nM CaMK-II (n = 8).
(C) Representative 10 pM GABA-activated currents recorded from HEK293 cells 
expressing alpl'fl.S receptors a t = 2 and 10 min following internal dialysis with 
100 nM a-CaMK-II in the patch pipette solution.
Note: Increased current amplitude compared to Fig 3.2C.
All points = mean ± s.e.
In A, B and C, the exposure to a-CaMK-II or CaM did not significantly affect the 
GABA currents recorded.
P < 0.05, t-test.
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3.3 DISCUSSION
CaMK-II has previously been shown to modulate GABAa receptor mediated 
currents in neurones that are known to express predominantly /32/3 and y2 subunits 
(Wang et al., 1995; Kano et al., 1996; Wei et al., 2004). Biochemical analysis of 
CaMK-II dependent phosphorylation of fusion proteins formed from the intracellular 
loops of different subunits, indicates that the /3 and y subunits are the main candidates 
for phosphorylation (McDonald and Moss, 1994; Connolly et al., 1996; McDonald 
and Moss, 1997). However, the present study shows that the expression of receptors 
containing /32/3 and y2S in HEK cells are not functionally modulated by CaMK-II.
It is possible that other subunits or subunit combinations that were not tested 
here are responsible for the CaMK-II mediated effect observed in neurones. For 
instance there is a potential site for phosphorylation in the 8 amino acid insert in the 
y2L splice variant. There are also potential sites for CaMK-II phosphorylation on the 
/31 subunit (See Chapter 1, Table 1.1). The majority of /? subunits expressed 
throughout the brain are /32 followed by lower levels of /53 and /31 (Benke et al.,
1994). The expression of y2 is widespread with relatively low expression levels of 
other y isoforms in a few selected cell types (Persohn et al., 1992; Wisden et al., 
1992; Laurie et al., 1992a; Laurie et al., 1992b; Pirker et al., 2000). CaMK-II 
dependent effects GABAa receptors have been observed in hippocampal CA1 
neurones, which are thought to express /32/3/y2 subunits. CaMK-II mediated effects 
have also been observed in cerebellar Purkinje cells that are thought to express 
predominantly orl/32y2 receptor subunits (Persohn et al., 1992; Laurie et al., 1992a) 
and so it would be predicted therefore, that GABAa receptors containing /32/3/y2 are 
good candidates for CaMK-II dependent modulation.
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More recently, it has been suggested that the GABAa receptor a l subunit 
may also be phosphorylated by CaMK-II and that this phosphorylation modulates 
agonist and allosteric-modulator binding (Chum et al., 2002). This subunit was 
included in all of the combinations tested and there was no evidence of altered 
GABAa receptor function. The majority of biochemical studies have identified (3 and 
7  and not a  as the main sites of phosphorylation suggesting the a  subunit is a poor 
substrate for phosphorylation (Moss et al., 1992; McDonald and Moss, 1994; Moss 
and Smart, 1996).
Given the contradictory nature of the literature and the present results it is a 
more likely possibility that CaMK-II dependent modulation of GABAa receptor 
mediated currents is not possible in HEK293 cells because of an inherent difference 
between a neuronal environment and that of a HEK cell which is of epithelial origin. 
For instance the background of protein kinase and protein phosphatase activity 
within the intracellular milieu may be quite different. A very high level of 
phosphatase activity in HEK cells may act to prevent any modulation by CaMK-II by 
acting to dephosphorylate the GABAa receptor itself. Recombinant GABAa 
receptors expressed within different cell lines have been shown to display different 
functional properties. Comparison of a\(32y2 mediated currents recorded in HEK293 
cells and QT6 cells reveals that the deactivation kinetics of the receptor can be 
modulated by the cell type used for expression. Possibly, this may result because of 
differences in endogenous kinases and phosphatases, or in the proteins linking the 
receptors to the cytoskeleton (Mercik et al., 2003). In support of this there is 
evidence that the scaffolding protein GABARAP, which is thought to promote 
clustering of GABAa receptors, also affects the channel properties of the receptor
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when GABARAP and GABAa receptors are co-expressed in L929 cells (Everitt et 
al., 2004).
In addition, there is some evidence that HEK293 cells can express 
endogenous GABAa receptor subunits that can co-assemble with subunits 
transfected into the cell altering the observed properties of the GABAa receptor 
mediated currents recorded from HEK293 cells (Ueno et al., 1996). However, this 
scenario has not been reported by all laboratories using HEK293 cells (Pritchett et 
al., 1988) and has not been observed using the batches of HEK293 cells used in the 
current experiments (Connolly et al., 1996; Thomas and Smart, 2005).
Despite these potential reservations, it is also clear that HEK cells have been 
used quite successfully in the study of PKA, PKC and the tyrosine kinase Src on 
GABAa receptor function (Moss et al., 1995; McDonald et al., 1998; Brandon et al., 
2002b). The apparent inability of CaMK-II to modulate receptor function in 
HEK293 cells may simply reflect the inability of CaMK-II to associate with the 
GABAa receptor in these cells.
There is a possibility that the diffusion of CaMK-II into the cell was too slow 
to reach full concentration in the time allowed. However, co-transfection of cDNA 
for CaMK-II would have produced a large amount of CaMK-II within the HEK cell 
before electrophysiological recording. The addition of CaM and an increase in free 
Ca still produced no obvious modulation of GABAa receptors. A recombinant 
form of a-CaMK-II, identical to the one used in these experiments, has been shown 
to have a diffusion coefficient of 4-5 pm2/s within rat basophilic leukemia cells (RBL 
2H3) (Shen and Meyer, 1998). This should be sufficient to allow diffusion 
throughout the relatively compact HEK cell within the time allowed. Examination of 
CaMK-II effects on AMPA receptors within HEK cells using a similar form of
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recombinant, truncated CaMK-II, activated by a similar autophosphorylation 
protocol, showed a significant modulation of currents within 10 min (Barria et al., 
1997). Another experiment with the same form of CaMK-II and using the in vitro 
autophosphorylation procedure as described in this study also demonstrated a 
functional effect on excitatory post synaptic currents (EPSCs) and whole-cell 
responses to AMP A in hippocampal pyramidal cells within 10-20 min (Lledo et al.,
1995).
There is also a possibility that CaMK-II activity was low when in the patch 
pipette solution either due to problems with the pre-activation reaction or due to 
deactivation within the patch pipette solution. This could be tested functionally by 
applying the same preparation to a neurone to establish whether neuronal GABAa 
receptors could be modulated by CaMK-II. Under such conditions, the same 
recombinant a-CaMK-II preparation as that used to record from HEK293 cells could 
functionally modulate GABA mediated currents recorded from cerebellar granule 
cells (See Chapter 4).
In addition to recombinant a-CaMK-II a second preparation of purified rat 
forebrain CaMK-II consisting of a mixture of different isoforms of CaMK-II was 
also pre-activated and added to the patch pipette solution. This preparation of 
CaMK-II was tested for its ability to phosphorylate a GST-fusion protein of the 
intracellular loop of the j33 subunit (See Fig 3.4B). This form of CaMK-II was 
shown to be able to phosphorylate the /33 subunit TM3-4 intracellular loop in vitro 
(McDonald and Moss, 1997) but the same preparation also failed to significantly 
modulate GABA currents recorded from HEK293 cells expressing al/32/3 after being 
included in the patch pipette in the same way as the recombinant a-CaMK-II (See 
Fig 3.4).
I l l
The evidence that CaMK-II can directly phosphorylate GABAa receptors 
conies from analysis of GST-fiision proteins (McDonald and Moss, 1994; McDonald 
and Moss, 1997). The results indicated that CaMK-II could phosphorylate j81/2 and 
3 receptor subunits and y2S/L at previously identified consensus sites on the 
intracellular loop between TM 3 and 4 (See Chapter 1, Table 1.1). It should be noted 
however that fusion proteins are not directly comparable to full-length, native 
receptor subunits. For example the /32 subunit cannot be functionally modulated by 
PKA within HEK293 cells although it can be phosphorylated in vitro (McDonald et 
al., 1998). It therefore needs to be confirmed that full-length native GABAa 
receptors can be phosphorylated by CaMK-II. It is possible that within neurones 
CaMK-II does not phosphorylate the GABAa receptor directly, acting instead, 
through another kinase or signalling pathway.
The signalling cascade involved in forms of excitatory plasticity such as LTP 
requires CaMK-II for induction. It has been revealed there are two mechanisms of 
action involved in CaMK-II modulation of AMP A receptors (Poncer et al., 2002). 
One involves a direct phosphorylation of the GluRl subunit at Ser831 (Barria et al., 
1997) and the other involving an insertion of AMP A receptors into the postsynaptic 
membrane. This insertion of receptors does not occur through direct phosphorylation 
but through CaMK-II dependent activation of a downstream-signalling cascade 
involving Ras/Rap GTPases (Hayashi et al., 2000; Zhu et al., 2002). So CaMK-II 
can act both directly and indirectly to modulate AMPA receptor function. It is 
interesting, however, that CaMK-II modulation of AMPA receptors can be observed 
in HEK cells (Barria et al., 1997), suggesting there is a key difference between 
CaMK-II modulation of AMPA and GABAa receptors.
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CaMK-II is found in high levels throughout the brain and has a large number 
of potential substrates (Hudmon and Schulman, 2002). It may be that in order to 
phosphorylate the GABAa receptor or other targets successfully, it has to be targeted 
to the correct location. Anchoring proteins can restrict the subcellular location, at 
which a signalling molecule like CaMK-II exerts its effect, controlling which 
substrates are phosphorylated, by the location of the kinase (Bayer and Schulman, 
2001; Schulman, 2004; Colbran, 2004). Such anchoring proteins can also have a 
direct effect on the activity of the kinase. The interaction between CaMK-II and the 
NMDA receptor is one example of this. Binding of CaMK-II to the NMDA receptor 
acts in the same way as Ca2+/CaM binding, allowing CaMK-II to be active when 
bound to the NMDA receptor. In this way CaMK-II is localised to a specific 
location and its activity is altered through an interaction with a binding partner 
(Bayer et al., 2001).
A number of potential CaMK-II anchoring proteins have been identified 
which localise the kinase to targets of phosphorylation (See Chapter 1). E.g. CaMK- 
II binding to the NMDA receptor (Strack et al., 2000; Bayer et al., 2001) localising 
the kinase at the excitatory post-synaptic density (PSD). In addition a non-catalytic 
subunit of CaMK-II has been identified which can localise CaMK-II to the 
sarcoplasmic reticulum in muscle cells (Bayer et al., 1998). It is thought that there 
are probably a number of other proteins with a similar function that have yet to be 
identified (Bayer and Schulman, 2001; Griffith et al., 2003; Colbran, 2004).
Other serine/threonine kinases like PKC are known to interact with anchoring 
proteins at the GABAa receptor, e.g. RACK-1, which binds to the GABAa receptor 
enhancing PKC phosphorylation of Ser409 (Brandon et al., 2002b). Furthermore the 
anchoring protein, AKAP150 can also directly bind the GABAa receptor and has
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been shown to be critical for PKA mediated phosphorylation of the j83 subunit 
(Brandon et al., 2003). Currently relatively little is known about the scaffolding and 
signalling complexes that exist for the GABAa receptor at inhibitory synapses. It 
may be that in order for CaMK-II to exert its effect, an additional anchoring protein 
may be required which is not present in HEK cells or alternatively, that CaMK-II 
phosphorylates another substrate closely linked to the GABAa receptor which then 
goes on to modulate GABAa receptor function.
It may be possible to determine in a neuronal preparation which subunits are 
important for CaMK-II modulation through transfection of neurones or the use of 
knock-out animals lacking specific subunits of the GABAa receptor. It seems a 
neuronal system or neuronal cell-type environment may be crucial to reliably 
determine the signalling pathways and mechanisms of action involved in CaMK-II 
dependent modulation of GABAa receptors. It is also important to try to determine 
if CaMK-II directly phosphorylates the GABAa receptor, or if  it acts through another 
kinase or signalling pathway.
3.4 CONCLUSIONS
• Intracellular dialysis of two different preparations of pre-activated 
CaMK-II failed to modulate cri/32/3'y2 GABAa receptors.
•  Co-transfection with a-CaMK-II cDNA and intracellular dialysis of CaM 
and Ca2+ fails to modulate GABAa receptors expressed in HEK293 cells.
•  Intracellular dialysis of CaM alone also had no effect on the amplitude of 
GABA mediated currents.
•  Recombinant GABAa receptors expressed in HEK293 cells cannot be 
modulated by CaMK-II.
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Chapter Four:
CaMK-II dependent modulation of GABAa receptors in
cerebellar granule cells.
4.1 INTRODUCTION
CaMK-II has previously been shown to modulate GABAa mediated currents 
in a number of neuronal preparations (Kano et al., 1992; Wang et al., 1995; Kano et 
al., 1996; Aguayo et al., 1998; Kawaguchi and Hirano, 2002; Mizoguchi et al., 2003; 
Wei et al., 2004). In order to confirm these results it was necessary to repeat the 
experiments of the previous chapter in a neuronal cell type, given the lack of 
significant modulation observed in HEK293 cells. The same protocols that were 
applied in chapter three were adapted for cerebellar granule cells maintained in 
culture. The aim was to determine if CaMK-II can modulate GABAa receptors in 
this cell type and if  so, to characterise this modulation.
Intracellular dialysis of pre-activated a-CaMK-II has been previously shown 
to increase the peak amplitude of whole-cell GABA currents and EPSCs recorded in 
rat spinal dorsal horn neurones, hippocampal pyramidal and cerebellar Purkinje cells 
(Wang et al., 1995; Kano et al., 1996). Calcium dependent increases in the peak 
amplitude of GABAa mediated currents that could be blocked by CaMK-II inhibitors 
have also been observed in mouse cortical neurones and hippocampal pyramidal 
neurones (Aguayo et al., 1998; Mizoguchi et al., 2003; Wei et al., 2004). As CaMK- 
II dependent modulation of GABAa occurs in a range of different neuronal cell 
types, it seemed reasonable to assume that CaMK-II dependent modulation of 
GABAa receptors might be observed in cerebellar granule cells (CGCs). CGCs are 
thought to express a wide variety of different GABAa receptor subunits (Wisden et
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al., 1996) so if  only certain subunits of GABAa receptors could be modulated by 
CaMK-II there was a high probability that they would exist in CGCs. This array of 
subunits could be important, since some GABAa receptors are differentially sensitive 
to phosphorylation. For example, the expression of different /3 subunits has been 
shown using heterologous expression systems and in neuronal preparations to alter 
the response to PKA phosphorylation (McDonald et al., 1998; Nusser et al., 1999).
Equally important in determining the phosphorylation state of GABAa 
receptors, and therefore potential changes in function, are protein phosphatases, 
which act to dephosphorylate the GABAa receptor itself and can also regulate 
CaMK-II activity. Wang and colleagues (1995) demonstrated that in isolated spinal 
dorsal hom neurones the addition of calyculin A, an inhibitor of protein phosphatase 
1 (PP1) and protein phosphatase 2A (PP2A), caused an increase in the peak 
amplitude of whole-cell GABA currents recorded similar to that observed after the 
addition of pre-activated CaMK-II. Although PP1, PP2A and protein phosphatase 
2B (PP2B)/calcineurin have been shown to directly modulate GABAa receptor 
mediated currents (Wang et al., 2003; Jovanovic et al., 2004; Terunuma et al., 2004; 
Sanchez et al., 2005), protein phosphatases can also directly modulate CaMK-II 
activity. For example in neurones, phosphatases can alter the levels of Thr286 
autophosphorylation and also the inhibitory autophosphorylation sites Thr30576 
(Fukunaga et al., 1989; Fukunaga et al., 1993; Kasahara et al., 1999; Colbran, 2004), 
which will have indirect consequences for GABAa receptor function.
The dynamic balance between phosphatase and kinase activities will 
determine the overall phosphorylation state of the receptor and result in altered 
function accordingly. Therefore the phosphatase inhibitor okadaic acid (OA) was 
used to determine the role of various phosphatases in cerebellar granule cells in
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altering GABAa receptor function. At different concentrations, OA inhibits various 
protein phosphatases (Bialojan and Takai, 1988) and so the relative contribution of 
different protein phosphatases in modulating GABAa receptor function could be 
determined. The relative balance between CaMK-II activity and phosphatase 
activity, under basal conditions, could then be determined in CGCs under these 
particular culture conditions.
4.2 RESULTS
Rat cerebellar granule cells were cultured in a 20 mM KCI supplemented, 
serum free medium and recorded from after 10-14 days in vitro (DIV, See Fig 2.IB). 
A recombinant form of a-CaMK-II, (Brickey et al., 1990; Suzuki-Takeuchi et al., 
1992) 1200-1500 nM (40-50 ng/pl), was pre-incubated in 2 mM CaCk,1.2 pM CaM, 
0.4 mM ATP-y-S, 10 mM MgCh in a total volume of 16-20 pi (See Chapter 2 and 
3.2.1). This was then transferred to the patch pipette solution at a dilution of at least 
1:12 and maintained on ice throughout the recording (Brickey et al., 1990; Suzuki- 
Takeuchi et al., 1992; McGlade-McCulloh et al., 1993). Controls consisted of using 
the same patch pipette solution containing pre-activation buffer diluted at the same 
ratio but without a-CaMK-II present or with heat-inactivated a-CaMK-II (95°C for 
15 min). Whole-cell patch clamp recordings were then made in response to 10 pM 
GABA applied intermittently for a period of 15-20 min. Cerebellar granule cells 
have very small cell bodies. Their relatively compact morphology results in 
recordings with very low noise and high fidelity for voltage clamp; however, due to 
their size, recordings of over 20  min were often difficult to maintain.
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4.2.1 Cerebellar granule cells in culture and modulation by a-CaMK-II
The inclusion of 100 nM a-CaMK-II in the patch pipette solution and 
subsequent dialysis into the cell resulted in a significant increase in the peak 
amplitude of GABA currents to 204.9 ± 24.7 % (n = 7) as compared to control 
currents, 96.5 ± 4.2 % (n = 7, Fig 4.1 A) 10 min into the recording. A reduction in 
the concentration of a-CaMK-II to 35 nM resulted in a smaller, but still statistically 
significant, increase in the peak amplitude of GABA currents recorded to 127.3 ± 4.7 
% (n = 7, Fig 4.1 A) at t = 10 min. It appeared therefore that the effect of a-CaMK-II 
was dose-dependent and reached a plateau within 10 min. As a second control, a- 
CaMK-II was heat-inactivated and applied in the same way (100 nM). In this case 
no increase was observed compared to control currents (93 ± 7.3 %, n = 7, Fig 4.1 A) 
at t = 10 min.
To confirm that this effect is present in different neuronal cell types, 85 nM 
pre-activated a-CaMK-II was added to the patch pipette solution and whole-cell 
currents were recorded from cortical pyramidal neurones in culture (DIV6 -8). 
Reducing the concentration to 85 nM improved the quality and duration of 
recordings whilst producing an easily observed effect. Intracellular addition of 
85 nM a-CaMK-II led to a significant increase in the peak amplitude of GABA 
currents recorded to 122.3 ± 5.3 % (n = 14, Fig 4.1C) at t = 10 min as compared to 
the equivalent time in control, 90.2 ±4.1 % (n = 9, Fig 4.1C). The increase in this 
case appeared to be proportionately smaller than in CGCs and diminished to control 
levels within 25 min. In CGCs the effect remained stable and did not decay, 
although recordings of over 20  min were not routinely possible.
In order to further characterise the nature of this up-regulation of GABAa 
receptor function the dose-response relationship to GABA was determined under
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control conditions at t = 10 min and in the presence of 85 nM a-CaMK-II. The EC50 
value for GABA in the presence of a-CaMK-II was 6.3 ± 0.5 pM (n = 13, Fig 4.2), 
and in control conditions, it was not significantly different, at 5.9 ± 0.7 pM (n = 12, 
Fig 4.2). Indicating there was no change in the potency of GABA at these receptors. 
There was also no significant difference in the Hill slope (Control = 0.85 ± 1.7, 
CaMK-II 0.93 ± 0.6). However the maximal response to GABA appeared to have 
significantly increased from 127.4 ±15.1 pA/pF to 212.1 ± 26.1 pA/pF.
Fig 4.1:
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Fig 4.1: a-CaMK-II modulation of whole-cell GABA currents recorded from
cerebellar granule and cortical pyramidal cells in culture.
Peak amplitudes o f  GABA-m ediated currents were recorded after application o f  
10 pM  G A B A  to cerebellar granule or cortical pyramidal neurones in culture. 
G A BA  w as re-applied at 2 m in intervals for up to 30 min. A ll currents were 
normalised to the peak response o f  the G A BA  current measured during the first 3-4  
min (=  100 %) after achieving the w hole-cell configuration (t =  0 min). Control 
recordings were made with normal patch pipette solution supplemented with the pre­
activation buffer without a-CaMK-II.
(A ) G A B A  currents recorded from cerebellar granule neurones using patch pipette 
solution supplemented with 100 nM pre-activated a-CaM K-II (n =  7), 35 nM  
a-CaM K-II (n = 7), 100 nM heat-inactivated (HI) a-CaM K-II (n =  7) or in the 
absence o f  CaMK-II (Control, n =  6).
(B) Representative 10 pM  GABA-activated currents recorded from a cerebellar 
granule cell at t =  2 and 10 min follow ing internal dialysis with 100 nM a-CaM K  in 
the patch pipette solution
(C) G A B A  currents recorded from cortical pyramidal neurones in the absence 
(Control, n =  14) or presence o f  85 nM a-CaM K-II introduced into the cells via the 
patch pipette solution (n =  9).
A ll data points =  mean ±  s.e.
Significance is indicated by the symbol * (100 nM) * (35 nM ), CaMK-II compared 
to control and *, CaMK-II (35 nM and 100 nM) compared to HI CaMK-II.
P <  0.05, t-test, A N O V A .
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Fig 4.2: The concentration response relationship of GABA in the absence and 
presence of a-CaMK-II.
Peak amplitudes GABA-mediated currents were recorded in response to various 
concentrations of GABA normalised to the cerebellar granule cell’s membrane 
capacitance (pA/pF).
GABA currents were recorded with a patch pipette solution supplemented with 
85 nM pre-activated a-CaMK-II (n = 13) and normal patch pipette solution 
supplemented with pre-activation buffer without CaMK-II (Control, n = 12). 
Currents were recorded at t = 10 min after the effect of a-CaMK-II had reached a 
plateau.
All data points = mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control.
P < 0.05, t-test.
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4.2.2 Modulation of GABAa receptors in cerebellar granule cells by 
endogenous CaMK-II.
CaMK-II is activated by the binding of Ca2+/CaM, which allows substrate
access to the catalytic site of the enzyme. Autophosphorylation at Thr286 can then
2 +
occur between adjacent subunits in the holoenzyme that have bound Ca /CaM 
(Hudmon and Schulman, 2002). The formation of a holoenzyme is critical for this 
autophosphorylation to occur within the cell (Hanson et al., 1994; Mukheiji and 
Soderling, 1994; Shen and Meyer, 1998). The recombinant form of CaMK-II used in 
this study lacks the association domain of the full-length a  subunit and so it cannot 
form a holoenzyme. However it has the same catalytic properties as native CaMK-II 
and can phosphorylate the same substrates (Suzuki-Takeuchi et al., 1992; Lledo et 
al., 1995). Incubation of Ca2+/CaM and ATP-y-S in vitro, in a small volume, enables 
autophosphorylation to occur.
The CaMK-II inhibitor, KN-93, prevents Ca2+/CaM binding and so in this 
way prevents Ca2+/CaM from increasing CaMK-II activity (Sumi et al., 1991). 
Application of KN-93 to the pre-activation buffer (15-20 fiM) should prevent 
Ca2+/CaM binding and autophosphorylation at Thr286 from occurring and therefore 
prevent CaMK-II activation. When a-CaMK-II and the pre-activation buffer are then 
diluted into the patch pipette solution the a-CaMK-II that then dialyses into the cell 
will be in its basal state and therefore inactive. Endogenous Ca2+/CaM within the 
cell is unlikely to activate the recombinant a-CaMK-II because it cannot form a 
holoenzyme and in addition KN-93 will still be present in the patch pipette solution 
at a concentration of 500 nM.
The addition of the pre-activation buffer containing KN-93 (500 nM in patch 
pipette solution) and a-CaMK-II (35 nM) to the patch pipette solution resulted in a
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significant depression of the peak amplitude of whole-cell GABA currents recorded 
to 71.9 ± 4.6 % at t = 10 min (n = 10, Fig 4.3A), compared to controls of, 96.5 ± 5.1 
% (n = 6 , Fig 4.3A). This suggested that endogenous CaMK-II is active and 
maintaining GABAa receptor function under basal conditions. The addition of KN- 
93 alone led to a similar significant decrease in the amplitude of currents recorded to
69.3 ± 7.6 % at t = 10 min. The fact that the depression with or without a-CaMK-II 
present was not significantly different suggests that pre-incubation in KN-93 was 
able to prevent the activation of exogenously applied, as well as endogenous a- 
CaMK-II.
As a control the inactive analogue of KN-93, KN-92 was added at the same 
concentration (500 nM) to the patch pipette. In this case there was no significant 
difference from controls over 16 min (91.2 ± 8.5 % at t = 10 min). Taken together,
04 -this suggests there is a basal level of Ca /CaM dependent activity within these cells 
that can be inhibited by KN-93. Inhibition of CaMK-II activity by KN-93 results in 
a depression of GABA currents, presumably due to a loss of CaMK-II dependent up- 
regulation of GABAa receptor function.
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Fig 4.3: Modulation of whole-cell GABA currents recorded from rat cerebellar 
granule cells in culture by KN-93.
Peak amplitudes of GABA-mediated currents were recorded after application of 
10 pM GABA to cerebellar granule cells in culture. GABA was re-applied at 2 min 
intervals for up to 20 min. All currents were normalised to the peak response of the 
GABA current measured during the first 3-4 min (= 100 %) after achieving the 
whole-cell configuration (t = 0 min). Control recordings were made with normal 
patch pipette solution supplemented with the pre-activation buffer without a-CaMK-
n.
(A) GABA currents recorded with: normal patch pipette solution (Control, n = 6); 
patch pipette solution supplemented with 500 nM KN-93 (n = 10); and patch pipette 
solution supplemented with 35 nM CaMK-II and 500 nM KN-93, pre-incubated 
during the pre-activation reaction (n = 10).
(B) GABA currents recorded with a patch pipette solution supplemented with 
500 nM KN-92 (n = 6) compared to normal patch pipette solution (Control, n = 6) 
and patch pipette solution with 500 nM KN-93 (n = 10, taken from A).
All data points = Mean ± s.e.
Significance is indicated by the symbol *, KN-93 compared to control and the 
symbol *, KN-92 compared to KN-93.
P < 0.05, t-test, ANOVA.
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4.2.3 Protein phosphatase activity in cerebellar granule cells in culture.
Regulation of ion channel function by phosphorylation is often bi-directional 
involving protein kinases and phosphatases. It is the balance of activity between the 
two that ultimately controls the functional effect. In this case it appeared that a- 
CaMK-II was able to functionally modulate GABAa receptors in granule cells under 
basal conditions in this culture. In order to see if this modulation was bi-directional 
the phosphatase inhibitor okadaic acid (OA) was added to the patch pipette. Okadaic 
acid is a general phosphatase inhibitor but at different concentrations affects a 
different range of phosphatases. At 10 pM, OA blocks the activity of PP1, PP2A and 
PP2B/calcineurin, but at 1 pM, only the activity of PP1 and PP2A would be affected 
(Bialojan and Takai, 1988). In this way the relative contribution of different 
phosphatases to the regulation of GABAa receptor function could be determined in 
this cell type (Lieberman and Mody, 1994; Kurz et al., 2001). In addition, inclusion 
of KN-93 could be used to determine the contribution of CaMK-II activity to the 
effect of blocking various protein phosphatases.
Including 10 pM OA in the patch pipette resulted in a significant increase in 
the peak amplitude of whole-cell GABA currents recorded within 4 min to 126 ±
11.5 % as compared to control, 95.6 ± 3.3 % (n = 7, Fig 4.4A). This increase was 
relatively short-lived and there was no significant difference from control after 15 
min. Lowering the concentration of okadaic acid to 1 pM appeared to have no 
significant effect on the increase in amplitude, 117.1 ± 4.3 % at t = 4 min (n = 6 , Fig 
4.4A). This suggested that PP2B/calcineuin activity played no significant role in the 
modulation of GABA currents observed in these cells under basal conditions.
This increase in amplitude could have been caused by a release of protein 
kinase activity from inhibition by protein phosphatases. A number of different
125
kinases may be involved. As it had already been established that CaMK-II might be 
involved in altering GABAa receptor function in these cells, the calcium chelator 
l,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA) was added to
94 - • •the patch pipette to see what proportion of the effect was related to Ca sensitive 
kinases. Inclusion of 20 mM BAPTA to the patch pipette with 5 pM OA completely 
blocked the rise in amplitude and resulted in a significant depression to 75.8 ± 5.7 % 
(n = 5, Fig 4.4B). This indicated that all of the effect produced by blocking 
phosphatase activity was mediated through Ca2+ sensitive processes and confirmed 
that some of this activity maintained GABAa receptor function under basal 
conditions.
In order to determine the role of CaMK-II in increasing GABAa receptor 
function after block of phosphatase activity, the CaMK-II inhibitor KN-93 (500 nM) 
was also added to the patch pipette containing 1 pM of okadaic acid. This led to a 
decrease in the effect of OA, 99.3 ± 3.5% (n = 6 , Fig 4.4C) at t = 4 min so that there 
was no significant difference from control, 95.6 ± 3.3 % (n = 6 , Fig 4.4C). The 
addition of 500 nM KN-93 previously led to a significant depression of amplitude. 
This did not occur with OA included in the patch pipette. This suggests that another 
kinase may also have been involved in increasing GABAa receptor activity when 
protein phosphatase activity was blocked. As the addition of 20 mM BAPTA led to 
a depression of currents recorded this might suggest the additional
• 9 -1-kinase/phosphatase is Ca sensitive. As an additional control, recordings were made 
with 1 pM OA and the inactive analogue of KN-93, KN-92. In this case the effect of 
1 pM OA was not significantly different from 1 pM OA alone, 125 ± 6.7 % at t = 4 
min (n = 6 , Fig 4.4C).
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The increase in amplitude caused by OA addition in all cases was rapid but 
transient. There were no significant differences from control after 15 min. This is 
possibly an indication that other OA insensitive phosphatases were present that 
counteracted the effect of blocking PP1/2A but on a slower time-scale.
Fig 4.4:
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Fig 4.4: Modulation of whole-cell GABA currents recorded from cerebellar 
granule cells by okadaic acid.
Peak amplitudes of GABA-mediated currents were recorded after application of 
10 pM GABA to cerebellar granule in culture. GABA was re-applied at 2 min 
intervals for up to 20 min. All currents were normalised to the peak response of the 
GABA current measured during the first 3-4 min (= 100 %) after achieving the 
whole-cell configuration (t = 0 min). Control recordings were made with normal 
patch pipette solution supplemented with the pre-activation buffer without 
a-CaMK-II.
(A) GABA currents recorded with normal patch pipette solution (Control, n = 6); a 
patch pipette solution supplemented with 10 pM okadaic acid (n = 7); and with a 
patch pipette solution supplemented with 1 pM okadaic acid (n = 6).
(B) GABA currents recorded with a patch pipette solution supplemented with 
20 mM BAPTA and 5 pM okadaic acid (n = 5) compared to control (n = 6).
(C) GABA currents recorded with a patch pipette solution supplemented with 1 pM 
okadaic acid and 500 nM KN-93 (n = 6) and with a patch pipette solution with 
1 pM okadaic acid and 500 nM KN-92 (n = 6) compared to control (n = 6).
All data points = Mean ± s.e.
Significance is indicated by the symbol *. Each group (indicated by colour) is 
compared to control, P < 0.05, t-test, ANOVA.
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4.2.4 Depolarisation of cerebellar granule cells
CaMK-II activity is increased in response to a Ca2+ signal. In order to 
determine if  endogenous CaMK-II in CGCs could be modulated by an increase in 
internal Ca2+ concentration, CGCs were depolarised to 0 mV for 2 s to allow Ca2+ 
entry through voltage-gated calcium channels (VGCCs). In this case depolarisation 
resulted in a slight but significant depression of currents recorded over time to 80 ±
4.5 % (n = 9, Fig 4.5) at t = 10 min. It is possible that this was due to activation of 
Ca2+ sensitive kinases/phosphatases or signalling pathways other than CaMK-II 
(Wang et al., 2003).
Calcium signalling is complex, controlling many cellular signalling 
complexes/pathways. Often slight changes in the amplitude and/or localisation of a 
calcium signal can alter significantly the target-signalling molecule that responds 
(Franks and Sejnowski, 2002; Augustine et al., 2003). It appeared that 
depolarisation was not sufficient to increase endogenous CaMK-II activity or that 
any increase was occluded by activation of other Ca2+ sensitive signalling molecules.
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Fig 4.5: Depolarisation of cerebellar granule cells.
Peak amplitudes GABA-mediated currents were recorded after application of 
10 pM GABA to cerebellar granule cells in culture. GABA was re-applied at 
2 min intervals for up to 20 min. All currents were normalised to the peak response 
of the GABA current measured during the first 3-4 min (= 100 %) after achieving 
the whole-cell configuration (t = 0 min). Control recordings were made with 
normal patch pipette solution supplemented with the pre-activation buffer without 
a-CaMK-II.
GABA currents were recorded from cerebellar granule cells with normal patch 
pipette solution (Control, n = 6). This is compared to cells that were depolarised to 
0 mV for 2 s (indicated by the arrow, n = 9).
All data points = Mean ± s.e.
Significance is indicated the symbol *, depolarisation compared to control.
P < 0.05, t-test.
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4.3 DISCUSSION
CaMK-II dependent modulation of GABAa receptors has been previously 
observed in a number of neuronal cell types (Wang et al., 1995; Kano et al., 1996; 
Aguayo et al., 1998; Kawaguchi and Hirano, 2002; Mizoguchi et al., 2003; Wei et 
al., 2004). In HEK293 cells it was not possible to observe any functional 
modification, however when recording GABA mediated currents from cerebellar 
granule cells the activity of CaMK-II had a significant effect on GABAa receptor 
function. CaMK-II appeared to up-regulate GABAa receptor function causing a 
significant increase in the peak amplitude of currents recorded. The lack of 
functional effect observed in HEK293 cells suggested that this modulation by 
CaMK-II required a “neuronal environment” to be operative.
Intracellular dialysis of pre-activated a-CaMK-II (100 nM) to cerebellar 
granule cells resulted in a significant potentiation of whole-cell currents recorded. 
This effect appeared to be concentration-dependent. Heat-inactivated a-CaMK-II 
had no significant effects compared to control suggesting it was CaMK-II activity 
that was responsible for the effect and not another non-specific mechanism (See Fig
4.1 A). Intracellular dialysis of a-CaMK-II into cortical pyramidal neurones in 
culture also induced a significant increase in GABA mediated currents (See Fig 
4.1C). This effect was comparatively smaller than that observed in granule cells 
suggesting a difference in sensitivity between the two cell types. This potentially 
could have been mediated by differences in GABAa receptor subunits present or 
differences in the background levels of kinase and phosphatase activities within the 
two cell types.
Construction of GABA dose-response relationships in control conditions and 
in the presence of CaMK-II revealed a difference in the maximal response without an
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alteration in the GABA EC50 (See Fig 4.2). A change in the number o f functional 
receptors at the cell surface, an increase in channel conductance or a change in the 
probability o f opening could mediate this increase in the maximal response. Aguayo 
and colleagues (1998) studied Ca2+ dependent potentiation o f GABAa currents in 
mouse cortical neurones. This modulation could be blocked by addition o f the 
CaMK inhibitor KN-62 and the CaM inhibitor W-7, indicating the likely 
involvement o f CaMK-II. They examined the GABA concentration-response 
relationship in the presence of high Ca2+ (10 pM) and saw no change in the GABA 
EC50. Using a saturating concentration o f GABA they still observed a Ca2+ 
dependent potentiation, indicating that an increase in the maximal GABAa receptor 
function had occurred. In cultured rat cortical neurones it has also been observed 
that mild stretch injury resulted in a potentiation of the maximal GABA current 
density (pA/pF - with no change in EC50) that could be blocked by KN-93 (Kao et 
al., 2004). An increase in the overall charge transfer on activation o f GABAa 
receptors could have significant effects on neuronal excitability. Modulation o f the 
maximal response to GABA with no change to EC50 appears to be a common feature 
of phosphorylation dependent modulation o f GABAa receptor function. For 
example PKC dependent down-regulation of receptor function results in a depression 
o f the maximal response to GABA without alteration o f the EC50 (Krishek et a l., 
1994; Brandon et al., 2000).
In the present study intracellular dialysis o f the CaMK inhibitor KN-93 led to 
a significant decrease in the amplitude of currents recorded indicating that there is a 
certain level o f Ca2+/CaM dependent CaMK-II activity under basal conditions that 
acts to enhance GABAa receptor function.
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Cerebellar granule cells in culture are often maintained in depolarising 
conditions (20 mM KC1) to increase CGC survival (Galli et al., 1995; Borodinsky et 
al., 2002; Borodinsky et al., 2003; Linseman et al., 2003). There is some 
controversy over how depolarisation increases cell survival but it seems that 
maintenance in chronically depolarising conditions significantly alters the 
development of these neurones. It would appear that basal calcium levels and 
calcium dynamics are also altered by such culture conditions (Moulder et al., 2003).
Borodinsky et al. (2002; 2003) observed after addition of KN-93 that CaMK- 
II activity was involved in neuritogenesis and neuronal survival of CGCs grown 
under depolarising conditions. Linesman et al. (2003) also identified basal levels of 
CaMK-II activity in CGCs in culture under depolarising conditions that were 
responsible for increased neuronal survival through activation of myocyte enhancer 
factor 2 (MEF2) transcription factors. MEF2 transcription factors are thought to be 
involved in activity dependent neuronal survival (McKinsey et al., 2002). CGCs 
cultured under depolarising conditions may therefore have significant levels of basal 
Ca2+/CaM dependent CaMK-II activity and this activity may mediate part of the 
observed increase in neuronal survival seen under these conditions (Hack et al., 
2004).
CaMK-II within the brain consists of two main isoforms, all3. These 
isoforms are able to phosphorylate the same substrates but they differ in their 
localisation and sensitivity to Ca2+/CaM (Hudmon and Schulman, 2002). CaMK-II 
isolated from the cerebellum is thought to contain a higher proportion of (3 subunits 
compared to that isolated from the forebrain. Cerebellar CaMK-II has a two-fold 
higher affinity to Ca2+ and associates differently with subcellular structures (Miller
133
and Kennedy, 1985). Under non-saturating levels of CaM, /3-CaMK-II has a higher 
sensitivity to lower levels of Ca2+ (Brocke et al., 1999).
Evidence suggests that the ratio of ce/3 CaMK-II may be important for 
CaMK-II modulation of AMPA receptors in terms of localisation and translocation 
(Shen et al., 1998; Shen and Meyer, 1999; Thiagarajan et al., 2002) even though both 
subunits can phosphorylate the same substrates. The role of the different isoforms of 
CaMK-II in modulation of inhibitory synaptic transmission has yet to be determined. 
Previous experiments have involved introduction of pre-activated a-CaMK-II (Wang 
et al., 1995; Kano et al., 1996). This along with the current study suggests a-CaMK- 
II when applied to the cell through intracellular dialysis is capable of modulating 
GABAa receptor function. However, it is thought that CGCs express a high level of 
/3-CaMK-II and little or no os-CaMK-II. This would suggest that the basal activity 
observed in cerebellar granule cells on application of KN-93 is mediated through (3- 
CaMK-II. Since /3-CaMK-II has a higher affinity for Ca2+ it is possible it may be 
basely active within CGCs which is in line with experiments that suggested basal 
CaMK-II activity is involved in CGC survival when cultured under depolarising 
conditions (Borodinsky et al., 2002; Linseman et al., 2003).
It can be predicted that the role of the a  and /3 subunits would have little 
significance on the effect observed in the current study as this involved pre­
activating CaMK-II in vitro. Pre-activated recombinant /5-CaMK-II applied to the 
cell through the patch pipette would be predicted to behave in exactly the same way 
as pre-activated a-CaMK-H. The role of the cc.(5 subunits within a CaMK-II 
heteromer would be significant in a physiological situation if CaMK-II is activated 
by an endogenous Ca2+ signal.
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The evidence suggests that basal CaMK-II activity within CGC cultures 
under depolarising conditions can modulate GABAa receptor function. Analysis of 
CaMK-II activity by Fukanaga et al (1989) in CGCs through examination of the 
proportion of CaMK activity that is Ca independent (presumed to be 
autophosphorylated at Thr286), revealed that 4-5 % of CaMK-II in CGCs was Ca2+ 
independent. This level could be reduced to 1-2 % (reduction of 50 %) by removal 
of extracellular Ca2+ suggesting basal intracellular Ca2+ levels must allow a certain 
level of CaMK-II autophosphorylation at Thr286.
They also provided evidence for high levels of phosphatase activity within 
these cells, which could reduce Ca2+ independent activity rapidly after an initial 
stimulus. Application of OA increased the amount of Ca2+ independent activity over 
basal levels but this was not sustained and returned to baseline within 10-15 min. 
They proposed that PP1/PP2A strongly regulated CaMK-II activity in CGCs and 
that another OA insensitive protein phosphatase (PP2C) was responsible for the slow 
return of CaMK-II activity to baseline (Fukunaga et al., 1989; Fukunaga et al.,
1993).
Analysis of CaMK-II activity in organotypic hippocampal slices also revealed 
a significant level of autophosphorylation under basal Ca2+ conditions that was 
reduced by the removal of extracellular Ca2+ and increased by treatment with OA. 
This suggested that the relatively high level of CaMK-II activity in basal conditions 
could allow for a bi-directional regulation of CaMK-II activity (Molloy and 
Kennedy, 1991).
Both Fukunaga et al. (1989) and Molloy and Kennedy (1991) looked at the 
relative proportions of Ca2+-independent activity as a measure of CaMK-II activity. 
This reveals levels of CaMK-II autophosphorylation at Thr286 but does not reveal the
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absolute levels of CaMK-II activity in the cell which would include Ca2+- 
independent and Ca2+-dependent activity. The levels of Ca2+-independent activity 
reported in these studies are low (<10%) however, even maximally 
autophosphorylated homogenates display only 45 % Ca2+-independent activity using 
the methods used in these studies (Molloy and Kennedy, 1991). It is interesting 
though that both of these studies suggest a certain level of basal Ca2+-independent 
activity (autophosphorylation at Thr286) which must reflect a basal level of CaMK-II 
activity which can be up or down-regulated by the activity of protein phosphatases.
Applying these details to CaMK-II modulation of CGC GABA currents, it 
can be speculated that endogenous CaMK-II within cerebellar granule cells, which 
predominantly express the /? isoform of CaMK-II, can be basally active in a 
Ca2+/CaM-dependent manner and that this basal activity acts to up-regulate GABAa 
receptor function.
The amplitude of GABA mediated currents within CGCs in this study was 
altered by the phosphatase inhibitor OA. Different concentrations of OA were used 
to determine which protein phosphatases regulated GABAa receptor function. 
Inclusion of OA in the patch pipette resulted in an increase in the amplitude of 
GABA mediated currents that was the same regardless of the concentration of OA 
used; suggesting that PP1/PP2A modulated GABAa receptor function but that PP2B 
did not. The increased amplitude returned to baseline within 15 min indicating that 
another OA insensitive protein phosphatase may also be involved. This time-course 
and sensitivity to OA of this effect on GABAa receptors was very similar to the 
observed effects of OA on Ca -independent CaMK-II activity levels (Fukunaga et 
a l , 1989).
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The increased amplitude caused by the block of these phosphatases was 
removed by the addition of BAPTA. Indeed, there was a decrease similar to that 
observed with KN-93, suggesting Ca2+ sensitive kinase/phosphatase activities 
mediated the increase in GABAa receptor function observed on addition of OA. 
Addition of KN-93 and OA resulted in no significant increase or decrease in 
amplitude. Suggesting CaMK activity was partly responsible for an increase in 
amplitude initiated by protein phosphatase blockade but that other Ca2+ sensitive 
kinases/phosphatases were also involved. It appears that GABAa receptor function 
can be bi-directionally altered by CaMK-II activity and protein phosphatase activity.
It may be that for CGCs maintained under depolarising conditions, a 
relatively high basal Ca2+ level and/or a proportionately high level of /3-CaMK-II, 
may act to allow a significant level of basal CaMK-II activity, which can modulate 
GABAa receptor function. Blocking the activity of protein phosphatases may act to 
increase the level of CaMK-II activity, e.g, PP1 is known to dephosphorylate CaMK- 
II (Colbran, 2004), or may act directly on the GABAa receptor itself. The presence 
of PP1 has been shown to alter the sensitivity of CaMK-II to Ca2+ levels (Bradshaw 
et al., 2003). Inhibition of PP1 has been linked to increased CaMK-II activity in a 
number of systems (Brown et al., 2000; Kawaguchi and Hirano, 2002; Colbran, 
2004). PP1 is also thought to modulate GABAa receptor function directly 
(Tenmuma et al., 2004). Moreover, PP2A has also been suggested to modulate 
CaMK-II activity (Fukunaga et al., 1989; Colbran, 2004) and GABAa receptor 
activity directly (Jovanovic et al., 2004).
Basal GABAa receptor phosphorylation by CaMK-II would require CaMK-II 
to be localised to inhibitory synapses. Attempts to identify the location of CaMK-II 
subunits have suggested that the a  subunit can be localised to excitatory but not
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inhibitory synapses within the CA1 region of the hippocampus, the thalamus and the 
cerebral cortex (Liu and Jones, 1996; Liu and Jones, 1997). However, in the rat 
basolateral amygdala a-CaMK-II has been identified postsynaptically at GABAergic 
synapses (McDonald et al., 2002). Differences between papers may be due to the 
different antibodies used and slight variations in immunocytochemical techniques. 
In addition, recent evidence suggests that CaMK-II is capable of very rapid 
translocation (Shen and Meyer, 1999; Gleason et al., 2003). It has also been 
suggested CaMK-II can alter localisation and form clusters in response to ischaemic 
stress and that the process of preparing tissue for staining may alter CaMK-II 
localisation (Dosemeci et al., 2000; Lengyel et al., 2001). Depolarisation and 
excitotoxic stress appears to increase the apparent accumulation of a-CaMK-II at the 
PSD (Tao-Cheng et al., 2002). Early on in development the /3-CaMK-II is more 
prevalent with an increase in a subunit occurring in the rat in the 2nd and 3rd postnatal 
week (Burgin et al., 1990). There is also variation in the relative proportion of cc/3 in 
different tissues (Miller and Kennedy, 1985; Vallano, 1990). Since the ratio of cc/3 
subunits can alter the localisation of the kinase, it may be that at different 
developmental time points the distribution of CaMK-II observed may also be 
different.
Maintenance of CGC cultures in depolarising conditions not only alters 
CaMK-II activity; it can also alter the expression of ligand-gated ion channels 
(Vallano et al., 1996; Mellor et al., 1998; Ives et al., 2002). Ives et al. (2002) studied 
mRNA levels and protein levels with immunocytochemistry of different GABAa 
subunits in mouse cerebellar granule cells cultured in 25 mM KC1, or 5 mM KC1. 
They reported that under depolarising conditions, a l, a6 and j82 expression was 
greatly reduced and they failed to detect any (32 subunit protein. In addition there
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was an increase in 0*3 and /33 subunit expression with no difference in od. Given that 
/32 shows a preference to assembly with a l and /33 with c£/3 (Benke e/ al., 1994) it 
could be predicted that CGCs grown in 20 mM KC1 medium, may express 
predominantly oi2/3/33 subunit-containing receptors. In more physiological 
conditions (5 mM KC1) there may be a mixture of al//32 and od!3/33 subunit- 
containing receptors.
The /33 subunit is, in many parts of the brain, expressed earlier in 
development with /32 expression increasing at later developmental stages (Laurie et 
al., 1992). In support of a crucial role for /33 in early development /33 knock-out 
mice display severe developmental impairments (Homanics et al., 1997; DeLorey et 
al., 1998). Ives et al. (2002) suggested that CGCs maintained under depolarising 
conditions are “arrested” in their development and that they represent an immature 
stage in CGC development. This is supported by the fact that these cells are 
generally electrically silent, characteristic of a lack of fully functional synapses. In 
further support of this idea, depolarisation appears to prevent o*6 subunit expression 
in mouse cerebellar granule cultures which is known to be expressed in mature CGCs 
(Mellor et al., 1998). It should be noted though that 0*6 expression has been reported 
in rat CGC cultures under depolarising conditions (Thompson and Stephenson,
1994). Rat CGC cultures appear to behave slightly differently and so the alteration 
in GABAa subunit expression may not be as pronounced as in mouse cultures. 
However rat CGCs are similar to mouse CGCs in that they are electrically silent and 
so they may also represent an earlier stage in development and express different 
levels of GABAa receptor /3 subunits accordingly.
The age of the animal used for culture will also have an impact on the 
GABAa subunits present. In the current study P0 rats were used. As 0*6/5
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expression does not occur until the end of the 1st postnatal week (Wisden et al., 
1996) the cultures used in these experiments would probably not have substantially 
expressed these subunits. CaMK-II has been shown to phosphorylate p and y 
subunits in vitro (Machu et al., 1993; McDonald and Moss, 1994; McDonald and 
Moss, 1997). It is reasonable to suggest that the cultures used in the current 
experiments may have expressed predominantly o£/3j33y2 subunit-containing 
receptors and so this suggests that /53 and y2 may be good candidates for CaMK-II 
modulation in this cell type.
In the current study, an attempt was also made to depolarise CGCs to 
encourage Ca2+ entry via VGCCs to see if  endogenous CaMK-II activity could be 
increased thereby increasing the amplitude of GABAa currents. However, 
depolarisation led to a small decrease in amplitude. There are several possible 
reasons why depolarisation did not appear to activate endogenous CaMK-II.
^  t
Calcium signalling is complex, Ca signals are often under tight spatial and 
temporal control to allow a neurone to use multiple Ca2+ sensitive signalling 
pathways (Augustine et al., 2003). The source and localisation of Ca2+ entry can 
have a profound effect on CaMK-II activation (Franks and Sejnowski, 2002). 
CaMK-II can respond with differing sensitivities to Ca2+ signals depending on the 
proportion of oc/3 subunits within the heteromer. In addition CaMK-II has been 
shown to respond not only to the amplitude of a Ca2+ signal but also to its frequency 
(De Koninck and Schulman, 1998). Complex processes within the cell can also 
regulate the availability of CaM (Gnegy, 2000). Therefore the link between 
depolarisation and increases in the intracellular Ca2+ concentration is not always 
straightforward and Ca2+ entry, in itself, is not a guarantee that CaMK-II will be 
activated.
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Global Ca2+ entry may have activated a number of different Ca2+ sensitive 
processes that may have had direct or indirect effects on GABAa receptor function. 
Using different concentrations of OA it appeared that PP2B/Calcineurin had little 
basal effect on GABAa receptor function. However, Ca2+ entry may have activated 
this phosphatase. Calcineurin has been shown to decrease the amplitude of IPSCs 
through an interaction with the y2 subunit (Wang et al., 2003). Previously the 
alteration of intracellular Ca2+ levels has been associated with both increased (Kano 
et al., 1992; Aguayo et al., 1998) and decreased GABAa receptor function (Martina 
et al., 1994; Stelzer and Shi, 1994). This may be due to GABAa receptor 
heterogeneity, but also to activation of different downstream signalling pathways. In 
addition the Ca2+ sensitive kinase PKC has also been shown to up or down-regulate 
GABAa receptor function depending on the cell type and the GABAa receptor 
subtypes present (Krishek et al., 1994; Lin et al., 1994; Lin et al., 1996; Brandon et 
al., 2000; Jovanovic et al., 2004).
^  I
In addition to the problems associated with the complexity of Ca signalling 
it has been reported by Moulder et al. (2003) that CGCs maintained in depolarising 
conditions have a reduced calcium channel density. Ca entry on depolarisation 
may be significantly reduced after maintenance in these conditions. The authors also
94-suggested that reduced Ca entry, presynaptically, might be responsible, in part, for 
the electrical silence of these cells.
In summary it appears that CaMK-II is capable of potentiating GABA 
currents recorded from cerebellar granule cells. There also appears to be a certain 
level of basal CaMK-II activity in these cells which acts to enhance GABAa receptor 
function under resting conditions. In order for CaMK-II modulation of GABAa 
receptors to play a physiological role, CaMK-II activity must be able to significantly
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modulate synaptic function. Since CGCs are electrically silent and morphologically 
immature when maintained under depolarising conditions it was necessary to alter 
the CGC culture conditions to those that are more physiologically representative (5 
mM KC1) in order to determine if CaMK-II activity can indeed modulate synaptic 
GABAa receptors.
4.4 CONCLUSIONS
• Of-CaMK-II activity was capable of potentiating GABAa receptor function in 
cerebellar granule and cortical pyramidal neurones.
• Within CGCs, CaMK-II activity appeared to play a basal role in maintaining 
GABAa receptor function.
• Protein phosphatase activity, probably involving PP1/PP2A, modulated 
CaMK-II activity towards GABAa receptors either acting on CaMK-II or the 
GABAa receptor directly.
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Chapter Five:
Modulation of inhibitory svnaptic transmission by
Qj-CaMK-II
5.1 INTRODUCTION
GABAa receptors mediate the majority of fast synaptic inhibition in the 
brain. Their activity can shape the output of a given neurone and the general 
excitability of a network and their function is thought to be crucial for the generation 
of network oscillations relevant to behaviour (Gaiarsa et al., 2002). Inhibitory 
synaptic transmission has also been shown to be altered in certain pathological 
conditions such as epilepsy (Macdonald et al., 2004). At the receptor level, covalent 
modification- by phosphorylation has been demonstrated to modulate GABAa 
receptor mediated synaptic transmission (Wang et al., 1995; Wang et al., 2003b; Wei 
et al., 2004; Jovanovic et al., 2004), although there is controversy over the exact 
effects observed in different cell types (Nusser et al., 1999; Poisbeau et al., 1999). 
Phosphorylation appears to play an important role in long-term plasticity of both 
excitatory and inhibitory synapses (Soderling and Derkach, 2000; Kittler and Moss, 
2003; Colbran and Brown, 2004; Liischer and Keller, 2004). For CaMK-II 
modulation of GABAa receptors to have any role in shaping the activity of a neurone 
or network it is important to establish if CaMK-II can modulate inhibitory synaptic 
transmission. Therefore this chapter addressed this issue by examining CaMK-II 
dependent effects on GABAa receptor mediated synaptic transmission in neurones.
There are a number of examples of kinase and phosphatase activities altering 
fast synaptic inhibition. PKC activity has been shown to increase miniature 
inhibitory postsynaptic current (mIPSC) amplitudes and protein phosphatase 2A
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(PP2A) has been shown to subsequently reverse this effect (Jovanovic et al., 2004), 
without any changes to mlPSC decay time constants. Using recombinant GABAa 
receptors expressed in Xenopus oocytes, PKC activity can lead to a depression of 
GABA currents (Krishek et al., 1994) with no change in the time constants for decay. 
More recent evidence suggests PKC can have different functional effects in different 
neuronal cell types (Poisbeau et al., 1999). PKA activity can also have different 
functional effects in different cell types and has been shown to lead to an increase, no 
change, or a depression of IPSC amplitudes. The decay time course of IPSCs was in 
some cases prolonged, but in others remaining unaffected (Nusser et al., 1999; 
Poisbeau et al., 1999).
Alteration in the decay phase of an IPSC appears to be a common 
mechanism for phosphorylation-dependent modulation of inhibitory synaptic 
transmission (Nusser et al., 1999; Poisbeau et al., 1999; Hinkle and Macdonald, 
2003). In addition to the lengthening of IPSC decay times by PKC and PKA, the 
phosphatase calcineurin (CaN)/PP2B has also been shown to regulate IPSC decay 
times (Martina et al., 1996; Jones and Westbrook, 1997; Sanchez et al., 2005). 
However under certain conditions CaN/PP2B causes a reduction in mlPSC amplitude 
without affecting decay times (Wang et al., 2003a). As well as Ser/Thr kinases, 
tyrosine kinase phosphorylation has been shown to up-regulate GABAa receptor 
function (Moss et al., 1995) and can increase mlPSC amplitude without apparent 
changes in their decay times (Boxall, 2000; Mizoguchi et al., 2003; Ma et al., 2003).
Similarly CaMK-II activity has been shown to alter fast synaptic inhibition. 
Wang and colleagues (1995) applied pre-activated o'-CaMK-II to hippocampal CA1 
neurones through inclusion in the patch pipette and observed an increase in evoked 
IPSP amplitudes. They also observed a reduction in desensitisation, a possible
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mechanism for alteration of IPSC decay (Jones and Westbrook, 1996). Kano et al. 
(1996) observed increases in the amplitude of mIPSCs recorded from Purkinje 
neurones without a change in the decay time constant after application of pre­
activated oCaMK-II. In addition, Wei and colleagues (2004) observed a calcium- 
dependent increase in spontaneous IPSC (sIPSC) amplitudes that could be blocked 
by CaMK-II inhibitors.
The evidence suggests that CaMK-II is capable of altering GABAa receptor 
mediated synaptic transmission through changes in amplitude and possibly the rate of 
desensitisation of IPSCs. However phosphorylation-dependent effects on inhibitory 
synaptic transmission mediated by other kinases/phosphatases have suggested 
considerable variation in the effect observed amongst different cell types.
Cerebellar granule cells (CGCs) maintained in depolarising conditions do not 
display synaptic activity and so these cells were cultured in more physiological 
conditions in order to examine synaptic transmission. Mixed cerebellar cultures 
maintained in physiological (5 mM KC1) conditions are able to form inhibitory 
synapses. In vivo cerebellar granule cells receive inhibitory inputs from Golgi cells 
and Purkinje cells receive inhibitory input from stellate and basket cells (Wisden et 
al., 1996; Nakanishi, 2005). In culture it is possible that GABAergic synapses were 
formed by all of these intemeurones onto the granule cell. Recordings were made 
from rat cerebellar granule cells with pre-activated a-CaMK-II in the patch pipette 
using the same protocol as described in the previous chapters (See Chapter 2 and 
3.2.2) to determine if there was a CaMK-II dependent effect on inhibitory synaptic 
transmission, and if  so, what form that modulation took.
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5.2 RESULTS
Cerebellar granule cells maintained in physiological levels of KC1 (5 mM) for 
7-14 days (See Chapter 2) had a slightly altered morphology to cells maintained 
under depolarising conditions (Moulder et al., 2003). Generally they had slightly 
smaller cell bodies and correspondingly lower cell capacitance (8.3 ± 0.5 pF, n = 15) 
compared to cells maintained in depolarising conditions (11.1 ± 0.6 pF, n = 15). In 5 
mM KC1, CGCs tended to form small clusters of cells (See Fig 2. IB) rather than the 
uniform distribution of cells maintained in 20 mM KC1 (Ives et al., 2002). Most 
CGCs within clusters displayed spontaneous synaptic activity, although a proportion 
displayed no activity at all (15-20 %). Both excitatory and inhibitory postsynaptic 
currents could be observed. Excitatory input from surrounding granule cells could be 
observed as spontaneous excitatory postsynaptic currents (sEPSCs). Application of 
the NMD A receptor blocker AP-5 (20 pM) and AMP A receptor blocker CNQX (10 
pM), revealed GABAergic currents (IPSCs) that could be blocked by the GABAa 
receptor antagonist bicuculline (20 pM; See Fig 5.1). Bath application of 
tetrodotoxin (TTX -  500 nM) almost completely abolished all IPSCs. This is in line 
with the observation that most CGC IPSCs in culture and in thin brain slices are 
action potential dependent (Puia et al., 1994; Leao et al., 2000; Farrant and Brickley, 
2003). The Na2+ channel blocker QX-314 (5 mM) was included within the patch 
pipette to prevent action potentials from occurring within the cell being recorded 
from whilst allowing the activity of the rest of the network to remain relatively 
unaltered. In this way action potential driven sIPSCs could be recorded.
A tonic GABAa receptor mediated current has been observed in cerebellar 
granule cells in culture and in slices, presumed to be mediated by the basal GABA 
concentration or by GABA spillover acting on a6l8 subunit containing extrasynaptic
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receptors (Brickley et al., 1996; Leao et al., 2000; Wall, 2002). On application of 
bicuculline the tonic noise was altered in only a small subset of the cells recorded 
from these cultures (1 in 20). This is possibly due to the immature nature of the 
cultures and a possible lack of 8 subunit expression, or perhaps due to a reduced 
number/density of GABA releasing cells in culture. Expression of 8 subunits is 
thought to be negligible until postnatal day 6-7 and does not reach adult levels until 
the third postnatal week (Wisden et al., 1996). As these cultures were prepared from 
P0 rats it may be that 8 subunit expression never reached high enough levels to 
support a tonic GABA current.
Fig 5.1:
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Fig 5.1: sIPSCs recorded from rat cerebellar granule cells in culture.
Representative synaptic currents recorded from rat cerebellar granule cells grown 
and maintained in a physiological culture medium containing (5 mM) KC1 and 5 % 
FCS.
Application of bicuculline (20 pM) reveals EPSCs. Application of AP-5 (20 pM), 
CNQX (10 pM) and bicuculline (20 pM) removes all events. Application of AP-5 
and CNQX reveals sIPSCs.
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5.2.1 CaMK-II modulation of sIPSC amplitude.
Recordings were made with either 85 nM pre-activated a-CaMK-II (See 
Chapter 2 and 3) within the patch pipette or normal patch pipette solution containing 
the pre-activation buffer without a-CaMK-II as a control. This was to ensure that the 
pre-activation buffer (although diluted in the patch pipette solution) did not activate 
endogenous CaMK-II or other Ca2+ sensitive kinases or phosphatases. Continuous 
recordings were made in 2 min periods starting 4-5 min after achieving the whole­
cell configuration (t = 0 min), for a total period of 20 min. Analysis of IPSC kinetics 
required continuous recordings to be made from t = 6 min to t = 12 min to ensure an 
adequate number of events for analysis.
The addition of 85 nM a-CaMK-II led to a significant increase in the mean 
peak amplitude of sIPSCs to 129.7 ±6.1 % (n = 7) as compared to control, 93.7 ± 7.8 
% (n = 9, Fig 5.2A) at t = 6-8 min. This effect reached a steady-state within 6 min. 
The observed increase in the mean sIPSC amplitude did not necessarily indicate a 
uniform increase in amplitude of all events within the population. In order to further 
evaluate the effects of CaMK-II on sIPSC amplitude, an amplitude distribution 
histogram was constructed. Under control conditions the population was best fitted 
by three Gaussian populations (n = 7, 7000 events). The presence of more than one 
population has been previously observed in rat cerebellar cultures (Leao et al., 2000) 
and is presumed to correspond to action potential dependent (sIPSCs) and action 
potential independent (mlPSC) forms of GABA release. However, the addition of 
TTX abolishes almost all IPSCs in this culture so it is difficult to confirm that large 
amplitude events are action potential driven as there are not enough mlPSCs for 
reliable analysis. The distribution of amplitudes appeared to be skewed towards
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higher amplitude events as has also been described previously (De Koninck and 
Mody, 1994; Nusser et al., 1997).
The addition of a-CaMK-II led to the appearance of a group of large 
amplitude IPSCs of over 400 pA (n = 4, 7000 events, Fig 5.2C). There was a large 
drop in the number of events of around 200 pA and an increase in the number of 
smaller amplitude events. The population was now composed of four Gaussian 
populations. The appearance of larger amplitude events appears to have been at the 
expense of the larger amplitude populations of events seen in controls (around 200 
pA). The smallest amplitude population seen in controls shifts slightly to the right 
(to give rise to a fourth population, around 70 pA) and the number of the smallest 
events (<70 pA) is increased. This could be partly due to smaller amplitude events 
that were previously undetectable, increasing in amplitude, and appearing out of the 
noise. This might be expected to be reflected by an increase in frequency, however, 
the frequency of events was not significantly altered over the time of recording (Fig 
5.2D) or in the presence of a-CaMK-II (n = 7, 2.2 ± 0.6 Hz) as compared to control 
(n = 8, 2.8 ± 1 .2  Hz). It appears though that the effect of CaMK-II is not uniform 
across the whole population.
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Fig 5.2: Of-CaMK-II modulation of sIPSCs recorded from rat cerebellar granule 
cells.
sIPSCs were recorded from cerebellar granule cells in culture (DIVIO-14) maintained 
in 5 mM KC1 and 5 % FCS. Recordings were made in 2 min periods with the first 
starting 4-5 min after achieving the whole-cell configuration (t = 0-2 min) or in 5-6 
min periods starting 6 min after achieving the whole-cell configuration. Control 
recordings were made using normal patch pipette solution supplemented with pre­
activation buffer without a-CaMK-II.
(A) Mean sIPSC peak amplitudes of events within a 2 min recording period were 
normalised to the mean peak amplitude at t = 0-2 min, in the absence (Control, n = 9) 
and presence of 85 nM O'-CaMK-II (n = 7). All points are mean ± s.e.
(B) Representative recordings of sIPSCs at t = 2 min and t = 8 min with 85 nM 
a-CaMK-II present within the patch pipette solution.
(C) Amplitude distribution histogram of sIPSCs in the absence (Control, n = 7, 7000 
events) and in the presence of 85 nM a-CaMK-II (n = 4, 7000 events) at t = 6-12 min.
(D) Bar chart showing the frequency at t = 6-8 min normalised to the frequency at 
t = 0-2 min in control conditions (n = 8) and in the presence of 85 nM a-CaMK-II 
(n = 7).
Significance is indicated by the symbol *, P < 0.05, t-test.
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5.2.2 CaMK-II modulation of sIPSC decay.
Previous studies have shown that there is considerable variation in the decay 
of IPSCs between different cell types, cells of the same type, and even within the 
same cell (Auger and Marty, 1997; Bacci et al., 2003; Mody and Pearce, 2004). 
Control recordings from rat CGCs in physiological KC1 (5 mM) revealed that there 
were three distinct Gaussian populations of decay times, as determined by half-width 
(time taken to decay to 50 % of peak amplitude; n = 6,2600 events, Fig 5.3 A).
The variation in decay times has been observed in other neuronal 
preparations and is thought to reflect the expression of different GABAa receptor 
subtypes within the cell (Puia et al., 1994; Koulen et al., 1996; Bacci et al., 2003) 
and different phosphorylation states (Jones and Westbrook, 1997), but may also 
reflect variations in GABA concentration within the synaptic cleft of different 
synapses (Nusser et al., 2001; Mody and Pearce, 2004). A typical example trace 
taken from a single CGC recording illustrates events with similar rise times but 
different decay profiles (Fig 5.3A).
The distribution of half-widths of sIPSCs recorded in the presence of a- 
CaMK-II displays a shift to the right towards a slower decay time (n = 7, 2600 
events, Fig 5.3A). There is an increase in the number of events decaying within the 
25-45 ms range and a drop in the number of events within the 10-25 ms range.
At t = 6-12 min, sIPSC events (50-100) were averaged from control cells and 
from those in the presence of O'-CaMK-II. Average traces were then used to 
calculate decay time constants (See Chapter 2, 2.7.2). Events recorded in the 
absence and in the presence of a-CaMK-II were best fitted by a bi-exponential decay. 
The decay constant Ti significantly increased from 10 ± 0.9 ms (n = 7) to 22.7 ±3.2 
ms in the presence of a-CaMK-II (n = 8, Fig 5.3C). The decay constant T2 also
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significantly increased from 46.7 ± 6 ms (n = 7) to 78 ± 10 ms in the presence of O'- 
CaMK-II (n = 8, Fig 5.3C). The proportion of area t i :X2 was not significantly altered 
(Al Control = 53.6 ± 4.7 %, n = 7, Al + CaMK-II = 51.7 ± 3.6 %, n = 7, Fig 5.3D) 
by the presence of O'-CaMK-II.
Variation in IPSC decay times could also result from dendritic filtering, 
however, CGCs are electrotonically very compact and so the effect of dendritic 
filtering should be comparatively low (Gabbiani et al., 1994; Rossi and Hamann,
1998). To confirm this, scatter plots of IPSC rise-time against IPSC amplitude were 
constructed for each cell to check there was no linear relationship between these two 
variables. Only cells lacking any clear correlation between IPSC rise-time and 
amplitude were used in the analysis of IPSC decay times (r = 0.15, Fig 5.4). This 
suggests that variation in decay times in the majority of cases is related to genuine 
differences in the properties of GABAa receptors at different synapses and not due to 
dendritic cabling. Moreover, O'-CaMK-II did not affect the mean rise-time of the 
IPSCs, from 10-90 % of peak amplitude (Control, 1.2 ± 0.2 ms, n = 8, + a-CaMK-II,
1.1 ± 0.1 ms, n = 7, Fig 5.4B).
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Fig 5.3: Modulation of sIPSC decay times by q-CaMK-II.
(A) Frequency distribution histogram of sIPSC half-widths (150) at t = 6-8 min in the 
absence (Control, n = 6, 2600 events) and the presence of a-CaMK-II (n = 7, 2600 
events). Inset is a representative trace illustrating variation in the decay times under 
control conditions.
(B) Superimposed scaled averages of 80 sIPSCs recorded from one cell in the 
presence of a-CaMK-II at t = 0-2 min and t = 6-8 min and re-scaled to the same 
amplitude.
(C) Bar charts of the mean values for the exponential decay time constants, xl and 
t2 at t = 6-12 min in the absence (Control, n = 8, minimum 50 events per cell) and 
the presence of a-CaMK-II (n = 9, minimum 50 events per cell).
(D) Bar chart showing the relative contribution of t1 (Al) and t2 (A2) at t = 6-12 
min in the absence (Control, n = 8) and presence of CaMK-II (n = 7).
Mean ± s.e. Significance is indicated by the symbol *, CaMK-II compared to 
control.
P < 0.05, t-test. ..............................................
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Fig 5.4: sIPSC rise-times in the absence and presence of a-CaMK-II.
(A) Example scatter plot of sIPSC amplitudes against sEPSC rise-times in the 
absence (Control, n = 3, 780 events) of O'-CaMK-II. Note the lack of a linear 
relationship (r = 0.15).
(B) Bar chart showing the mean sIPSC rise-time in the absence (n = 8) and the 
presence of 85 nM O'-CaMK-II (n = 7). For each cell the mean rise-time was 
calculated from 50-100 events averaged from recordings, t = 6-12 min.
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5.2.3 CaMK-II modulation of the whole population of sIPSCs.
Currently, little is known about CaMK-II dependent modulation of GABAa 
receptors, so the possibility remains that CaMK-II preferentially modulates certain 
GABAa receptor subtypes or can differentially modulate certain subtypes in different 
ways. The latter may involve either direct phosphorylation, indirect phosphorylation 
of GABAa receptor-associated proteins or possibly may act through downstream 
signalling pathways. Scatter plots of sIPSC amplitudes against half-widths recorded 
at t = 6-12 min in the absence (Control, n = 7, 7000 events) and in the presence of 
85 nM a-CaMK-II (n = 4, 7000 events, Fig 5.5A) were constructed to examine the 
effects of a-CaMK-II on the population as a whole. Addition of a-CaMK-II results 
in a shift of a sub-population of IPSCs to much larger amplitudes with relatively little 
change in decay. In addition another population of events appears to increase in half­
width with relatively little change in amplitude. There is also another sub-population 
of events that are not significantly altered by a-CaMK-II at all.
It is possible this is a reflection of a variation in response to a-CaMK-II, with 
one population responding to a-CaMK-II with a large increase in amplitude and 
another separate population increasing in decay time. It certainly appears that the 
effect of a-CaMK-II was not uniform and consistent across the whole population of 
IPSCs.
Increases in sIPSC amplitude and decay would increase the area of each IPSC 
and therefore the overall charge transfer. The amplitude distribution histogram of 
sIPSC areas in the absence (n = 6, 2600 events) and the presence of a-CaMK-II (n = 
7, 2600 events, Fig 5.4B) at t = 6-12 min displays a significant shift to events with 
much greater area. This would be consistent with a significant increase in the overall 
charge transfer. In addition the mean area of sIPSCs significantly increases from
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Fig 5.5: CaMK-II modulation of sIPSCs as a population and changes in
synaptic charge transfer.
(A) Scatter plots of sIPSC amplitude against half-width at t = 6-12 min in the 
absence (left, Control, n = 7, 7000 events) and presence (right) of 85 nM a-CaMK-II
(n = 4, 7000 events).
Different populations are highlighted by the circles.
(B) Frequency distribution histogram of the area of each IPSC (pC) at t = 6-12 min 
in control conditions (n = 6, 2600 events) and in the presence of 85 nM a-CaMK-II 
(n = 7, 2600 events). ( InA . ms = lpC; 1C = 1 coulomb of charge)
(C) Bar chart showing the mean area of IPSCs (fC) in the absence (Control, n = 14) 
or presence of 85 nM a-CaMK-II (n = 9) at t = 6-12 min and t = 6-8 min.
Data points = mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control.
P < 0.05, t-test.
5.3 DISCUSSION
The application of pre-activated a-CaMK-II to CGCs appears to enhance 
inhibitory synaptic transmission. This occurs through an increase in the mean peak 
amplitude and decay time constants of sIPSCs. These changes are consistent with 
other studies on phosphorylation-dependent effects on IPSCs with both PKA/PKC 
being shown to alter IPSC amplitude and/or decay in different preparations (Nusser 
et al., 1999; Poisbeau et al., 1999; Jovanovic et al., 2004). Such changes potentially 
have significant implications for the modulation of inhibition and subsequently, 
neuronal excitability.
The dose-response relationship in the presence of a-CaMK-II (See Chapter 4, 
Fig 4.2) revealed an increase in the maximal response to GABA. This implies an 
increase in the number of functional receptors at the synapse, a change in
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conductance or a change in the probability of ion channel opening may be 
responsible for the up-regulation of GABAa receptor function observed. A change 
in the number of receptors at a synapse has been proposed to be the most efficient 
way of enhancing GABAergic transmission given that GABA is presumably 
saturating at those synapses (Nusser et al., 1998).
There is some evidence that at certain synapses in certain cell types, GABA is 
indeed saturating (De Koninck and Mody, 1994; Nusser et al., 1997; Hajos et al.,
2000). Non-stationary noise analysis has allowed the numbers of functional 
receptors at synapses to be estimated (Traynelis and Jaramillo, 1998) and has shown 
that in some cases up-regulation of GABAa receptor function is attributable to 
increases in receptor number (Otis et al., 1994; De Koninck and Mody, 1994; 
Mizoguchi et al., 2003). These increases are usually not associated with a change in 
decay. Recently Wang et al (2003) demonstrated that PKB phosphorylation can 
increase the number of receptors at the cell surface via phosphorylation of the /52 
subunit at Ser410, which results in an increase in mIPSC amplitude without affecting 
IPSC decay.
Recent evidence, however, has suggested that GABA is not saturating at all 
synapses in the CNS (Perrais and Ropert, 1999) and that receptor occupancy can 
vary between cell types and synapses within the same cell (Nusser et al., 1997; Hajos 
et al., 2000). Application of benzodiazepines (BDZ’s) will increase the amplitude 
and the decay time constant of IPSCs, but only the decay time constant, if GABA is 
saturating. A number of studies have shown BDZs can increase IPSC amplitude in a 
number of cell types at different synapses. This is true for multi-quantal release 
(sIPSCs) as well as spontaneous miniature release (mIPSCs) of GABA (Rumpel and 
Behrends, 2000).
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In the current study it is not yet apparent whether some or all of the synapses 
formed in these cultures are saturating. However there is a possibility that, as in 
other cell types, receptor occupancy is variable (Hajos et al., 2000). Nusser and 
colleagues (1997) observed that a quantum of GABA results in incomplete receptor 
occupancy for a sub-population of events recorded from cerebellar stellate cells 
whilst others were thought to be saturated. Hajos et al. (2000) also observed 
differential receptor occupancy in olfactory bulb granule cells. They observed two 
populations of events with different decay time constants only one of which appeared 
to be saturated by a quantum of GABA. In the current study, a-CaMK-II appeared to 
have different effects on different populations of events; one possible explanation for 
this could be differences in the level of receptor occupancy after GABA release at 
different synapses within these cells.
An alteration in the probability of channel opening and the conductance of a 
channel could account for the apparent changes in amplitude observed (Moss et al., 
1995). An increase in the probability of channel opening could increase the apparent 
amplitude of whole-cell GABA currents and sIPSCs but would only produce large 
effects if GABA were non-saturating (Nusser et al., 1998). Probability of opening 
may also affect the decay phase of IPSCs. These parameters could be changed by 
the covalent addition of a phosphate group (phosphorylation) altering conformation 
of the receptor, resulting in an alteration of single channel properties (Soltesz and 
Mody, 1995). Tyrosine kinase phosphorylation of the i l  subunit has been shown to 
increase the mean open time and the probability of opening of the GABAa receptor 
(Moss et al., 1995) corresponding to an increase in the amplitude of whole-cell 
currents recorded.
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Another potential mechanism for the increase of IPSC amplitude and decay 
times observed could involve changes in the desensitisation of the receptor. 
Alterations in desensitisation have been shown to occur through 
phosphorylation/dephosphorylation (Jones and Westbrook, 1997). This may be a 
relatively common mechanism to modulate fast synaptic transmission (Jones and 
Westbrook, 1996). The bi-exponential decay of most IPSCs is thought to reflect the 
movement of the GABAa receptor through desensitised states (representing the 
slower phase of decay). Although no or limited current flows through the 
desensitised channel, entering into a desensitised state prolongs the amount of time 
the channel can be active after a transient exposure to GABA.
The number of IPSCs with a bi-exponential decay and the relative 
contribution of each phase has been shown to be modulated by phosphorylation 
(Nusser et al., 1999; Poisbeau et al., 1999). The current study reveals an increase in 
amplitude and a slowing of the decay phase without alteration in the relative 
contribution of each component, resulting in a significant increase in synaptic charge 
transfer. Soltesz and Mody (1995) identified a calcium-dependent alteration in decay 
from a single exponential decay to a prolonged double exponential after amputation 
of dentate gyrus granule cell dendrites (>66 % of the dendritic tree -  dendrotomy), 
which resulted in a significant increase in synaptic charge transfer. a-CaMK-II has 
been observed to alter desensitisation in rat spinal dorsal horn neurons acting to 
prolong decay times (Wang et al., 1995). In addition the Ca2+ sensitive phosphatase 
calcineurin (CaN) has been reported to modulate desensitisation acting to lengthen 
and in some cases to shorten decay times (Martina et al., 1996; Jones and Westbrook, 
1997; Mozrzymas and Cherubini, 1998).
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EPSCs in general display considerable variation in decay times between 
different cell types and even within the same cell (Banks et al., 1998; Bacci et al.,
2003). The different populations of decay times seen in the present study were 
entirely consistent with this. Such variation may have significant functional effects 
with different GABAa receptor subtypes and their distinct kinetic properties being 
incorporated into discrete synapses to perform particular roles in controlling neuronal 
excitability (Jones and Westbrook, 1996; Somogyi, 2005). Variation can occur as a 
result of several different reasons. Different GABAa receptor subunit combinations 
can produce receptors with different kinetic properties (Puia et al., 1994; Gingrich et 
al., 1995; Haas and Macdonald, 1999; Bacci et al., 2003). Often these subunit 
combinations and their corresponding decay time constants can alter during 
development (Tia et al., 1996; Hollrigel and Soltesz, 1997; Hutcheon et al., 2000; 
Vicini et al., 2001). For example, 02/3/53 receptors have a slower apparent IPSC 
decay time and are often expressed earlier in development being replaced by faster 
decaying al/32 receptors as synapses reach maturity (Vicini et al., 2001; Jiittner et 
al., 2001). The GABAa receptor /33 subunit, knock-out mouse displays CGC IPSCs 
that decay faster than their wild-type counterparts, which may be a result of an 
associated down-regulation of o2/3 expression (Ramadan et al., 2003). There is 
evidence that different synapses within the same cell may express different GABAa 
receptor subunits and that accordingly, decay time constants at different synapses 
within the same cell are different (Koulen et al, 1996; Banks et a l, 1998; Briinig et 
al., 2002). This possibly suggests that the slower decaying events in the current 
study may correspond to 02/3/33 subunit-containing receptors.
Variation in the rate of decay can also result from the activation of 
perisynaptic receptors, activated by the spillover of GABA from the synaptic cleft
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(Wall, 2002; Wei et al., 2003). This phenomenon has been observed at Golgi- 
granule cell synapses in the cerebellum (Rossi and Hamann, 1998; Hamann et al., 
2002). A preferential up-regulation of these perisynaptic receptors by CaMK-II 
dependent phosphorylation could theoretically increase the apparent decay of 
synaptic events without involving phosphorylation of the synaptic GABAa receptors 
themselves. However, this would affect the rise-times of IPSCs as well as the decay 
times which was not observed in the current study.
Variations in IPSC decay times can also result at non-saturating synapses as a 
result of variations in GABA concentration within the synaptic cleft (Nusser et al.,
2001). Clustering of receptors and associated scaffolding proteins at the synapse can 
also alter decay. Co-expression of recombinant aXfil'iZL receptors with GABARAP 
in QT6 quail fibroblasts promoted clustering. These clustered receptors deactivated 
faster and densensitised slower (Chen et al., 2000).
Alteration in the level of variation around the mean (IPSC amplitude and/or 
decay) can in itself alter neuronal excitability. Increasing event to event variance of 
peri-somatically injected IPSCs caused either a decrease, an increase or no change in 
the firing rate of CA1 hippocampal pyramidal cells, depending on the mean around 
which the scatter was introduced and the degree of scatter (Aradi et al., 2002; Aradi 
et al., 2004). Alterations in the decays of IPSCs can have significant effects on 
synaptic inhibition and the excitability of a cell (Jones and Westbrook, 1996). 
Changes in decay have also been linked to pathological states, for example, receptor 
mutations that alter the decay phase of IPSCs have been linked to familial epilepsy 
and insomnia (Bianchi et al., 2002; Buhr et al., 2002; Fisher, 2004).
It is possible that in the current study some of the variation in IPSC decay 
times observed occurred as a result of dendritic filtering. An inadequate voltage
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clamp may alter the profile of IPSCs occurring at distant synaptic sites. It is unlikely 
this effect is significant in these cells as they are electrotonically compact (Gabbiani 
et al., 1994; Rossi and Hamann, 1998), so the effect of dendritic filtering should be 
minimal. To confirm this, scatter plots of sIPSC rise-times were plotted against 
amplitudes and it was confirmed there was no linear relationship between the two.
Given the large number of potential mechanisms that could result in the 
changes in sIPSC amplitude and decay times observed in the present study it is not 
possible to say precisely how O'-CaMK-II mediates its effects on IPSCs. It is also not 
clear whether this effect is through direct phosphorylation or whether modulation 
occurs indirectly. There is some evidence to suggest that CaMK-II can bind to the (3 
subunit TM3-4 intracellular loop and that phosphorylation of the (33 subunit occurs 
within embryonic cortical neurones in culture in response to CaMK-II activation 
(McAinsh K, Jovanovic JN and Moss SJ, unpublished observations). However, the 
data in the current study suggests that the effect of O'-CaMK-II is not uniform across 
all IPSC events. It may be that more than one process is involved and/or that some 
GABAa receptor subunit combinations are functionally modulated in different ways 
by a-CaMK-II. In addition, variation in synapses such as receptor occupancy, 
receptor number and GABA concentration within the synaptic cleft following action 
potential driven release could alter the way an IPSC is modulated by CaMK-II 
phosphorylation.
It is interesting that a-CaMK-II appears to potentiate GABAa receptor 
function when CaMK-II is also involved in potentiation of AMPA receptor function 
(Lisman et al., 2002; Colbran and Brown, 2004). There are a number of parallels 
that exist between excitatory and inhibitory long-term synaptic plasticity, in that both 
respond bi-directionally to Ca2+ signals (Aizenman et al., 1998; Yang et al., 1999;
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Cormier et al., 2001). These Ca2+ signals, at excitatory synapses, are thought to 
preferentially activate either calcineurin or CaMK-II (Xia and Storm, 2005). 
GABAergic synapses have also been shown to be depressed by calcineurin and 
potentiated by CaMK-II (Kano et al., 1996; Wang et al., 2003a). It may be that this 
form of potentiation of GABAa receptor synapses occurs as a homeostatic 
mechanism in response to large increases in excitatory drive (Turrigiano and Nelson, 
2004). Long lasting changes in inhibitory synaptic transmission can as a 
consequence alter the thresholds for inducing excitatory LTP, a process known as 
metaplasticity (Abraham and Tate, 1997; Chevaleyre and Castillo, 2004).
Kano et al (1992; 1996) identified a phenomenon termed rebound 
potentiation, involving an a-CaMK-II dependent increase in amplitude (with no 
change in the decay times) of sIPSCs in cerebellar Purkinje neurones. Purkinje cells 
are thought to express predominantly alfil'il receptors (Persohn et al., 1992). The 
CGCs in the current study are thought to express al/2/3/6, j(32/3, 'fi and possibly 8 
subunit-containing receptors. Maintaining cells in depolarising conditions may shift 
the expression of GABAa receptor subunits towards 02/3, /33 subunit-containing 
receptors (Ives et al., 2002) but in low KC1 (5 mM), CGC development may be 
expected to follow the same pattern of development as in vivo and as a result express 
an increased number of different GABAa receptor subunits (Wisden et al., 1996). 
The differential effect of a-CaMK-II on different populations of IPSCs may reflect 
different GABAa receptor subtypes at different synapses. As modulation of IPSCs 
in Purkinje cells by CaMK-II involves an increase in amplitude with no change in 
decay the sub-population of events in the current study that increases in amplitude 
with little change in decay times could be proposed to be mediated by the same 
GABAa receptor subtype as that in Purkinje cells. The alteration in decay times seen
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in the current study may reflect a-CaMK-II action on another GABAa receptor 
subtype other than that seen in Purkinje cells.
In order to understand the variations in response to a-CaMK-II observed in 
the present study and within the literature it is necessary to determine the effect of 
CaMK-II on defined receptor populations. This has proved effective in investigating 
the variation in response to PKA dependent phosphorylation of GABAa receptors 
(McDonald et al., 1998). The lack of response to a-CaMK-II in HEK293 cells 
suggests a neuronal environment may be needed to observe any effects. However, it 
is difficult to control the expression of GABAa receptor subunits expressed in 
neuronal cells. A cell line of neuronal origin may allow CaMK-II dependent 
modulation of the GABAa receptor to be observed whilst allowing more control over 
the GABAa receptor subunits that are expressed.
5.4 CONCLUSIONS
• Application of a-CaMK-II results in a significant potentiation of the 
amplitudes and an increase in the decay times of sIPSCs recorded from 
cerebellar granule cells.
• The effect of a-CaMK-II is not uniform across all events in the population 
suggesting possible differential effects of a-CaMK-II at different synapses 
possibly expressing different GABAa receptor subtypes.
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Chapter Six: 
CaMK-II modulation of recombinant GABAa receptors 
expressed in NG108-15 cells.
6.1 INTRODUCTION
CaMK-II is capable of modulating GABAa receptor mediated currents in a 
number of neuronal cell types (Wang et al., 1995; Kano et al., 1996; Wei et al.,
2004) including cerebellar granule cells (Chapters 4-5). However it appears unable 
to modulate recombinant GABAa receptors expressed in HEK293 cells. This is 
presumed to be because the intracellular environment of a HEK293 cell is unable to 
support the CaMK-II modulation of GABAa receptors. However, expression of 
recombinant receptors in a cell line that does not express endogenous GABAa 
receptors is desirable because it allows the exact subunit combination present to be 
controlled (McDonald et al., 1998). For this reason, and to find an environment that 
would support CaMK-II modulation, GABAa receptor subunits were expressed in 
NG108-15 cells, a cell line of neuronal and glial origin (Klee and Nirenberg, 1974; 
Daniels and Hamprecht, 1974). In this way, CaMK-II modulation of recombinant 
GABAa receptors could be investigated and used to determine the relative effects of 
the kinase on different subunit types.
The NG108-15 clonal cell line is a hybrid cell line formed from the fusion of 
mouse neuroblastoma N18TG-2 cells and rat glioma C6BU-1 cells (Klee and 
Nirenberg, 1974; Daniels and Hamprecht, 1974). Since the formation of this cell line 
in the 1970s these cells have been used extensively to study neuronal differentiation 
(Tojima and Ito, 2004). Under basic culture conditions NG108-15 cells proliferate, 
but after treatment to increase internal cAMP levels, they stop proliferating and
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produce extended processes consistent with a neuronal cell-type morphology 
(Docherty et al., 1991; Wu et al., 1998; Tojima and Ito, 2004). This property has 
been used as a model for the study of neuritogenesis and synaptogenesis (Nirenberg 
et al., 1983; Han et al., 1991; Chen et al., 2001; Tojima et al., 2003a; Tojima et al., 
2003b).
These cells display a wide range of voltage-dependent currents comparable to 
those observed in neurones (Docherty et al., 1991; Lukyanetz, 1998; Bowden et al.,
1999). They are thought to be comparable to sympathetic neurones of the autonomic 
nervous system and are known to express choline acetyltransferase (ChAT; Daniels 
and Hamprecht, 1974). In co-culture with myotubes they form synapses and 
miniature endplate potentials (mEPPS) can be recorded (Nelson et al., 1976; 
Christian et al., 1977; Chen et al., 2001). For this reason they have also been used as 
a basic model of the neuromuscular junction. Furthermore, under certain culture 
conditions, they can express a number of ligand-gated ion channels. For example, 
they have been reported to express 5HT3 receptors (Chan et al., 1994; Bartrup and 
Newberry, 1996; Boddeke et al., 1996), 5 opioid receptors (Beczkowska et al., 1997; 
Buzas et al., 1998), NMDA receptors (Ohkuma et al., 1994; Beczkowska et al., 
1997) and muscarinic acetylcholine receptors (Fukuda et al., 1988). It should be 
noted that although this cell line is termed clonal, this refers to the fact that they are 
derived from a common ancestor and does not indicate that all cells are genetically 
identical. Over time in culture they can undergo selection depending on the specific 
culture conditions within a given laboratory. For this reason not all NG108-15s will 
display the same characteristics and may not express the same neuronal receptors 
(Docherty et al., 1991).
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NG108-15 cells have even been reported to display spontaneous synaptic 
currents when cultured alone (Tojima et al., 2000a; Tojima et al., 2003a). In general 
they are able, given the appropriate culture conditions, to form morphological 
characteristics of neurones as well as certain pre- and post-synaptic structures.
Under non-differentiating conditions when they are allowed to grow freely, 
they can display some neuronal-type morphological characteristics with some small 
processes present (Docherty et al., 1991); however the expression of neuronal 
markers (ChAT, synaptophysin, syntaxin-1), the formation of large processes, and 
the establishment of synaptic connections, tends to occur after alteration of culture 
conditions to increase intracellular cAMP levels (Tojima et al., 2000b). Under non­
differentiating conditions they can express some cytoskeletal components associated 
with neurones, such as certain neurofilaments (e.g. NF200), and the actin 
depolymerising protein, cofilin (Tojima et al., 2000b; Tojima et al., 2003b). Under 
both proliferating and differentiated conditions they are not thought to express 
GABAa receptors (Searles and Singer, 1988; Ishizawa et al., 1997) although they 
have been reported to express glutamic acid decarboxylase (GAD) and possibly 
GABA (Searles and Singer, 1988).
NG108-15 cells have been used to study the properties of recombinant ion 
channels in the same way as HEK293 cells have by transfection with the relevant 
cDNAs. They have been stably transfected with dopamine D3 receptors which have 
been shown to be functionally coupled to G-proteins. Dopamine D3 receptors only 
couple weakly with G-proteins in Chinese Hamster Ovary cells, GH4C1 pituitary 
cells and non-differentiated NG108-15 cells (Pilon et al., 1994; Seabrook et al., 
1994). NG108-15 cells have also been successfully transfected with GABAb
receptors to study GABAb receptor function. This approach revealed possible
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endogenous but non-functional GABAb receptor subunits within these cells (Easter 
and Spruce, 2002).
NG108-15 cells have also been used to investigate Ca2+ dependent signalling 
pathways involving Ca2+/CaM dependent phosphatase and kinase activity.
2"bCalcineurin activity has been shown to regulate the function of voltage-operated Ca 
channels and 5 -HT3 receptors in NG108-15 cells (Boddeke et al., 1996; Lukyanetz et 
al., 1998). It has also been shown that calcineurin and possibly CaMK activity can 
modulate 5 opioid mRNA expression in these cells (Buzas et al., 1998). CaMK-II 
and CaMK-IV activity has been detected in NG108-15 cells after stimulation by 
direct depolarisation or following application of bradykinin (Yamakawa et al., 1992; 
Enslen et al., 1996). Endogenous CaMK-II within NG108-15s exists at a low level 
but is significantly increased by treatment that induces cellular differentiation 
(Vallano and Beaman-Hall, 1989). Activation of endogenous CaMK-II has been 
linked to peripheral actin polymerization and filopodia formation (Chen et al., 2003) 
and overexpression of a-CaMK-II and autophosphorylation of a-CaMK-II have been 
shown to alter growth cone motility and neurite outgrowth in this cell line (Goshima 
et al., 1993).
It seemed, therefore, that because of its neuronal origin and evidence of 
endogenous Ca2+/CaM signalling pathways, that CaMK-II may be able to modulate 
the function of recombinant GABAa receptors expressed within this cell line. In 
order to eliminate the possibility of endogenous GABAa/b receptors being present or 
other ligand-gated ion channels, and to limit the contribution of endogenous CaMK- 
II; proliferating, undifferentiated NG108-15s were transfected with various GABAa 
receptor subunit cDNAs. In this way NG108-15s provided a neuronal-like 
environment where a-CaMK-II modulation of recombinant receptors could be
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observed and the relative contribution of different receptor subunits to the action of 
CaMK-II could be determined.
6.2 RESULTS
Using a similar protocol to that established in the previous chapters, pre­
activated recombinant a-CaMK-II (Suzuki-Takeuchi et al., 1992) was included in the 
patch pipette solution (McGlade-McCulloh et al., 1993) and whole-cell GABA 
currents were recorded from transfected NG108-15 cells. This was compared to 
controls which included either pre-activation buffer without a-CaMK-II or heat- 
inactivated a-CaMK-II (pre-incubated in activation buffer) in the patch pipette. The 
peak amplitude of GABA currents were recorded over time as a-CaMK-II dialysed 
into the cell and normalised to the peak GABA current amplitude obtained 3-4 min 
after achieving the whole-cell configuration.
As NG108-15 cells in their undifferentiated state have a more compact round 
morphology (Docherty et al., 1991) compared to cerebellar granule cells, and as in 
previous experiments 85-100 nM a-CaMK-II produced large increases in amplitude, 
the concentration was reduced to 60 nM a-CaMK-II to produce an easily observable 
effect whilst maintaining stable recordings. After stimulation to undergo 
differentiation NG108-15 cells can form large processes that make it difficult to 
establish an ideal voltage clamp of membrane currents (Docherty et al., 1991). 
Using undifferentiated cells therefore, had the added advantage of avoiding problems 
of inadequate space clamp, as in this state, cellular processes are generally small.
NG108-15 cells were transfected with an equal ratio of a:/3:7 subunit and 
enhanced GFP cDNAs using the transfection reagent Effectene (See Chapter 2). 
Transfected cells were subsequently identified by their fluorescence. As NG108-15
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cells tended to form aggregates, they were plated at a low density following 
transfection and recorded from 24-72 hrs later. Cells were selected for 
electrophysiology if they were isolated from other cells, had only a few small 
processes and displayed low levels of fluorescence. As the cells were large and 
generally transfection efficiency was high, some GABA currents recorded were over 
4000pA in amplitude even with a 10 jiM GABA application (EC50). These currents 
were discarded from further analysis due to the potential for insufficient voltage 
clamp and series resistance problems.
6.2.1 NG108-15 cells did not express functional endogenous GABAa receptors.
It is thought that NG108-15 cells do not express GABAa receptors, however 
as these cells differ in their characteristics depending on the culture conditions and 
there was no systematic or thorough demonstration of this lack of expression in the 
literature, cells were transfected with cDNAs for GFP alone or for GFP and a l 
subunits alone, and GABA was applied to untransfected and transfected cells. As 
can be seen in Fig 6.1 no response to GABA was seen in any control situation (Un­
transfected, n = 9, GFP only, n = 5, a l subunit only, n = 4). This confirmed that 
there were no functional GABAa receptors expressed at the cell surface of un­
transfected cells. As a l subunit transfected cells also failed to respond to GABA this 
confirmed that there were no endogenous /? subunits present as if there had been, it 
would be predicted that the co-expression of a l would allow al/3 receptors to be 
formed as has been observed in some cases with HEK293 cells (Ueno et al., 1996; 
Davies et al., 2000). As transfection with cDNAs for c*j8/7  subunits produced large 
currents in response to GABA it appeared that recombinant GABAa receptors were
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expressed with high efficiency. It was thought, therefore, that recombinant subunits 
would dominate any endogenous protein that might be present (Davies et al., 2000).
Fig 6.1:
10pM GABA
NG108-15 GFP -
500pA
NG108-15 GFP +
2s
N G 108-15 GFP + a1
N G 108-15 GFP + a ip 3
Fig 6.1: Expression of GABAa receptors in NG108-15 cells.
Representative membrane currents showing response to applied GABA (10 jiM) 
recorded from:
(A) Untransfected NG108-15 cell (n = 9).
(B) Enhanced GFP (EGFP) positive NG108-15 cell transfected with EGFP alone 
(n = 5).
(C) EGFP positive NG108-15 cell transfected with the EGFP and the a l subunit 
only (n =5).
(D) EGFP positive NG108-15 cell transfected with enhanced EGFP and alp3.
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6.2.2 Recombinant aft receptors and CaMK-II.
Application of 60 nM a-CaMK-II to cells transfected with cd/31 produced no 
significant effects (107.4 ± 7.3 %, n = 7) as compared to control (93.8 ± 3.7 %, n = 3, 
Fig 6.2A) at t = 6 min. Although a slight increase seemed apparent in the first few 
minutes this was not statistically significant and was indistinguishable from control 
at t = 8 min. Application of 60 nM CaMK-II to al/32 receptors also produced no 
significant differences (85.5 ± 4.2 %, n = 5) from control GABA currents (91 ± 6.3 
%, n = 4, Fig 6.2B) at t = 6 min.
However, application of 60 nM a-CaMK-II to cd/33 receptors produced a 
statistically significant increase in the peak amplitude of currents recorded to 118 ±
4.8 % (n = 7) as compared to control, 96.4 ± 4.6 % (n = 7, Fig 6.2C) at t = 6 min 
which reached a plateau within 6-8 min.
6.2.3 Recombinant ct@y receptors and CaMK-II.
Application of 60 nM a-CaMK-II to cd/?l'>2S receptors expressed in NG1 OS- 
15 cells resulted in a significant potentiation of the whole cell currents recorded to 
125.6 ± 6.4 % (n = 11) as compared to control, 97.1 ± 3.9 % (n = 5) at t = 6 min. 
The inclusion of heat inactivated a-CaMK-II though, had no significant effects (89.2 
± 3.1 % at t = 6 min, n = 7, Fig 6.3A).
As for the cd/32 receptor, application of 60 nM O'-CaMK-II to 0:1/3272S 
expressing NG108-15 cells had no significant effect (102.5 ± 5.3 %, n = 11) as 
compared to control (105.1 ± 6.7 %, n = 6, Fig 6.3B). However, application of 
60 nM O'-CaMK-II to o:l /53^ y2S receptors significantly increased the peak amplitude 
of whole-cell currents to 145.8 ± 10.8 % (n = 7) at t = 6 min as compared to control,
102.8 ± 5 % (n = 4). Heat inactivated a-CaMK-II again had no significant effect
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(90.5 ± 11.6, n = 5, Fig 6.3C) as compared to control, but was significantly different 
from addition of pre-activated CaMK-II, at t = 6 min. The response to a-CaMK-II 
for cd/33 receptors was significantly increased by the inclusion of the subunit.
Transfection with cDNA for ctfiy subunits in equal ratio should ensure that the 
majority of receptors at the surface of the cell are afiy containing receptors as 
opposed to aJ3 (Angelotti et al., 1993; Angelotti and Macdonald, 1993). In 
agreement with this the amplitudes of currents recorded from cd/33y2S receptors 
were larger than those recorded from a/3 receptors (Angelotti et al., 1993). In 
addition, application of 10 pM diazepam (Herring et al., 2003) routinely increased 
the amplitude of the currents recorded indicating the presence of the y2 subunit (Fig 
6.3D).
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Fig 6.2: Whole-cell currents recorded from NG108-15 cells expressing alffl-3 
subunits were differentially modulated by q-CaMK-II.
Peak amplitude of GABA mediated currents recorded following the application of 
10 pM GABA to transfected NG108-15 cells expressing al/31, al/32 and cd/33 
GABAa receptors. GABA was re-applied at 2 min intervals for up to 20 min. All 
currents were normalised to the peak amplitude of the response measured during the 
first 3-4 min (= 100 %) after achieving the whole-cell configuration (t = 0 min). 
Control recordings were made with normal patch pipette solution supplemented with 
the pre-activation buffer without a-CaMK-II.
(A) GABA currents recorded from NG108-15 cells transfected with cd/31 subunits 
in the absence (Control, n = 3) and presence of 60 nM pre-activated a-CaMK-II, 
which was introduced into the cells via the patch pipette solution (n = 7).
(B) GABA currents recorded from NG108-15 cells transfected with cd/32 subunits 
in the absence (Control, n = 4) and the presence of 60 nM a-CaMK-II (n = 5).
(C) GABA currents recorded from NG108-15 cells transfected with cd/33 subunits 
in the absence (Control, n = 7) and the presence of 60nM a-CaMK-II (n = 7).
All points -  mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control.
P < 0.05, t-test.
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Fig 6.3: Whole-cell currents recorded from NG108-15 cells expressing a lffl- 
3t2S subunits were differentially modulated by O'-CaMK-II.
Peak amplitude of GABA mediated currents recorded following the application of 
10 pM GABA to transfected NG108-15 cells expressing aljS l^S , al(32^2S and 
«l/53'y2S GABAa receptors. GABA was re-applied at 2 min intervals for up to 20 
min. All currents were normalised to the peak amplitude of the response measured 
during the first 3-4 min (= 100 %) after achieving the whole-cell configuration (t = 0 
min). Control recordings were made with normal patch pipette solution 
supplemented with the pre-activation buffer without a-CaMK-II.
(A) GABA currents recorded from NG108-15 cells transfected with alpl-flS 
subunits in the absence (Control, n = 5) and presence of 60 nM pre-activated 
a-CaMK-II (n = 11) and with 60 nM heat inactivated (HI) a-CaMK-II (n = 7).
(B) GABA currents recorded from NG108-15 cells transfected with al/3272S 
subunits in the absence (Control, n = 6) and the presence of 60 nM a-CaMK-II 
(n= 11).
(C) GABA currents recorded from NG108-15 cells transfected with al/33Y2S 
subunits in the absence (Control, n = 4) and the presence of 60 nM a-CaMK-II 
(n = 7) and in the presence of 60 nM heat inactivated (HI) a-CaMK-II (n = 5).
(D) Representative membrane currents recorded from NG108-15 cells expressing 
al/33Y2S receptors before and after the bath application of 10 pM diazepam.
All points = mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control and the 
symbol *, CaMK-II compared to HI CaMK-II.
P < 0.05, t-test, ANOVA.
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6.3 DISCUSSION
Recombinant GABAa receptors expressed in NG108-15 cells can be 
functionally modulated by a-CaMK-II in a manner similar to that observed in 
cerebellar granule cells. However, control over the subunits that are expressed 
revealed different CaMK-II dependent effects depending on the precise subunit 
combination present. The only a@ heteromer that could be modulated by a-CaMK-II 
was al/33 suggesting a significant role for the /33 subunit in the a-CaMK-II 
modulation of GABAa receptors. Addition of the subunit increased this level of 
modulation significantly and revealed a lower, but still significant, level of 
modulation of al/31 subunit-containing receptors. However, both al/32 and al/5272S 
receptors failed to be modulated by a-CaMK-II. It appears, therefore, that CaMK-II 
has a differential effect on GABAa receptors depending on the subunits present, a 
phenomena that has been observed in relation to other phosphorylation-dependent 
effects on GABAa receptor function (McDonald et al., 1998; Nusser et al., 1999).
The different responses to CaMK-II mediated by different /? subunits shows 
some similarity to the effects seen on GABAa receptors mediated by PKA 
(McDonald et al., 1998). In this case PKA phosphorylation of /33 is thought to 
increase the peak amplitude of GABA currents and have no effect on /32 subunit- 
containing receptors. However, phosphorylation of the /31 subunit by PKA caused a 
depression of receptor function. In addition PKC is thought to have different effects 
on different GABAa receptor subtypes. Again phosphorylation of /33 subunit- 
containing receptors is thought to increase GABAa receptor function (Jovanovic et 
al., 2004) whilst PKC dependent phosphorylation of /51 subunit-containing receptors 
depresses GABAa receptor function (Leidenheimer et al., 1992; Krishek et al., 1994;
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Brandon et al., 2002b). Although there is some discrepancy in the functional effect 
observed (Lin et al., 1994; Lin et al., 1996).
The variation in response of native GABAa receptors to activation of these 
kinases in neurones is thought, in part, to be mediated by these differential effects of 
kinases on different receptor subunit combinations. PKA and PKC have both been 
shown in neurones to have slightly different effects on GABAa receptor mediated 
mEPSCs (Nusser et al., 1999; Poisbeau et al., 1999). However the response in 
neurones does not always correlate to that seen in recombinant systems. For 
instance, PKA appears able to modulate IPSCs in cells that predominantly express 
the j82 subunit (Nusser et al., 1999) despite a lack of response of the /32 subunit- 
containing GABAa receptors in HEK293 cells to PKA (McDonald et al., 1998).
In different recombinant systems there is also reported variation in the effects 
of phosphorylation. For example PKC activity has been reported to increase the 
amplitude of GABA currents mediated by cd/Sl^L receptors expressed in L929 
fibroblasts (Lin et al., 1996) although in Xenopus oocytes and HEK293 cells this has 
been reported to result in a depression of receptor function (Krishek et al., 1994). In 
addition, examination of desensitisation rates of and cd /B ^L  receptors
expressed in HEK293 cells in response to fast application of GABA revealed 
identical effects of PKA phosphorylation on macroscopic desensitisation rates 
(Hinkle and Macdonald, 2003) regardless of the /3 subunit present.
An important observation in the current study is that the addition of *y2S to 
the cel/53 heteromer increased the response to a-CaMK-II. It appeared that both /53 
and 72S subunits might be important for CaMK-II modulation and that both subunits 
are required for the full effect to be observed. It is thought that ocfiy receptors form 
the majority of GABAa receptors in neurones (Benke et al., 1994) and the ^2S
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subunit is thought to be required for GABAa receptors to be correctly targeted to the 
synapse (Essrich et al., 1998). It is significant, therefore, that a-CaMK-II modulates 
*y2S subunit-containing receptors to a greater degree than a(3 heteromers, as these are 
the synaptic and therefore more physiologically relevant receptor subtype. This 
finding also supports data from the previous chapter that a-CaMK-II is capable of 
significant modulation of synaptic GABA currents in cerebellar granule cells.
Modulation of GABAa receptors by PKA and PKC has also been suggested 
to be dependent on both /3 and y  subunits, with both being required for the full effect 
to be observed (Krishek et al., 1994). Ser409 on the /31 subunit with Ser327/343 on the 
T2L were found to be important for PKC modulation in L929 fibroblasts (Krishek et 
al., 1994; Lin et al., 1996). Ser410 and Ser327 were also found to be important when 
looking at PKC modulation of alj8272S receptors in Xenopus oocytes (Kellenberger 
et al., 1992). In both cases it was suggested that phosphorylation of both (3 and y  
subunits were required for the full PKC mediated effect to be apparent.
The /3 and y  subunits are thought to be the main targets of phosphorylation of 
GABAa receptors. It may be that phosphorylation of both subunits is required in 
some cases to mediate a functional effect. Little is currently known about how the 
intracellular loops of different subunits might interact. There is evidence that *y2 
intracellular loops can interact with (3 subunit intracellular loops (Nymann-Andersen 
et al., 2002). It is also thought intracellular loops between neighbouring receptors 
may be able to interact as the *y2 TM3-4 intracellular loop can also associate with 
other ^2 TM3-4 intracellular loops expressed as GST fusion proteins and this may 
play a role in receptor clustering (Nymann-Andersen et al., 2002). It has become 
apparent that phosphorylation can be regulated by the targeting of kinases to specific 
sites and that anchoring proteins can significantly alter how a kinase behaves
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(Brandon et al., 2002a). It may be that the phosphorylation of /3 and y  subunits is 
intricately linked within the receptor complex.
In the current study, /32 subunit-containing receptors are not modulated by a- 
CaMK-II (similar to PKA). The presence of ^ 2, therefore, is not enough on its own 
to ensure CaMK-II dependent modulation. In the case of /31 subunit-containing 
receptors CaMK-II modulation is only observed with present. This implies that 
individual subunits cannot be regarded in isolation, but that the receptor as a whole 
and all its subunits together, determine the effects of phosphorylation. It might be 
that the /3 subunit acts in a permissive manner to allow t2S related phosphorylation.
Cerebellar granule cells maintained in depolarising or more physiological 
conditions may both express /32//33 subunits. In depolarising conditions it has been 
suggested there may be a higher level of /33 subunit expression (Ives et al., 2002a) 
possibly reflecting the immature nature of these cultures. This would be consistent 
with the large response to a-CaMK-II in these cultures and the large response to a- 
CaMK-II seen in NG108-15 cells expressing cd/33t2S. In more physiological 
conditions, it is likely that the expression of GABAa receptor subunits more closely 
follows that seen in vivo (Laurie et al., 1992a; Wisden et al., 1996). As a result /32 
and /33 expression may both be significant, although /31 levels would be expected to 
be low (Persohn et al., 1992; Laurie et al., 1992b). IPSCs in CGCs were modulated 
by a-CaMK-II but there was evidence for some variation in the response to a-CaMK- 
II of different populations of sIPSCs. It is possible this may reflect differences in 
response to a-CaMK-II of /33 versus /32 subunit-containing receptors.
Between subunit isoforms of the GABAa receptor, there is typically around 
70-90 % sequence homology (Moss and Smart, 1996). The (3 subunits are similar in 
structure with the main differences between isoforms related to the TM 3-4
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intracellular domain (Moss and Smart, 1996). It is known that the /32 subunit is the 
most prevalent throughout the CNS (Benke et al., 1994), but the /33 subunit is 
thought to be expressed more predominantly at early stages in development in certain 
brain regions (Laurie et al., 1992b). This is possibly significant given that /33 
appears to be strongly regulated by phosphorylation by a number of kinases. In the 
adult brain there are clear differences in the pattern of /32 and /33 subunit expression 
(Miralles et al., 1999). As another example of the differences between these two 
subunits, /32 subunit knock-out mice are apparently normal in development and 
behaviour (Sur et al., 2001) whereas /53 knock-out mice are severely 
developmentally impaired (Homanics et al., 1997; DeLorey et al., 1998).
It is surprising that recombinant receptors containing /32 do not appear to be 
modulated by PKA (McDonald et al., 1998) or CaMK-II given the large number of 
these receptors within the brain. There are also surprisingly few examples of /32 
subunit dependent phosphorylation in the literature, however, phosphorylation of 
Ser410 by PKB causing an up-regulation of receptor number has been reported (Wang 
et al., 2003). Ser410 appears, so far, to be the main identified Ser/Thr kinase site of 
phosphorylation on this subunit (McDonald and Moss, 1997). Interestingly when /32 
Ser410 is phosphorylated by PKC it appears to result in a down-regulation in receptor 
function (Kellenberger et al., 1992) when receptors are expressed in Xenopus 
oocytes. Chapell et al. (1998) also observed this down-regulation and related it to a 
loss of receptors from the cell surface, however, in this case, mutation of Ser410 had 
no effect on PKC modulation. Both of these studies involved activation of PKC via 
addition of phorbol 12-myristate 13-acetate (PMA). Differences may reflect 
variations in experimental protocol (application of PMA) or may of course reflect
182
another example of the cellular environment, in this case Xenopus oocytes, affecting 
the functional consequences of phosphorylation.
The trafficking of receptors to the synapse can also be altered by 
phosphorylation and alterations in the number of receptors at the synapse have been 
suggested to mediate changes in synaptic strength (Kittler and Moss, 2003; Liischer 
and Keller, 2004). PKC dependent phosphorylation of /32 subunit-containing 
GABAa receptors has been linked to alterations in the cell surface stability of the 
receptors (Chapell et al., 1998; Connolly et al., 1999). PKB dependent 
phosphorylation at Ser410 has also been suggested to alter receptor number at the cell 
surface. PKA activity has been shown to differentially regulate trafficking and cell 
surface expression of /32 and (33 subunit-containing receptors in CGCs (Ives et al., 
2002b). Moreover, there is evidence that /32 and /33 subunits can be targeted 
differently within cells to different locations (Connolly et al., 1996). Interestingly, 
/32 and /81/3 subunits are reported to require different assembly signals within cd and 
T2 to be correctly assembled and trafficked to the cell surface (Bollan et al., 2003). It 
is possible that phosphorylation may differentially affect the trafficking of these 
subunits and some of the variation in response to phosphorylation, observed in 
neurones, may be due to different levels of activation of mechanisms that alter the 
number of receptors at the synapse through changes in cell surface stability, or 
insertion, and those that alter the channel properties of the receptors directly. This 
type of model has also been proposed for modulation of AMPA receptors by CaMK- 
II (Hayashi et al., 2000; Shi et al., 2001; Malinow and Malenka, 2002).
The phenomena of rebound potentiation of GABAa receptor function that 
occurs in Purkinje cells of the cerebellum, is also CaMK-II dependent (Kano et al., 
1992; Kano et al., 1996; Kawaguchi and Hirano, 2002). This cell type is thought to
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express predominantly alfil'fl. receptors (Persohn et al., 1992; Laurie et al., 1992b), 
however, this subunit combination, in a recombinant system, is not modulated by O '- 
CaMK-II. As yet there is no apparent explanation for this; however, the lack of 
response to phosphorylation seen in recombinant systems expressing /32 subunit- 
containing receptors may reflect unique functional properties of such receptors. A 
possible explanation is the need for additional co-factors scaffolding/anchoring 
proteins for /32 subunit phosphorylation to occur, or that phosphorylation dependent 
effects on /32 subunit-containing receptors are indirect, occurring through 
downstream pathways or phosphorylation of associated proteins. Interestingly the 
insertion of AMPA receptors stimulated by CaMK-II activity is dependent on GluRl 
receptors but not by their direct phosphorylation (Hayashi et al., 2000). It could be 
speculated that modulation of /32 subunit-containing receptors by CaMK-II is similar 
in that modulation of function occurs via downstream pathways / indirect effects and 
that this is difficult to observe in recombinant systems.
Expression of recombinant receptors in NG108-15 cells suggests that CaMK- 
II modulation of GABAa receptors is mediated mainly through al(33i2S receptors 
and partially through alfil'fiS . Within the /31//33 and *y2S subunits there are a 
number of potential sites for phosphorylation by a-CaMK-II (McDonald and Moss, 
1994; McDonald and Moss, 1997). Mutation of these residues so they cannot be 
phosphorylated will allow determination of which sites are the most important on 
each subunit and also if CaMK-II mediates its effects through direct phosphorylation 
or whether it can act indirectly through other downstream signalling pathways.
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CONCLUSIONS
Recombinant cd/33 receptors expressed in NG108-15 cells can be 
functionally up-regulated by a-CaMK-II.
Recombinant al/31 and al/32 receptors are not functionally modulated by 
a-CaMK-II.
Inclusion of the *y2S subunit to al/33 subunit-containing receptors enhances 
the modulation by a-CaMK-II.
Inclusion of the subunit to al/31 subunit-containing receptors reveals a
functional modulation by a-CaMK-II that is smaller than the effect 
observed for a l j ^ ^ S  receptors.
Inclusion of the subunit to al/32 subunit-containing receptors has no 
effect. GABAa receptors containing the /32 subunit do not appear to be 
regulated by a-CaMK-II in a recombinant system.
Chapter Seven:
Sites of CaMK-II phosphorylation on recombinant GABA^
receptors expressed in NG108-15 cells and cerebellar
granule cells.
7.1 INTRODUCTION
Modulation of the GABAa receptor by a-CaMK-II was observed in 
cerebellar granule cells and modulation of recombinant GABAa receptor subunits 
was also observed in the neuronal cell line NG108-15 (See Chapter 6). a-CaMK-II 
was capable of potentiating GABA currents recorded from NG108-15 cells 
expressing al/33 / al/31 t2S and alfft'flS  receptors implying that the /31/3 and *y2S 
subunits were required for the effect. It was, however, unclear if a-CaMK-II 
mediated its effect through: direct phosphorylation of these subunits;
phosphorylation of accessory proteins associated with them; or through activation of 
further downstream signalling pathways. In order to address these questions, 
potential phosphorylation sites on the /3 and /y1 subunits were altered through site- 
directed mutagenesis to prevent phosphorylation. These mutated recombinant 
receptors were then expressed in NG108-15 cells, which do not express endogenous 
GABAa receptors, and the effect on a-CaMK-II modulation was determined. To 
confirm the importance of potential sites of phosphorylation recombinant receptors 
were also expressed in cerebellar granule cells in culture.
The use of site-directed mutagenesis and expression of recombinant receptors 
in a cell line with no endogenous receptors has been used successfully to determine 
the sites of phosphorylation important for modulation of GABAa receptors by
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PKC/PKA and the tyrosine kinase, Src (Kellenberger et al., 1992; Moss et al., 1995; 
Lin et al., 1996; McDonald et al., 1998; Chapell et al., 1998). In addition, GST 
fusion proteins, formed from the TM3-4 intracellular loop of different subunits, have 
been used to identify potential sites of phosphorylation by different kinases on 
GABAa receptors (Machu et al., 1993; McDonald and Moss, 1994; McDonald and 
Moss, 1997). The fusion proteins formed from the /31 subunit could be 
phosphorylated by PKG, PKA, PKC and CaMK-II on Ser409, and on Ser384 by 
CaMK-II only (Moss et al., 1992; McDonald and Moss, 1994). The Ser409 site was 
found to be important for PKC dependent functional modulation of GABAa 
receptors (Krishek et al., 1994; Lin et al., 1996; McDonald et al., 1998; Brandon et 
al., 2002b; Hinkle and Macdonald, 2003).
The /32 subunit has one main site of phosphorylation at Ser410, (the equivalent
of Ser409 in /31/3). PKG, PKC, PKA and CaMK-II were all capable of
phosphorylating this site on a GST fusion protein of the TM3-4 intacellular loop of 
the /32 subunit (McDonald and Moss, 1997). This site has been shown to be 
important in PKC dependent modulation of whole-cell currents recorded from 
recombinant 0:1/3272S receptors expressed in Xenopus oocytes (Kellenberger et al., 
1992). It has also been shown to be required for PKB mediated increases in the 
number of /32 subunit-containing receptors at the cell surface of HEK293 cells and 
hippocampal neurones (Wang et al., 2003a).
The use of GST-fusion proteins has also identified Ser409 as the major site of 
phosphorylation in the /33 subunit. Using such constructs PKC, PKA, PKG and 
CaMK-II all phosphorylated this site. Moreover, Ser408 was additionally
phosphorylated by PKC, and Ser383 was also subject to phosphorylation, but only by 
CaMK-II (See Table 1.1). In a recombinant system, Ser408 and Ser409
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phosphorylation of /33 by PKA was required for an up-regulation of function and 
mutation of Ser408 converted the up-regulation into a down-regulation similar to that 
observed for PKA modulation of /31 subunit-containing receptors (McDonald et al., 
1998). It appears, therefore, that there are three potential sites of CaMK-II 
phosphorylation on the /53 subunit, Ser 383,408,409.
The *y2S subunit intracellular loop, expressed as a fusion protein, can be 
phosphorylated by PKC at Ser327, and at Ser348 and Thr350 by CaMK-II (Moss et al., 
1992; McDonald and Moss, 1994). Both PKC and CaMK-II were capable of 
phosphorylating Ser343 within the 8 amino acid insert that forms the ^2L splice 
variant (Moss et al., 1992; Machu et al., 1993; McDonald and Moss, 1994). PKA 
did not phosphorylate the *y2S subunit intracellular loop fusion protein (Moss et al., 
1992). Phosphorylation of Ser327 and Ser343 in t2L by PKC have both been shown to 
be functionally important for GABAa receptors expressed in heterologous systems 
(Kellenberger et al., 1992; Krishek et al., 1994; Lin et al., 1996).
As well as Ser/Thr kinases, tyrosine kinases have also been shown to 
phosphorylate the GABAa receptor and modulate function in both heterologous 
expression (Moss et al., 1995; Wan et al., 1997) and neuronal systems (Moss et al., 
1995; Valenzuela et al., 1995). Tyrosine kinase activity has been shown to 
potentiate GABA currents (Moss et al., 1995; Huang and Dillon, 1998) including 
IPSC amplitudes (Boxall, 2000; Ma et al., 2003). It has been reported that 
application of pp60°'src to HEK293 cells resulted in phosphorylation of /J2/3 subunits 
(Wan et al., 1997). Modulation of cd/31 receptors expressed in Xenopus oocytes by 
tyrosine kinase activity has also been reported (Valenzuela et al., 1995). In addition 
phosphorylation of tyrosines 384 and 386 within the /31 subunit has also been 
reported, but in this case, phosphorylation appeared to be functionally silent (Moss et
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al., 1995). Mutation of the tyrosine residues at 365 and 367 on the ^2L subunit 
(corresponding to Y357 and Y359 on *y2S) was found to block functional modulation 
by Src of GABAa receptors in HEK293 cells (Moss et al., 1995). It appears 
therefore that these two residues may be the most functionally relevant sites of 
phosphorylation on the subunit. These sites have been shown to be 
phosphorylated within the brain and can be dynamically regulated by tyrosine 
phosphatase activity in cultured cortical neurones (Brandon et al., 2001).
Thus, there are a number of sites identified on GABAa receptors that may be 
directly phosphorylated by CaMK-II. Expression of aft heteromers in NG108-15 
cells suggests that /33 is the only /3 subunit that could be directly phosphorylated by 
a-CaMK-II. In addition, t2S subunits appeared to play a role in a-CaMK-II 
modulation of a lp l'fiS  and al03'ftS receptors. A series of mutant receptor subunits 
were prepared, with potential sites of phosphorylation ablated so they could not be 
phosphorylated, using site-specific mutagenesis (See Chapter 2.1). These mutant 
receptors were expressed in NG108-15 cells and cerebellar granule cells to determine 
the functional effect on a-CaMK-II modulation.
7.2 RESULTS
In each case, NG108-15 cells and cerebellar granule cells were transfected 
with a(3 or afiy subunit cDNA combinations, in equal ratios, along with enhanced 
GFP for identification of transfected cells. 60 nM a-CaMK-II (pre-activated) was 
introduced into the cells via the patch pipette solution (See Chapter 2 and 3.2.1). 
Control recordings consisted of a normal patch pipette solution containing the pre­
activation buffer without a-CaMK-II. Whole-cell currents were recorded in response 
to GABA and the percentage change in the peak current amplitude was recorded over
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time. Current amplitudes were then normalised to the peak amplitude recorded 3-4 
min after first achieving the whole-cell configuration.
7.2.1 a-CaMK-II modulation of GABAa receptor mutant afi heteromers.
The al (33 receptor was selected as this exhibited the most significant 
modulation by a-CaMK-II (See Fig 6.2). All three potential phosphorylation sites, 
Ser383,408,409 were converted to alanines within the /33 subunit. It was presumed that 
this would remove all the potential sites of CaMK-II phosphorylation within this 
subunit. On the sequential application of 10 pM GABA over 20 min in control 
conditions, the amplitude of GABA currents recorded was quite stable with little run­
down.
On application of 60 nM a-CaMK-II, no significant effect was seen on the 
amplitude of the currents recorded (93.2 ± 7.6 %, n = 8) as compared to the controls 
(101.3 ± 4.6 %, n = 5 at t = 6 min, Fig 7.1A) indicating that phosphorylation of at 
least one of these residues was capable of mediating the a-CaMK-II modulation of 
the al/33 receptor. PKA phosphorylation of j33 has been reported to increase the 
amplitude of GABAa receptor mediated currents through phosphorylation of 
Ser408,409. However, the application of 60 nM a-CaMK-II to al/33S408A,S409A receptors 
resulted in a significant potentiation of the amplitude of currents recorded to 120.6 ±
6.2 % (n = 7) as compared to control, 93.9 ± 3.8 % (n = 4) at t = 6 min, which was 
not significantly different from the effect of 60 nM a-CaMK-II on al/33 wild-type 
receptors (118 ± 4.8 %, n = 7, Fig 7.IB). This effect of a-CaMK-II had a similar 
time-course to the effect on wild-type receptors reaching a steady-state within 6 min.
Although Ser408,409 appeared unimportant for the a-CaMK-II effect, 
application of 60 nM a-CaMK-II to al/33S383A receptors resulted in no significant
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increase in amplitude (94 ± 6.8 %, n = 5) as compared to control (101.7 ± 1.5 %, n = 
6 at t = 6 min, Fig 7.1C). This indicates that a-CaMK-II modulation of the cd/33 
receptor is mediated solely through phosphorylation of Ser383.
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Fig 7.1: a-CaMK-II modulation of al#3 heteromers is mediated through
phosphorylation of Ser383.
Peak amplitudes of GABA-mediated currents recorded following the application of 
10 |xM GABA to transfected NG108-15 cells expressing: cd ^ S383A.S408A,S409A. 
a l0 3 S4O8A,S4O9A or al/33S383A GABAa receptors. GABA was re-applied at 2 min 
intervals for up to 20 min. All currents were normalised to the peak amplitude of the 
response measured during the first 3-4 min (= 100 %) after achieving the whole-cell 
configuration (t = 0 min). Control recordings were made with a normal patch pipette 
solution supplemented with the pre-activation buffer without a-CaMK-II.
(A) GABA currents recorded from NG108-15 cells transfected with 
al/33S383A’S408A,S409A subunits in the absence (Control, n = 5) and presence of internal 
60 nM pre-activated a-CaMK-II (n = 8). In this figure, al/33 wild-type responses to 
60 nM CaMK-II (taken from Fig 6.2C) are shown for comparison (n = 7).
(B) GABA currents recorded from NG108-15 cells transfected with al/33S408A,S409A 
subunits in the absence (Control, n = 4) and the presence of 60 nM a-CaMK-II
(n = 7).
(C) GABA currents recorded from NG108-15 cells transfected with al/33s383A 
subunits in the absence (Control, n = 6) and the presence of 60 nM a-CaMK-II
(n = 5).
All points = mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control and *, 
CaMK-II wild-type compared to CaMK-II mutant.
P < 0.05, t-test, ANOVA.
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7.2.2 a-CaMK-II modulation of mutant aljff372S subunit-containing receptors.
CaMK-II modulation of al/33T2S receptors appeared significantly larger 
when compared to the modulation of cd/33 receptors (Figs 6.2C, 6.3C) indicating that 
a-CaMK-II modulation may be partly mediated through the subunit. 
Application of 60 nM a-CaMK-II to «1 ^ 3S383A»S408A>S409A^ 2s  receptors still resulted 
in a significant potentiation of the amplitude of GABA (10 pM) currents recorded to 
117.8 ± 5 % (n = 8) as compared to control, 94.9 ± 4 % (n = 4, Fig 7.2A) at t = 6 
min. However, this effect was significantly smaller (107.5 ± 3.5 %, n = 8) than the 
effect of a-CaMK-II on al/33/y2S wild-type receptors (145.8 ± 10.8 %, n = 7) at t = 4 
min. This confirmed the likelihood that a-CaMK-II mediated part of its functional 
modulation via the subunit and that mutation of all known sites of 
phosphorylation in the /33 subunit did not remove the CaMK-II modulation. The 
time-course of the residual response appeared slightly slower than for wild-type 
receptors and the effect was also transient with amplitudes returning to baseline 
levels within 20 min.
Analysis of the potential sites for CaMK-II phosphorylation on the ^2S 
subunit, using fusion proteins, suggested that the main sites involved were Ser348 and 
Thr350. Application of 60 nM a-CaMK-II to al/33/y2SS348A,T350A receptors resulted in 
a significant potentiation of GABA currents recorded to 142.7 ± 11.2 % (n = 8) as 
compared to control, 101.3 ± 6.7 % (n = 5, Fig 7.2B) at t = 6 min. Interestingly, this 
was not significantly different from the potentiation seen when CaMK-II was applied 
to wild-type alfiS'fiS receptors indicating that these residues are not functionally 
important in modulating the amplitude of al/33T2S receptor mediated currents via 
CaMK-II phosphorylation.
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The application of 60 nM a-CaMK-II to the combined mutant receptor 
al/33S383A’S408A’S409A-y2sS348A,T350A also resulted in a significant potentiation to 127.4 ± 
S % (n = 8) as compared to control, 104.2 ± 2.8 % (n = 4, Fig 7.2C) at t = 6 min. 
This was not significantly different from that seen on a l /33S383A>S408A’S409A^ 2 s  
receptors, further indicating that phosphorylation of Ser348 and Thr350, in this case, 
does not mediate the effect of a-CaMK-II. Again, the effect was transient and by t = 
10 min the effect of a-CaMK on o:l /S3s383A>S408A»S409A^ y2sS348A,T350A receptors was 
significantly different (114.2 ± 6.4 %, n = 8) from the effect on wild-type (148.5 ±
12.2 %, n = 7) but was not significantly different from control (102.7 ± 5.8 %, n = 4, 
Fig7.2C).
Application of 10 pM diazepam to a l  ^ 3^2sS348A,T350A receptors resulted in
potentiation of GABA currents, indicating that the y2SS348A,T350A subunit was
expressed at the cell surface (Fig 7.2D). In addition, if this subunit was not
expressed, it would be predicted that a-CaMK-II would be without effect as previous
results indicated a-CaMK-II could not functionally modulate al/33S383A,S408A,S409A
receptors (Fig 7.1 A), however, a significant increase in amplitude was observed on 
a-CaMK-II application to o,i /33s383A:S408A:S409a^ 2Ss348a,t350a receptors suggesting an
a^yheteromer was correctly assembled and expressed (Fig 7.2C).
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Fig 7.2: CaMK-II modulation of y2S subunit-containing receptors is not
mediated through phosphorylation of GABAa Ser348 and Thr350.
Peak amplitude GABA mediated currents recorded following the application of
10 (xM GABA to transfected NG108-15 cells expressing: a i/BS383A-S408A’S409A-y2S; 
al/S3-y2SS348A:T350A or 0(i ^S383a,s408a^ a72SS348a,t350a GABAa reCeptors. GABA
was re-applied at 2 min intervals for up to 20 min. All currents were normalised to 
the peak amplitude of the response measured during the first 3-4 min (= 100 %) after 
achieving the whole-cell configuration (t = 0 min). Control recordings were made 
with normal patch pipette solution supplemented with the pre-activation buffer 
without O'-CaMK-II.
(A) GABA currents recorded from NG108-15 cells transfected with
al/53S383A,S408A,S409A'y2S subunits in the absence (Control, n = 4) and presence of 
60 nM pre-activated a-CaMK-II (n = 8). In this figure, wild-type
responses to 60 nM CaMK-II (taken from Fig 6.3C) are shown for comparison
(n = 7).
(B) GABA currents recorded from NG108-15 cells transfected with
al/5372SS348A’T350A subunits in the absence (Control, n = 5) and presence of 60 nM 
a-CaMK-II (n = 8).
(C) GABA currents recorded from NG108-15 cells transfected with
aip3S383A,S408A,S409A'y2Ss348,T350A subunits in the absence (n = 4) and the presence of 
60 nM a-CaMK-II (n= 8).
(D) Representative currents recorded from NG108-15 cells expressing 
alj63'y2SS348A,T350A receptors, before and after bath application of 10 pM diazepam.
All points -  mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control and the 
symbol *, CaMK-II wild-type compared to CaMK-II mutant.
P < 0.05, t-test, ANOVA.
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7.2.3 Cross-talk between CaMK-II and tyrosine kinase phosphorylation of the 
cd/3372S receptor.
Analysis of fusion proteins in vitro suggested that Ser348 and Thr350 were the 
main sites of CaMK-II phosphorylation on the y2S subunit however mutation of 
these sites to alanines clearly had no effect on a-CaMK-II modulation of al03')2S 
receptors. This left three possibilities, either CaMK-II was capable of 
phosphorylating at another site in an NG108-15 cell that it could not 
phosphorylate in vitro; or CaMK-II was acting on the subunit through 
phosphorylation of an accessory protein; or CaMK-II was acting through the 
subsequent activation of another downstream kinase. It has previously been shown 
that phosphorylation of two tyrosine residues in the *y2S subunit can result in an 
increase in whole-cell current amplitudes similar in magnitude to that observed 
following the action of a-CaMK-II on subunit-containing receptors (Moss et al., 
1995). Therefore, 100 pM genistein an inhibitor of tyrosine kinase activity 
(Akiyama et al., 1987), was co-applied in the patch pipette solution with 60 nM a- 
CaMK-II. It was not possible to pre-apply genistein in the bath, because if applied 
extracellularly, genistein is capable of directly inhibiting the GABAa receptor 
(Dunne et al., 1998). Application of 60 nM CaMK-II and 100 pM genistein to 
receptors resulted in a significant increase in the amplitude of currents 
recorded to 120.3 ± 7.6 % (n = 7) as compared to control, 100.2 ± 2.3 % (n = 4, Fig 
7.3A) at t = 4 min. This potentiation however was significantly smaller than that 
seen on application of a-CaMK-II alone (145.8 ± 10.8 %, n = 7). It should also be 
noted in this case that application of genistein alone had no effect on the amplitude of 
currents recorded over 20 min. This indicated that, in this cell type, the *y2S subunit 
is not subject to significant basal phosphorylation by tyrosine kinases. Application
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of 60 nM a-CaMK-II and 100 |nM genistein to cdj83S383A*y2S receptors resulted in no 
significant changes in amplitude (103.6 ± 2.8 %, n= 7) over 20 min as compared to 
control (97 ± 7.1 %, n = 4 at t = 6 min, Fig 7.3B). This suggested that 
phosphorylation at Ser383 in the /33 subunit and O'-CaMK-II dependent activation of 
tyrosine kinase activity was fully responsible for the modulation of GABAa 
receptors by O'-CaMK-II.
The application of 60 nM a-CaMK-II to cd/33'y2SY357F,Y359F receptors resulted 
in a significant potentiation of the amplitude of currents recorded to 126.2 ± 4 % (n = 
7) as compared to control, 107.6 ± 6.5 % (n = 4, Fig 7.3C) at t = 4 min. However, as 
before, this potentiation was significantly less than the effect of O'-CaMK-II on 
0'l/33/y2S receptors (145.7 ± 10.2 %, n = 7) at t = 6 min. However after 8-10 min of 
recording, there was no significant difference in response to a-CaMK-II as compared 
to wild-type. This coincides with the observation that the response to a-CaMK-II 
mediated by the i2S subunit is transient and is no longer evident after 10-15 min.
Finally, application of 60 nM Of-CaMK-II to al/33s383A/y2SY357F,Y359F receptors 
abolished the response to O'-CaMK-II with no significant effect on the amplitude of 
currents recorded over 20 min (103.3 ± 3.4 %, n = 6, at t = 6 min) as compared to 
control (108.4 ± 4.3 %, n = 6, at t = 6 min, Fig 7.3D). This indicated that CaMK-II 
dependent phosphorylation of /53 Ser383 and *y2S Tyr357’359 mediates O'-CaMK-II 
dependent modulation of a lj& ^ S  receptors. This suggested a possible direct site of 
phosphorylation by Of-CaMK-II and the activation of a second signalling pathway, 
acting through tyrosine kinase phosphorylation of the *y2S subunit.
Application of 10 pM diazepam to Q'lj33'y2SY357F,Y359F receptors resulted in a 
potentiation of the current recorded indicating that the ^2SY357F,Y359F subunit was 
expressed and correctly assembled at the cell surface (Fig 7.4A). It has been
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observed that the addition of the 7 subunit to a(3 heteromers increases the amplitudes 
of the GABA currents recorded (Angelotti et al., 1993). The current density 
recorded from NG108-15 cells expressing cd/?3 (20.2 ±11.5 pA/pF, n = 6) was 
significantly increased for cdj3372S receptors (94.1 ± 1 9  pA/pF, n = 6, Fig 7.4B). 
There were no significant differences in current density between cd/3372S, 
al|33y2SS348A,T350A (87.1 ± 21.3 pA/pF, n=7) and al/33y2SY357F’Y359F (82.1 ± 15.6 
pA/pF, n = 6, Fig 7.4B) receptors, indicating that site-specific mutation of 
phosphorylation sites in the 72S subunit was unlikely to interfere with subunit 
expression or trafficking to the cell surface.
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Fig 7.3: q-CaMK-II modulation of criff372S subunit-containing GABAa 
receptors is mediated partly through tyrosine kinase phosphorylation of
T y r 357,359
Peak amplitudes of GABA mediated currents recorded following the application of 
10 pM GABA to transfected NG108-15 cells expressing: a l/f t^ S ; 0:1/33 S383A,y2S; 
alj(33'y2sY357F,Y359F or cd/33S383AT2SY357F,Y359F GABAa receptors. GABA was re­
applied at 2 min intervals for up to 20 min. All currents were normalised to the peak 
amplitude of the response measured during the first 3-4 min (= 100 %) after 
achieving the whole-cell configuration (t = 0 min). Control recordings were made 
with normal patch pipette solution supplemented with the pre-activation buffer 
without a-CaMK-II.
(A) GABA currents recorded from NG108-15 cells transfected with a\^2^2S 
subunits in the absence (Control, n = 4) and presence of 60 nM pre-activated 
O'-CaMK-II (n = 7) which also contained 100 pM genistein. In this panel and C 
cd/33'y2S wild-type responses to 60 nM CaMK-II (taken from Fig 6.3C) are shown 
for comparison (n = 7).
(B) GABA currents recorded from NG108-15 cells transfected with al|83S383A'y2S 
subunits in the absence (Control, n = 4) and the presence of internal 60 nM 
O'-CaMK-II (n = 7) but always including 100 pM genistein.
(C) GABA currents recorded from NG108-15 cells transfected with 
cd/33y2SY357F,Y359F subunits in the absence (Control, n = 4) and the presence of 
60 nM O'-CaMK-II (n = 7).
(D) GABA currents recorded from NG108-15 cells transfected with 
0'ljS3S383A'y2SY357F,Y359F subunits in the absence (Control, n = 6) and the presence of 
60 nM a-CaMK-II (n = 6).
All points = mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control, the symbol 
*, CaMK-II wild-type compared to CaMK-II mutant and the symbol *, CaMK-II and 
inhibitor compared to control.
P < 0.05, t-test, ANOVA.
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Fig 7.4: ^ s 8348^ 3^  and 2^s Y3S7F>Y359F receptor subunits are expressed at 
the cell surface.
(A) Representative GABA currents recorded from NG108-15 cells expressing 
cd/?3'y2SY357F,Y359F receptors before and after bath application of 10 pM 
diazepam.
(B) Bar chart showing the mean current density (pA/pF) of NG108-15 cells 
expressing al03 (n = 6), cd /B ^S  (n = 6), al/33'y2SS348A’T350A (n = 7) and 
cd/53S383A'y2SY357F,Y359F (n = 6) GABA receptors after application of 10 pM 
GABA at t = 0 min in control conditions.
Significance is indicated by the symbol *, al/33 compared to alfi3i2S.
P < 0.05, t-test.
201
7.2.4 Cross-talk between CaMK-II and tyrosine kinases acting on OJI/JI72S 
receptors.
O'-CaMK-II was capable of modulating a lfililS  receptors, but not cd/Sl 
receptors, suggesting that modulation of alfil'ft.S receptors occurred primarily 
through the 72S subunit. In order to confirm if the same tyrosine kinase dependent 
mechanism revealed for al(33i2S receptors, was also involved, 60 nM O'-CaMK-II 
and 100 pM genistein were internally applied to otlfil'flS receptors. In this case 
there was no significant effect on the amplitude of currents recorded (98.5 ± 5 %, n = 
6) as compared to control (105.1 ± 2.5 %, n = 4, Fig 7.5A) at t = 6 min. The 
application of genistein in control conditions again had no significant effect on the 
amplitude of the GABA currents recorded, suggesting a lack of any basal tyrosine 
kinase phosphorylation of these receptors in NG108-15 cells.
Application of 60 nM a-CaMK-II to Q'l/31'y5Y3576F,Y359F receptors abolished 
the effect of O'-CaMK-II, with no significant difference in the amplitude of GABA 
currents (99.7 ± 5.5 %, n = 7) compared to control (102.1 ± 3.5 %, n = 4, Fig 7.5B) at 
t = 6 min. This indicated that the effect of O'-CaMK-II on G'1/?1')2S receptors was 
entirely mediated by CaMK-II dependent activation of tyrosine kinase activity.
The current density of cd/Sl^S receptors (87.9 ± 16.3 pA/pF, n = 6) was 
significantly higher than the current density of odjSl receptors (19.5 ± 4.8 pA/pF, n = 
6) and the current density of 0'lj81,y2SY357F,Y359F receptors was not significantly 
different (75.2 ± 32 pA/pF, n = 6, Fig 7.5C) from alpl'fi.S. This indicated that the 
'y2gY357F,Y359F subunit was most likely expressed at the cell surface and assembled 
correctly with cd/31.
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Fig 7.5: CaMK-II modulation of Oil&lt2S subunit-containing GABAa receptors 
is mediated through tyrosine kinase phosphorylation of Tyr357,359.
Peak amplitudes of GABA-mediated currents recorded following the application of 
10 pM GABA to transfected NG108-15 cells expressing od/3l72S and 
cd/31'y2SY357F,Y359F GABAa receptors. GABA was re-applied at 2 min intervals for 
up to 20 min. All currents were normalised to the peak amplitude of the response 
measured during the first 3-4 min (= 100 %) after achieving the whole-cell 
configuration (t = 0 min). Control recordings were made with normal patch pipette 
solution supplemented with the pre-activation buffer without a-CaMK-II.
(A) GABA currents recorded from NG108-15 cells transfected with a ljS l^S  
subunits in the absence (Control, n = 4) and presence of 60 nM pre-activated 
a-CaMK-ll with 100 pM genistein present throughout (n = 6). Data for al(3\^2S 
wild-type responses to 60 nM CaMK-II (taken from Fig 6.3A) are shown for 
comparison (n = 11).
(B) GABA currents recorded from NG108-15 cells transfected with 
0'l/51'y2SY357F,Y359F subunits in the absence (Control, n = 4) and the presence of 
60 nM a-CaMK-II (n = 7).
(C) Bar chart showing the mean current densities (pA/pF) of NG108-15 cells 
expressing: al/31 (n = 6), cd/Sl^S (n = 6), Oil /31 s Y357,Y367F (n = 6) GABAa 
receptors after application of 10 pM GABA at t = 0 min in control conditions.
All points = mean ± s.e.
Significance is indicated by the symbol *, CaMK-II wild-type compared to CaMK-II 
mutant or CaMK-II and inhibitor.
P < 0.05, t-test, ANOVA.
204
7.2.5 Recombinant GABAa receptors expressed in cerebellar granule cells are
expressed at the cell surface.
There is a certain amount of discrepancy between the reported effects of 
phosphorylation in recombinant systems and that observed in neuronal systems (See 
Chapter 1). In addition, it has been suggested that the expression of recombinant 
receptors in different cell lines can alter the properties of the receptors expressed 
(Ueno et al., 1996; Mercik et al., 2003; Everitt et al., 2004) as has also been 
demonstrated in the current study (See Chapter 3). In order to confirm the 
importance of the sites of phosphorylation identified in NG108-15 cells in a neuronal 
system, recombinant GABAa receptors were expressed in cerebellar granule cells in 
culture.
A number of studies have reported that expression of single GABAa receptor 
subunits in neurones allows expression of these recombinant receptors at the surface 
through assembly with endogenous subunits (Okada et al., 2000; Cheng et a l , 2001). 
However a number of other studies have reported that recombinant single subunits 
cannot be expressed at the cell surface without co-transfection of the other 
recombinant GABAa receptor subunits required for cell surface expression (Gorrie et 
al., 1997; Kittler et al., 2000).
Cerebellar granule cells maintained in depolarising conditions were 
transfected using Effectene (See Chapter 2) with a l GABAa receptor subunit cDNA 
co-expressed with /32 subunit cDNA containing a functionally silent extracellular 
myc epitope (See Chapter 2) inserted at the N terminus (Connolly et al., 1996a; 
Connolly et al., 1996b; Farrar et al., 1999). The presence of recombinant receptors 
at the cell surface was determined by immunocytochemistry. Cultures were 
immunolabeled with a primary antibody directed against the myc epitope. As these
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cells were not permeabilised and the myc epitope was inserted in a part of the subunit 
expected to be extracellular, the presence of fluorescence would indicate cell surface 
expression of the recombinant subunit.
In order to observe strong cell surface expression in the current study it was 
observed that /3 subunits had to be co-expressed with a recombinant a  subunit. Co­
expression of a l with /32 and a l with /53 resulted in strong cell surface expression 
suggesting that these granule cells now expressed a large number of a(3 heteromers at 
the cell surface most likely in excess of endogenous receptors given the strong viral 
promoter within the plasmid cDNA (See Fig 7.6A and B).
Co-expression of a l with /53S408A,S409A and /53S383A revealed that despite the 
disruption to the phosphorylation sites in these recombinant subunits they were still 
strongly expressed at the cell surface of cerebellar granule cells after transfection 
(See Fig 7.6 C and D). Co-expression of />2Smyc with a l and /32 or /33 resulted in 
strong surface expression suggesting that these cells now predominantly express 
recombinant a(3y GABAa receptors (See Fig 7.7 A and B). Co-expression of a l  and 
/33 with Y2s Y357F>Y359F’myc ajso resulted in expression of the recombinant 
alj83'y2Y357F,Y359F,myc receptors at the cell surface (See Fig 7.7C).
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Fig 7.6: Expression of recombinant aS subunit-containing GABAa receptors at 
the cell surface of transfected cerebellar granule cells:
Cultures of rat cerebellar granule cells maintained in depolarising conditions were 
transfected with al/32myc, al/33myc, al/33S408A,s409A,myc m i  GABAa
receptor subunits along with enhanced GFP for identification of transfected cells. 
Cells were immunolabelled with an anti-myc epitope antibody without 
permeabilisation so that only subunits at the cell-surface were detected. Images 
were obtained on a Zeiss Meta 510 laser scanning confocal microscope. Unless 
otherwise stated each image consists of a Z series of 8-10 images at intervals of 0.3- 
0.4/rni (See Chapter 2). Each image is representative of at least five different 
transfected cells (GFP expressing). All transfected cells observed showed cell 
surface expression of recombinant receptors.
(A) Cerebellar granule cell transfected with al/32myc GABAa receptor subunits. 
First panel shows GFP fluorescence indicating transfection (Green), the second 
panel shows anti-myc immunolabelling (red) and the third panel is an overlay of the 
two showing co-localisation (yellow).
(B) Cerebellar granule cell transfected with al/33myc GABAa receptor subunits.
(C) Cerebellar granule cell transfected with al/33S408A'S4mA'myc GABAa receptor 
subunits.
(D) Cerebellar granule cell transfected with al/33S383A,myc GABAa receptor subunits. 
(Calibration bar =10 /mi)
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Fig 7.7: Expression of recombinant ot6y subunit-containing GABAa receptors at 
the cell surface of transfected cerebellar granule cells:
Cultures of rat cerebellar granule cells maintained in depolarising conditions were 
transfected with al/3372Smyc, al/32-y2Smyc and al)3372SY357F’Y359F'myc GABAa 
receptor subunits along with enhanced GFP for identification of transfected cells. 
Cells were immunolabelled with an anti-myc epitope antibody without 
permeabilisation so that only subunits at the cell-surface were detected (See Chapter 
2). Each image is representative of at least five different transfected cells (GFP 
expressing). All transfected cells observed showed cell surface expression of 
recombinant receptors.
(A) Cerebellar granule cell transfected with al/33'y2Smyc GABAa receptor subunits.
(B) Cerebellar granule cell transfected with cdj32"y2Smyc GABAa receptor subunits.
(C) Cerebellar granule cell transfected with o:lj(33'y2SY357F,Y359F’myc GABAa receptor 
subunits. (Calibration bar =10 /zm)
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7.2.6 Of-CaMK-II modulation of recombinant otfi heteromers expressed in
cerebellar granule cells.
Cerebellar granule cells transfected with GFP only were recorded from with 
normal patch pipette solution supplemented with pre-activation buffer without 
CaMK-II. The whole-cell GABA currents recorded remained stable throughout 16 
minutes of recording (See Fig 7.8). The resting potential of transfected cerebellar 
granule cells was recorded as an indication that transfection did not significantly alter 
cell physiology. The resting potential of transfected granule cells was not 
significantly different (-43.9 ± 2.8 mV, n = 8) to untransfected granule cells -39.2 ± 
2.5 mV (n = 6).
Application of 60 nM O'-CaMK-II to granule cells expressing cd/33 
heteromers resulted in a significant potentiation of the amplitude of whole-cell 
currents to 130.6 ± 6.3 % at t = 4 min (n = 7) as compared to 60 nM a-CaMK-II 
applied to granule cells expressing cd/32 heteromers (105.6 ± 2.6 %, n = 7, at t = 4 
min, Fig 7.8A). Application of 60 nM a-CaMK-II to al/33S408A,S409A expressing 
granule cells resulted in a significant increase in amplitude to 127.1 ± 8 % (n = 4) at t 
= 6 min as compared to application of O'-CaMK-II to cd/33S383A expressing granule 
cells (104.2 ± 2.6 %, n = 4, at t = 6 min, Fig 7.8B), which for al/33S408A,S409A, was not 
significantly different from the application of O'-CaMK-II to wild-type cd/33 
heteromers.
The response of cerebellar granule cells expressing recombinant GABAa 
receptors to O'-CaMK-II was similar to that observed in NG108-15 cells (See Fig 
7.1). Again, the results indicated that cd/32 heteromers were not modulated by a- 
CaMK-II in this system and that Ser383 on the /33 subunit appeared to mediate the a- 
CaMK-II dependent effect on cd/33 heteromers. The extent of a-CaMK-II
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modulation was also similar to that observed in NG108-15 cells, suggesting that in 
granule cells the *y2 subunit may also mediate part of the response to CaMK-II. It 
also suggested that the expressed recombinant a/3 heteromers dominated over 
endogenous receptors in granule cells which would be expected to consist of a(3y 
receptors.
7.2.7 a-CaMK-II modulation of afiy receptors expressed in cerebellar granule 
cells.
Application of 60 nM a-CaMK-II to granule cells expressing CLlfi3~/2S 
recombinant receptors resulted in a significant potentiation of the amplitude of 
whole-cell currents to 167.8 ± 13.7 % (n = 4) at t = 6 min, as compared to granule 
cells expressing otl(32'fl.S recombinant receptors (112.8 ± 8 %, n = 7, at t = 6 min, 
Fig 7.9A). In addition this increase was significantly greater than the effect of a- 
CaMK-II on al/33 expressing granule cells at t = 6 min (127.1 ± 8 %, n = 7, Fig 
7.8A). This indicated that similar to NG108-15 cells, the t2S subunit mediated part 
of the GABAa receptor response to a-CaMK-II. In contrast to NG108-15 cells (Fig 
6.3), application of a-CaMK-II to al/32*y2S expressing granule cells resulted in a 
significant but transient potentiation of whole cell currents to 115.6 ± 4.2 % (n = 7) 
at t = 4 min as compared to control (96.4 ±6.1 %, n =7, at t = 4 min, Fig 7.8A). This 
was possibly as a result of CaMK-II modulation of a population of endogenous 
GABAa receptors. Again, this suggests that the recombinant receptor expression 
dominates over the endogenous receptors when measuring whole-cell currents from 
transfected cells.
Application of 60 nM a-CaMK-II to granule cells expressing 
al/33t2SY357F,Y359F resulted in a significant increase of the amplitude of whole-cell
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currents measured to 120.4 ± 8 % (n = 7) at t = 6 min as compared to control (92.3 ± 
5.8 %, n = 7, at t = 6 min, Fig 7.9B). This increase, however, was significantly 
smaller than the increase observed after application of a-CaMK-II to al@3i2S 
expressing granule cells (167.8 ± 13.7 %, n = 4, at t = 6 min, Fig 7.9B). This 
indicated that, as in NG108-15 cells (See Fig 7.3), a proportion of the effect of O'- 
CaMK-II on Ofl)S3'y2S receptors was mediated through tyrosine kinase 
phosphorylation of the subunit. In addition, similar to that observed in NG1 OS- 
15 cells (See Fig 7.3C), this proportion of the effect was transient as there was no 
significant difference between ctlfft'flS and al]83'y2SY357F,Y359F in the presence of O'- 
CaMK-II after 10 min. The overall similarity between results obtained in NG108-15 
cells and cerebellar granule cells confirms that NG108-15 cells are an appropriate 
model for the study of CaMK-II phosphorylation of GABAa receptors. The 
mechanisms and signalling pathways involved in CaMK-II modulation of GABAa 
receptors in NG108-15 cells must, therefore, be comparable to that observed in 
cerebellar granule cells (maintained in depolarising conditions).
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Fig 7.8: CaMK-II dependent modulation of whole-cell currents recorded from 
transfected cerebellar granule cells.
Peak amplitude of GABA mediated currents recorded following the application of 
10 fiM GABA to cerebellar granule cells transfected with cel/52, cd/33, 
a l j g 3 s408A,S409A and a l / 33 s 383A GABAa receptor subunits. GABA was re-applied at 2
min intervals for up to 16 min. All currents were normalised to the peak amplitude 
of the response measured during the first 3-4 min (= 100 %) after achieving the 
whole-cell configuration (t = 0 min). Control recordings were made with normal 
patch pipette solution supplemented with the pre-activation buffer without a-CaMK- 
II.
(A) GABA currents recorded from cerebellar granule cells transfected with GFP 
only in the absence of a-CaMK-II (Control, n = 7) and transfected with al/33 (n = 7) 
and al/32 (n = 7) GABAa receptor subunits in the presence of 60 nM a-CaMK-II.
(B) GABA currents recorded from cerebellar granule cells transfected with GFP 
only in the absence of a-CaMK-II (Control, n = 7, taken from A) and transfected 
with al/33S408A’S409A (n = 4), aljS3S383A (n = 4) and al/33 (n = 7, taken from A) 
GABAa receptor subunits in the presence of 60 nM a-CaMK-II.
All data points mean ± s.e.
Significance is indicated by the symbol *, comparing different subunit combinations 
and mutants in the presence of CaMK-II.
P<0.05%, t-test, ANOVA.
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Fig 7.9: CaMK-II dependent modulation of whole-cell currents recorded from 
cerebellar granule cells transfected with recombinant o/3y receptors.
Peak amplitude of GABA mediated currents recorded following the application of 
10 pM GABA to cerebellar granule cells transfected with cd/3272S, Ofl/53'y2S and 
cd/3372sY365F,Y367F GABAa receptor subunits. GABA was re-applied at 2 min 
intervals for up to 16 min. All currents were normalised to the peak amplitude of the 
response measured during the first 3-4 min (= 100 %) after achieving the whole-cell 
configuration (t = 0 min). Control recordings were made with normal patch pipette 
solution supplemented with the pre-activation buffer without a-CaMK-II.
(A) GABA currents recorded from cerebellar granule cells transfected with GFP 
only in the absence of a-CaMK-II (Control, n = 7) and transfected with a\^2^2S 
(n = 7), al/3372S (n = 6) and al/33 (n = 7, taken from A) GABAa receptor subunits 
in the presence of 60 nM a-CaMK-II.
(B) GABA currents recorded from cerebellar granule cells transfected with GFP 
only in the absence of a-CaMK-II (Control, n = 7) and transfected with al/33t2S 
(n = 8, taken from A) and al/33t2SY357F,y359f (n =7 ) GABAa receptor subunits in 
the presence of 60 nM a-CaMK-II.
All data points mean ± s.e.
Significance is indicated by the symbol *, comparing a l ^ ^ S  to al/32T2S and 
CiiP3'fiSY351¥,Y359F in the presence of a-CaMK-II. The symbol * indicates al/33t2S 
compared to al/33 and the symbol *, indicates a\(32^2S and al/3372S 
CaMK-II compared to control.
P < 0.05, t-test, ANOVA.
Y357F.Y359F a -
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7.3 DISCUSSION
Using site-directed mutagenesis and the expression of recombinant GABAa 
receptors in NG108-15 cells and cerebellar granule cells, it was possible to identify 
the sites of phosphorylation that are important for a-CaMK-II dependent modulation 
of a ljS l^S  and al/33 t2S GABAa receptors. It appeared that phosphorylation of 
Ser383 on the /33 subunit mediated part of this response to a-CaMK-II through direct 
phosphorylation of the GABAa receptor. In addition, phosphorylation of the *y2S 
subunit contributed to the effect, but in this case via CaMK-II dependent activation 
of tyrosine kinase activity and phosphorylation of Tyr357’359 in the subunit.
To date, the Ser383 site on the (33 subunit is the only site reported to be 
phosphorylated by a-CaMK-II and no other Ser/Thr kinases when the TM3-4 
intracellular loop is expressed as a fusion protein (McDonald and Moss, 1997). The 
same comparable site, Ser384, can be phosphorylated by CaMK-II on the /31 subunit, 
when expressed as a fusion protein (McDonald and Moss, 1994), but 
phosphorylation of this site does not seem to be involved in mediating the functional 
effect of a-CaMK-II on a ljS l^S  receptors, as al/31 heteromers do not respond to a- 
CaMK-II. It appears that the tyrosine kinase-dependent phosphorylation of the *y2S 
subunit must also be dependent on the /3 subunit present in the receptor complex, as 
al/32T2S receptors are not modulated by a-CaMK-II at all in NG108-15 cells, or in 
transfected cerebellar granule cells.
This may be an emerging theme in phosphorylation dependent modulation of 
GABAa receptors as differences between (31/3 and /32 subunits have previously been 
demonstrated. PKA appears able to phosphorylate /31/3 in a recombinant system 
whereas (32 is not (McDonald et al., 1998), even though in a neuronal environment 
PKA can modulate mEPSCs thought to be mediated by al/32Y2S receptors (Kano and
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Konnerth, 1992; Nusser et al., 1999). This is comparable to the fact that 
recombinant a\f32'i2$ receptors cannot be modulated by CaMK-II in NG108-15 cells 
or cerebellar granule cells, but CaMK-II dependent modulation of GABAa receptors 
involved in rebound potentiation (Kano et al., 1996; Kawaguchi and Hirano, 2002) 
may be mediated by all82^2 receptors (Persohn et al., 1992). Despite the high level 
of homology in the /? subunit family, it has been demonstrated that jSl/3 and /32 
subunits require different assembly signals on the a  / y subunits for correct assembly 
and trafficking to the cell surface (Bollan et al., 2003). In addition, different /? 
subunits appear to be targeted to different specific regions of a cell (Connolly et al., 
1996b). This implies that GABAa receptors containing different (3 subunits are 
assembled, trafficked and targeted differentially to different synaptic sites. It is not 
surprising therefore that they might also be modulated by phosphorylation in 
different ways.
It is also becoming increasingly clear that for many multi-functional kinases 
with multiple substrates to function efficiently, correct targeting within the cell or 
localization to points of action is necessary (Pawson and Scott, 1997; Brandon et al., 
2002a). The action of kinase anchoring proteins that can bind both kinase and 
receptor substrate may provide explanations for some of the conflicting reports 
regarding the effects of phosphorylation on GABAa receptors. For example, the 
kinase anchoring protein RACK-1, which potentiates PKC dependent 
phosphorylation of the /3 subunit of the GABAa receptor (Brandon et al., 2002b), has 
been shown to associate with /31/3 subunits (Brandon et al., 1999; Brandon et al., 
2002b). Interestingly, RACK-1 is able to bind tyrosine kinases as well, in particular 
the cytosolic Src family (Yaka et al., 2002). The action of PKA has also been 
reported to be dependent on AKAP 79/150 which only binds /31 and /33 and not /32
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subunits (Brandon et al., 2003) giving a possible mechanism for the observed lack of 
functional modulation of /22 subunit-containing GABAa receptors in HEK293 cells 
(McDonald et al., 1998). It is possible that another, as yet unidentified, anchoring 
protein mediates PKA dependent effects on al (32*^ 2 receptors observed in some 
neuronal cell-types (Kano and Konnerth, 1992; Nusser et al., 1999). The differential 
effect of a-CaMK-II on al(3l/3i2S and al^2i2S  receptors may be mediated by an 
anchoring protein with differential binding affinities for the different subunits. This 
model of phosphorylation may also explain why a-CaMK-II modulation was not 
observed at all in HEK293 cells, if this cell line lacks the relevant anchoring 
protein(s).
The fact that t2SY357F,y359f mutant subunit-containing GABAa receptors had 
their response to a-CaMK-II reduced or abolished, suggests that a-CaMK-II is 
capable of directly or indirectly activating a tyrosine kinase which can then 
phosphorylate the t2S subunit. As there did not appear to be any basal tyrosine 
phosphorylation of GABAa receptors in this cell line, as has been reported elsewhere 
(Moss et al., 1995; Brandon et al., 2001), phosphorylation of these residues would be 
expected to result in an increase in the whole-cell GABA current amplitude. Moss et 
al (1995) determined that phosphorylation of these residues led to an increase in 
whole-cell GABA currents primarily due to an increase in the single GABA channel 
mean open time and probability of opening. They also suggested that in neurones, 
these residues are basally phosphorylated. Using phospho-specific antibodies 
directed against Y365 and Y367 on the 'fiL  subunit, Brandon et al (2001) 
demonstrated that phosphorylation of these residues occurred in rat brain extracts and 
further demonstrated a dynamic regulation of phosphorylation of these sites through 
tyrosine kinase / phosphatase activities in cortical neurones in culture.
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In cells where tyrosine phosphorylation has already occurred under basal 
conditions, this may be expected to reduce the effect of CaMK-II modulation. 
Interestingly, in cortical neuronal cultures, addition of a-CaMK-II had a less 
profound effect on GABA currents than that observed in cerebellar granule cell 
cultures (See Chapter 4, Fig 4.1). Cortical neuronal cultures of this type have been 
reported to have a very high level of tyrosine phosphatase activity and subsequently 
low levels of basal phosphorylation of Y365 and Y367 even after stimulation to 
activate tyrosine kinases (Brandon et al., 2001). This may also explain why the 
response of GABAa receptors to a-CaMK-II in cortical neurones (Chapter 4, Fig 4.1) 
appeared comparably lower. The importance of these sites of tyrosine kinase 
phosphorylation on the 'ft subunit has been recently demonstrated by the formation 
of a transgenic mouse where these tyrosine residues have been mutated to prevent 
tyrosine kinase phosphorylation of the ^2 subunit. This mutation is fatal with -/- 
mice not surviving beyond birth (V. Tretter, C. Houston, T. Smart and S. Moss, 
unpublished observations).
It is also possible that mutation of these tyrosine residues to phenylalanines 
altered the normal behaviour of the receptor such that it appeared to reduce the 
response to a-CaMK-II, but in fact, was simply an indirect effect, altering the 
receptors basal phosphorylation state. In addition it is always possible that in 
different neuronal cell types phosphorylation of other residues that have not yet been 
identified might also be important. However, these hypotheses are not the simplest 
ones to adopt. Within the *y2S subunit the only residue that was not tested was Ser327 
the residue thought to be partially responsible for a PKC dependent depression 
(Kellenberger et al., 1992; Krishek et al., 1994) and a potentiation of a l /S l^ ^ S  
containing receptors (Lin et al., 1996). In addition a reduction in the level of
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phosphorylation of this residue was reported after induction of a calcineurin- 
dependent form of LTD of inhibitory synapses (Wang et al., 2003). Given that 
CaMK-II appeared unable to phosphorylate this residue in vitro (fusion proteins) it 
seems a-CaMK-II action on the *y2S subunit is unlikely to be through direct 
phosphorylation of this residue. Downstream activation by CaMK-II of PKA and/or 
PKC is also possible but Ser408,409 mutants in /33 subunits seemed to have no effect, 
arguing against this. The residues Ser348 and Thr350, identified in fusion proteins, 
were thought to be main the main sites of phosphorylation by CaMK-II in *y2S 
subunits (McDonald and Moss, 1994). Mutation of these residues to alanine 
abolished CaMK-II dependent phosphorylation in vitro. However, mutation of these 
residues had no functional effect on a-CaMK-II modulation of al/33T2S GABAa 
receptors in NG108-15 cells. The evidence therefore suggests that CaMK-II 
modulation of GABAa receptors is dependent on both the fi and ^2 subunits, but not 
through direct phosphorylation by CaMK-II of the *y2S subunit. The depression of 
CaMK-II mediated effects by tyrosine kinase inhibitors and mutation of sites of 
tyrosine kinase phosphorylation on the *y2S subunit both suggest that CaMK-II may 
activate a tyrosine kinase which in turn phosphorylates the ^1S subunit and up- 
regulates receptor function.
An important question relating to the above hypothesis is can CaMK-II 
activate a tyrosine kinase? There is some evidence that Ca2+ sensitive tyrosine 
kinases exist (Rusanescu et al., 1995; Boxall and Lancaster, 1998). In addition, it 
has been determined that PKC can influence the activity of the non-receptor tyrosine 
kinase Src, suggesting that an interaction between Ser/Thr kinases and the Src family 
of tyrosine kinases is possible (Lu et al., 1999; Ali and Salter, 2001). It is generally 
thought that activation of Src through PKC is mediated by activation of PYK2 (Dikic
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et al., 1996), a member of the focal adhesion kinase family highly expressed in the 
nervous system (Sasaki et al., 1995; Lev et al., 1995), which responds to calcium 
(Lev et al., 1995). Activation of PYK2 leads to autophosphorylation which creates 
an SH2 ligand that can bind the SH2 domain of Src, thereby activating it (Dikic et 
al., 1996; Ali and Salter, 2001).
Activation of PYK2, and subsequently, Src has been demonstrated in some 
cases to be Ca2+/Calmodulin dependent, but not PKC dependent (Della Rocca et al., 
1997; Heidinger et al., 2002). Indeed, there is evidence for CaMK-II dependent 
activation of Src in glomerular mesangial cells (Wang et al., 2003b) and HEK293 
cells (Lo and Wong, 2004). There is also evidence for CaMK-II dependent 
activation of PYK2 and Src in vascular smooth muscle (Ginnan and Singer, 2002; 
Ginnan et al., 2004), PC 12 cells (Zwick et al., 1999) and in hippocampal neurones 
following ischemia (Guo et al., 2004). It is unknown if NG108-15 cells express 
PYK2, but given that this protein is abundant in the CNS (Sasaki et al., 1995; Lev et 
al., 1995) and the neuronal origin of the cell line, it seems a plausible possibility 
especially considering how NG108-15 cells are also used as a model of neuronal 
differentiation and neuritogenesis.
Src activation has been implicated in the regulation of excitatory synaptic 
plasticity through the action of Src on the NMDA receptor (Lu et al., 1999; Huang 
and Hsu, 1999; Salter and Kalia, 2004). PYK2 induced Src activation is thought to 
be necessary for certain forms of excitatory LTP (Huang et al., 2001). At the 
NMDA receptor, Src kinase acts as a point of convergence for a number of different 
signalling pathways (Salter and Kalia, 2004).
For Src and also other tyrosine kinases, binding to the NMDA receptor is 
thought to occur via association with PSD-95, or possibly another adaptor protein
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rather than directly interacting with the receptor itself (Tezuka et al., 1999; Gingrich 
et al., 2004). For the present study, it may be that binding of the PYK2:Src complex, 
either directly or through an intermediate protein to the GABAa receptor, may be 
dependent on the subunits present. Binding may be /31/3 subunit dependent and 
unable to occur if  /32 is present within the receptor complex. This would explain the 
lack of a tyrosine kinase dependent effect seen on a\^2^2S receptors.
The actions of Src on GABAa receptors in neurones suggest that Src can 
increase whole-cell current amplitudes (Moss et al., 1995; Wan et al., 1997). There 
is also evidence for a Src mediated increase in the amplitude of IPSCs without a 
change in their decays (Boxall, 2000). This was considered to be in accord with the 
findings of Moss et al. (1995) and the observed increase in mean open time and 
probability of channel opening. Activation of PYK2 and Src in prefrontal cortical 
neurones was also shown to increase the amplitude of IPSCs without changing their 
decays (Ma et al., 2003). The known association between Ca and PYK2 (Lev et 
al., 1995) and the activation of Src (Rusanescu et al., 1995; Dikic et al., 1996), 
together with the evidence for CaMK-II dependent activation of Src (Wang et al., 
2003b; Lo and Wong, 2004; Ginnan et al., 2004) possibly through PYK2 (Zwick et 
al., 1999; Ginnan and Singer, 2002), links several signal transduction pathways. It 
seems that a CaMK-II dependent activation of PYK2 and subsequent activation of 
Src tyrosine kinase is the most plausible, potential signalling pathway for CaMK-II 
dependent, tyrosine kinase dependent, phosphorylation of the GABAa receptor.
The application of a-CaMK-II to cerebellar granule cells (maintained in 
physiological conditions) led to an increase in IPSC amplitude and a change in 
decay. It appeared that CaMK-II did not have a uniform effect across all populations 
of synaptic events. It is possible that the analysis of the effect of CaMK-II on sIPSCs
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is further complicated by the fact that there may be two different effects being 
mediated by phosphorylation of the /33 subunit and the 'fi.S subunit.
In conclusion, the evidence suggests that a-CaMK-II mediates its effects on 
al/S l^S  and a l / f t^ S  receptors in NG108-15 cells and cerebellar granule cells 
through a direct phosphorylation of the /33 subunit at Ser383 and through CaMK-II 
activation of a tyrosine kinase that phosphorylates *y2S at Tyr357,359. This tyrosine 
kinase dependent phosphorylation is partially dependent on the identity of the /3 
subunit, as it is only observed if the /31/3 subunit is present and not when /32 is 
present. It is assumed that the modulation of GABAa receptors expressed in NG108- 
15 cells is comparable to that of native receptors in neurones; however, there remain 
unanswered questions about the role of the /32 subunit-containing GABAa receptors.
7.4 CONCLUSIONS
• The modulation of al/33 heteromers expressed in NG108-15 cells and 
cerebellar granule cells by a-CaMK-II is mediated through phosphorylation 
of the Ser383 residue.
• Modulation of al/3372S receptors expressed in NG108-15 cells and 
cerebellar granule cells is mediated through phosphorylation of /33 Ser and 
through tyrosine kinase mediated phosphorylation of Tyr357,359 on the ^2S 
subunit.
• Modulation of a ljftl^S  receptors expressed in NG108-15 cells is mediated 
through tyrosine kinase phosphorylation of Tyr357,359.
• CaMK-II modulation of the GABAa receptor can occur through direct 
phosphorylation of the receptor and through activation of a second 
downstream kinase signalling pathway.
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Chapter Eight:
CaMK-IJ modulation of sIPSCs in cerebellar granule cells
from 32 knockout mice.
8.1 INTRODUCTION
Analysis of the effects of a-CaMK-II on recombinant GABAa receptors 
expressed in NG108-15 cells and cerebellar granule cells suggested that there was a 
differential effect of CaMK-II on GABAa receptors depending on the combination of 
(3 and y  subunits assembled within the receptor. The evidence suggested that (32 
subunit-containing receptors could not be functionally modulated by a-CaMK-II in a 
recombinant system or in neurones expressing recombinant receptors but that /31/3 
subunit-containing recombinant receptors can be up-regulated by a direct 
phosphorylation of the /33 subunit and a downstream activation of a tyrosine kinase 
and subsequent phosphorylation of the t2S subunit. However, a lack of PKA 
dependent modulation of recombinant receptors containing the /32 subunit has been 
observed in HEK293 cells (McDonald et al., 1998), but PKA activity in neurones 
can alter IPSCs within cells that express predominantly a\(32~{2 receptors (Kano and 
Konnerth, 1992; Nusser et al., 1999). A lack of functional modulation of (32 subunit- 
containing receptors in a recombinant system is therefore not necessarily an 
indication that modulation cannot occur for native GABAa receptors at the synapse.
In order to determine more clearly how CaMK-II might modulate /32 versus 
/33 subunit-containing receptors in a neuronal environment it was necessary to make 
use of a GABAa receptor /32 subunit knockout mouse (Sur et al., 2001). In any 
neuronal preparation it is difficult to study the effects of phosphorylation on a 
discrete receptor population because of heterogeneity. However, cultures prepared 
from /32 knockout mice will always lack this subunit and so after comparison with
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wild-type mice it may be possible to determine if there are any differences between 
modulation of receptors that contain different /3 subunits.
Knockout mice have been used to study the relative importance and 
contribution of different GABAa receptor subunits to synaptic transmission. At 
present knockout mice lacking the a l, a5, a 6, (32, (33, 8 and *y2S/L subunits have been 
generated (Vicini and Ortinski, 2004; Rudolph and Mohler, 2004). The *y2 subunit 
knockout mouse revealed the importance of this subunit in receptor clustering at the 
synapse (Essrich et al., 1998) and for survival as homozygotes have a high level of 
morbidity. By contrast, the a l knockout mouse has provided insight into the 
observed reduction in decay time of IPSCs during development observed in some 
cell types (Vicini et al., 2001; Jiittner et al., 2001; Goldstein et al., 2002; Ortinski et 
al., 2004). This is thought to be a result of increased a l expression later in 
development (Ortinski et al., 2004). The a l knockout mouse phenotype is relatively 
normal; except for an occasional handling induced tremor, these mice are 
indistinguishable from wild-type (Sur et al., 2001) in many behavioural tests.
The /33 subunit knockout mouse suffers from severe neurological 
impairments including epilepsy (Homanics et al., 1997) and has many of the 
phenotypic characteristics of the human neurodevelopmental disorder, Angelman 
syndrome (DeLorey et al., 1998). Interestingly Angelman syndrome has also been 
linked to deficits in normal CaMK-II signalling pathways (Weeber et al., 2003).
The removal of the (33 subunit reduces IPSC duration in (33 -/- mouse cortical 
neurones in culture and also decreases expression of the a2/3 subunits (Ramadan et 
al., 2003). This supports the idea that there is a preferential association of 02/3 with 
(33 and a l with /32. Disruption of (33 has been shown in /33 -/- mice to alter network 
oscillations in the olfactory bulb (Nusser et al., 2001)
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demonstrating that specific /? subunit-containing receptors can play specific 
physiological roles.
The /32 knockout mouse unlike the /33 knockout mouse is behaviourally 
normal with no evidence of spontaneous seizures. The only distinguishable 
difference from wild-type is a slight increase in locomotor activity (Sur et al., 2001). 
The difference between the /32 and /33 knockout mice is striking given the 
comparable loss in receptor density across the brain seen in the two lines of mice 
(Homanics et al., 1997; Sur et al., 2001; Vicini and Ortinski, 2004). There was no 
observed compensatory increase in /31/3 subunits observed in the /32 knockout mouse 
but there was a decrease in expression of all six a  subunits (Sur et al., 2001). The 
generation of knockout mice lacking subunits of the GABAa receptor has started to 
reveal differences in the function of different GABAa receptor subtypes. Although 
compensatory increased expression of subunits can sometimes mask the role(s) of 
particular receptor subtypes, it appears that jS2 and /33 subunit-containing receptors 
must play very different roles in development (Homanics et al., 1997; DeLorey et al., 
1998; Sur et al., 2001; Sinkkonen et al., 2003) and potentially in pathological states 
such as epilepsy (Brooks-Kayal et al., 1998; DeLorey et al., 1998; Sur et al., 2001; 
Jones-Davis and Macdonald, 2003). Knock-in mice which lack the developmental 
changes that can occur in whole-subunit knockouts have revealed that different 
effects of anaesthetics are mediated through specific /32 or /33 subunit-containing 
GABAa receptors (Jurd et al., 2003; Reynolds et al., 2003; Rudolph and Mohler, 
2004). Using the /32 knockout mouse, changes in the response of GABAa receptors 
to phosphorylation may reveal how distinct receptor populations are modulated by 
protein kinases.
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Application of a-CaMK-II to rat cerebellar granule cells in culture under 
depolarising conditions (20 mM KC1) led to a significant increase in the whole-cell 
currents recorded (see Chapter 4). Application of a-CaMK-II to cerebellar granule 
cells cultured under more physiological conditions (5 mM KC1) led to a significant 
modulation of the amplitude and decay times of sIPSCs. This modulation of sIPSCs 
was not consistent across the whole population suggesting that there were possibly 
different effects of phosphorylation at different synapses (See Chapter 5). This could 
be related to differential effects of a-CaMK-II on different GABAa receptor subunit 
combinations.
Cerebellar granule cells are thought to express a number of different GABAa 
receptor subunits. Including cd/2/3/6, jS2/3, ^2 and 8 subunits (Persohn et al., 1992; 
Laurie et al., 1992b; Wisden et al., 1996; Pirker et al., 2000). They are thought to 
express very low levels of the j(31 subunit (Persohn et al., 1992; Laurie et al., 1992b). 
The /32 subunit knockout mouse causes a concurrent decrease in the expression of all 
six a  subunits but there has been no reported compensatory increase in the 
expression of different /3 subunits (Sur et al., 2001). Therefore cultures obtained 
from /32 knockout mice may be expected to consist predominantly of /33 subunit- 
containing receptors as compared to wild-type mice which may be expected to 
express both /52 and /33.
Mouse cerebellar cultures maintained under depolarising conditions have 
been reported to express high levels of /33 subunits and a decreased expression of /32 
subunits as compared to cultures maintained under more physiological conditions 
(Ives et al., 2002a). The a-CaMK-II dependent effect observed on whole-cell 
currents under depolarising conditions therefore may reflect CaMK-II action on /33 
subunit-containing receptors. Cells maintained under physiological conditions are
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thought to express both (32 and /33 subunits (Laurie et al., 1992b; Ives et al., 2002a; 
Ortinski et al., 2004) so the effect of CaMK-II on sIPSCs could potentially be 
mediated by receptors containing either or both of these subunits. Analysis of the 
effects of a-CaMK-II cultures prepared from /32 knockout mice maintained under 
both conditions should allow the determination of the relative contribution of the (32 
subunit to GABA currents and reveal whether a-CaMK-II can modulate /32 subunit- 
containing receptors at the inhibitory synapse.
8.2 RESULTS
Cerebellar cultures were prepared from (32 knockout and wild-type mice at 
PO-2 using the same protocol as that used in the culture of rat cerebellar granule cells 
(See methods). The /32 knockout mouse was generated by deletion of exons 6 and 7 
of the /32 subunit gene by homologous recombination (Sur et al., 2001). 
Heterozygous F3 generation mice were bred to produce (32 -/- and wild-type strains 
of mice of the same genetic background (50 % C57BL6, 50 % 129SvEv; Sur et al., 
2001). Litters of mice were taken at PO-2 from F5-7 generation wild-type (wt) or /32 
knockout (-/-) mice to produce cerebellar cultures. Tissue (in the form of tail snips) 
was taken from each mouse pup used for culturing and PCR was used for genotyping 
(See Chapter 2).
Recombinant a-CaMK-II (Suzuki-Takeuchi et al., 1992) pre-activated by 
incubation with CaM, CaCfe, and ATP-7-S (McGlade-McCulloh et al., 1993) was 
applied to cerebellar granule cells through inclusion in the patch pipette solution (See 
Chapter 2 and 3.2.1). The pre-activated a-CaMK-II was diluted into the internal 
solution (85 nM) and maintained on ice prior to recording. Control recordings were
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made by supplementing normal patch pipette solution with the pre-activation buffer 
but without a-CaMK-IL
Whole-cell currents were recorded from cerebellar granule cells maintained 
in depolarising conditions in response to application of 10 pM GAB A every 2 min 
for 20 min (See Chapter 4). Recordings of sIPSCs were made in the presence of 
10 pM CNQX, 20 pM AP-5 to block excitatory postsynaptic currents (EPSCs). All 
the remaining synaptic currents could be blocked by 20 pM bicuculline indicating 
they were GABAa receptor mediated. In a small proportion of cells (15 %) there 
was evidence of a small tonic current (Fig 8.1) revealed by a shift in baseline current 
after the application of bicuculline (Brickley et al., 1996; Leao et al., 2000). 
Application of 500 nM TTX abolished nearly all IPSCs recorded indicating that the 
majority of IPSCs in this cell-type are action potential driven as has been previously 
described (Puia et al., 1994; Leao et al., 2000; Farrant and Brickley, 2003). 
Recordings were made with 5 mM QX-314 in the patch pipette solution to allow 
recordings of action potential driven sIPSCs whilst suppressing action potentials 
within the cell being recorded from (See Chapter 5). Continuous 5 min recordings 
were made starting 5 min after achieving the whole-cell configuration. Cerebellar 
granule cells were identified by their rounded cell body morphology measuring 
<8 pm in diameter (See Fig 2.1 and Fig 7.6).
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Fig 8.1:
AP-5 + CNQX
Bicuculline
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Fig 8.1: sIPSCs recorded from mouse cerebellar granule cells in wt cultures.
Representative synaptic currents recorded from mouse cerebellar granule cells 
grown and maintained in a physiological culture medium (5 mM KC1). Neurones 
were cultured from PO-2 wt mice.
Recordings were made with 5 mM QX-314 within the patch pipette solution. Bath 
applied AP-5 (20 pM) and CNQX (10 pM) reveals sIPSCs. Additional application 
of bicuculline (20 pM) reveals a tonic GABAa receptor-mediated current.
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8.2.1 CaMK-II modulation of whole-cell currents recorded from wt and 02 -/- 
mice.
Application of 85 nM a-CaMK-II to cerebellar granule cells grown in 
depolarising conditions (20 mM KC1) resulted in a significant potentiation of the 
amplitude of whole-cell currents recorded from wt cultures to 146 ± 4.6 % (n = 8) as 
compared to control, 95.4 ± 4 % (n = 6, Fig 8.2A) at t = 8 min. Application of 85 
nM a-CaMK-II was also significantly potentiated in 02 -/- cultures to the same 
extent, where the amplitude was potentiated to 142.8 ± 9 % (n = 10) as compared to 
control, 100.6 ± 5.7 % (n = 9, Fig 8.2B) at t = 8 min. This indicated that either the 
02 subunit-containing receptors are not functionally modulated by O'-CaMK-II in 
cerebellar granule cells under these culture conditions or that there was a low level of 
02 subunits present even in wild-type cultures. There was no significant difference 
in the current density of GABA currents recorded in response to 10 pM GAB A in 
either culture (wt, n = 8, 02 -/-, n = 10, Fig 8.2.C) suggesting that there was a 
comparable number of functional GABAa receptors in wt and 02-/- cultures.
8.2.2 CaMK-II modulation of sIPSCs.
Application of 85 nM a-CaMK-II to wt cerebellar granule cells grown in 
physiological (5 mM KC1) conditions resulted in a significant increase in the mean 
peak amplitude of sIPSCs from 44.9 ± 7.6 pA (n = 9) to 95.4 ± 22.6 pA (n = 12, Fig 
8.3A). Application of 85 nM a-CaMK-II to 02 -/- cerebellar granule cells resulted in 
no significant change in mean peak amplitude (Control, 47.1 ± 8 pA, n = 8, + CaMK- 
II, 46.7 ± 5.6 pA, n= 9, Fig 8.3B and Table 8.1). There was also no significant 
difference between the mean peak amplitude of wt and 02 -/- mice in control 
conditions indicating that there was relatively little 02 subunit expression even under
230
physiological culture conditions (5 mM KC1) or that there was a compensatory 
increase in the expression of /51/3 subunit-containing receptors.
Application of a-CaMK-II significantly increased the half-width (time taken 
to decay to 50 % amplitude) of sIPSCs recorded from wt cultures from 9.8 ± 1.4 ms 
(n = 9) to 17.7 ± 2.9 ms (n = 12, Fig 8.3B). Application of a-CaMK-II to /32 -/- 
cultures also resulted in a significant increase in the half-width of sIPSCs from 10.4 
± 1.3 ms (n = 8) to 17.8 ± 3 ms (n = 9, Fig 8.3B and Table 8.1). The half-width was 
not significantly different from wt and /32 -/- cultures in control conditions. There 
was also no significant difference between half-widths after application of a-CaMK- 
II in either culture, indicating that removal of the /32 subunit had little effect on the 
lengthening of decay by a-CaMK-II. Unlike a l knockout mice (Vicini et al., 2001; 
Goldstein et al., 2002; Ortinski et al., 2004) removal of /32 does not significantly 
alter the mean decay time of IPSCs in control conditions.
Application of a-CaMK-II to wt cultures had no significant effect on sIPSC 
frequency (Control, 3.5 ± 0.8 Hz, n = 9, + CaMK-II, 2.4 ± 0.8 Hz, n = 12). There 
was no significant difference between wt and /32 -/- cultures in control conditions and 
there was no significant effect on /32 -/- cultures after application of a-CaMK-II 
(Control, 2.6 ± 1 Hz, n = 8, + CaMK-II -/-, 2.5 ± 0.7 Hz, n = 9, Fig 8.3C).
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Fig 8.2: Modulation of whole-cell currents by a-CaMK-II recorded from 
cerebellar granule cells in culture (20 mM KC1) from wild-type (wt) and 82 
knockout mice (-/-).
Peak amplitudes of GABA-mediated currents recorded after application of 10 pM 
GABA to mouse cerebellar granule neurones in culture (20 mM KC1) prepared from 
wild-type (wt) or /32 knockout mice (-/-). GABA was re-applied at 2 min intervals 
for up to 20 min. All currents were normalised to the peak response of the GABA 
current measured during the first 3-4 min (= 100 %) after achieving the whole-cell 
configuration (t = 0 min). Control recordings were made with normal patch pipette 
solution supplemented with the pre-activation buffer without a-CaMK-II.
(A) GABA currents recorded from cerebellar granule cells in culture prepared from 
wt cultures in the absence (Control, n = 8) and presence of 85 nM pre-activated 
a-CaMK-II (n=6) applied through inclusion in the patch pipette solution.
(B) GABA currents recorded from cerebellar granule cells in culture prepared from 
/32 -/- cultures in the absence (Control, n = 10) and presence of 85 nM a-CaMK-II
(n = 9).
(C) A bar chart showing 10 pM GABA current density (pA/pF) recorded from wt 
(n = 8) and /32 -/- (n = 10) mouse cultures at t = 0 min in control conditions.
All points = mean ± s.e.
Significance is indicated by the symbol *, CaMK-II compared to control.
P < 0.05, t-test.
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Fig 8.3: Mean amplitude, half-width and frequency of sIPSCs recorded from 
cerebellar granule cells in culture (5 mM KCD from wt and 82 -/- knockout 
mice.
Continuous recordings were made from cerebellar granule cells in culture (5 mM 
KC1) from t = 5-10 min after achieving the whole-cell configuration in the presence 
of 10 pM CNQX, 20 pM AP-5 and 5 mM QX-314. Control recordings were made 
with normal patch pipette solution supplemented with the pre-activation buffer 
without a-CaMK-II.
(A) Bar chart showing the mean peak amplitude of sIPSCs in the absence and 
presence of 85 nM a-CaMK-II recorded from cerebellar granule cells in culture 
prepared from wt (Control, n = 9, CaMK-II, n = 12) and (32 -/- (Control, n = 8, 
CaMK-II, n = 9) mouse cultures.
(B) Bar chart showing the mean half-width (150) of sIPSCs in the absence and 
presence of 85 nM a-CaMK-II recorded from cerebellar granule cells in culture 
prepared from wt (Control, n = 9, CaMK-II, n = 12) and /32 -/- (Control, n = 8, 
CaMK-II, n = 9) mouse cultures.
(C) Bar chart showing the mean frequency of sIPSCs in the absence and presence of 
85 nM a-CaMK-II recorded from cerebellar granule cells in culture prepared from 
wt (Control, n = 9, CaMK-II, n = 12) and /32 -/- (Control, n = 8, CaMK-II, n = 9) 
mouse cultures.
Mean ± s.e. Significance is indicated by the symbol *, CaMK-II compared to 
control.
P < 0.05, t-test.
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8.2.3 CaMK-II modulation of decay times.
To look at decay times more carefully groups of 50-100 events were selected 
from each cell that had no deflections in either the rising or decay phases, and which 
decayed back to the baseline. These average traces were best fitted by a bi­
exponential decay (See Chapter 2, 2.7.2). The mean xl (fast component of decay) of 
sIPSCs was significantly increased to 29.5 ± 5.3 ms (n = 8) as compared to control,
16.1 ± 2 ms (n = 8) on application of a-CaMK-II to wt cultures. Application of a- 
CaMK-II to /32 -/- cultures also resulted in a significant increase in xl to 22.6 ± 2.2 
ms (n = 7) as compared to control, 11.7 ± 1.3 ms (n = 7, Fig 8.4A,E and Table 8.1). 
There was no significant difference between xl in control conditions in wt or /32 -/- 
cultures, or after the application of a-CaMK-II (Fig 8.4B).
Analysis of x2 values for wt cultures also showed a significant increase on 
application of a-CaMK-II to 109 ± 15.9 ms (n = 8) as compared to control, 55.2 ± 7 
ms (n = 8). Application of a-CaMK-II to /32 -/- cultures also resulted in a significant 
increase in x2 to 78.8 ± 5.1 ms (n = 7) as compared to control 55.2 ± 4.3 ms (n = 7, 
Fig 8.4B and Table 8.1). There was no significant difference between x2 in control 
conditions in wt or /32 -/- cultures or on application of a-CaMK-II between wt and (32 
-/- cultures (Fig 8.4B).
Phosphorylation has been reported to alter the relative area or contribution of 
fast and slow decay time constants. However, the proportional area of xl in wt 
cultures was unaffected by the application of a-CaMK-II (69.5 ± 1.8 %, n =8, as 
compared to control; 58.7 ±5.1 %, n = 8). Application of a-CaMK-II to /32 -/- 
cultures also did not affect the relative areas (xl area control, 45.5 ± 7.3 %, n = 7; 
CaMK-II, 59.5 ±3.1 %, n = 7, Fig 8.4C,E). The data obtained from rat cerebellar 
cultures also showed no observable change in the proportional area of xl on
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application of a-CaMK-II (Fig 5.3D). In addition there was no significant change 
between the proportional area of xl from wt cultures in control conditions (58.7 ±5.1 
%, n = 8) and that for j82 -/- cultures (45.5 ± 7.3 %, n = 7, Fig 8.4C and Table 8.1) in 
control conditions. However, the relative contribution of t2 on application of a- 
CaMK-II to (32 -/- cultures was significantly greater than when a-CaMK-II was 
applied to wt cultures (Fig 8.4C).
Changes in IPSC decay in control conditions can also result from dendritic 
filtering. In order to avoid problems associated with dendritic filtering when 
analysing decay constants only events with fast rise-times (<3 ms) and clear peak 
amplitudes were used in the analyses. As cerebellar granule cells are electrotonically 
compact the effect of filtering should have been relatively small (Gabbiani et al., 
1994; Rossi and Hamann, 1998). Synaptic events for analysis were only chosen if 
there were no deflections in the rising or decaying phase from cells there was 
no correlation between rise-times and amplitudes (See Chapter 5, Fig 5.4). The 
mean rise-times calculated from the grouped average traces used to analyse kinetics 
showed no significant differences between application of a-CaMK-II (0.76 ± 0.06 
ms, n = 8) and control (0.73 ± 0.08 ms, n = 8) in wt cultures. In /32 -/- cultures there 
was no change in the rise-times on application of a-CaMK-II (0.75 ± 0.06 ms, n = 7) 
as compared to control (0.59 ± 0.06 ms, n = 7, Fig 8.4D,E) and there was no 
significant difference between rise-times after application of a-CaMK-II when 
comparing wt and (32 -/- cultures.
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Fig 8.4: Modulation of sIPSC decay times bv a-CaMK-II in wt and 82 -/- mouse 
cultures.
Continuous recordings were made from t = 5-10 min after achieving the whole-cell 
configuration in the presence of 10 pM CNQX, 20 pM AP-5 and 5 mM QX-314. 
50-100 IPSCs were grouped together from each cell that had no deflections in either 
their rising or decaying phases. These average traces were then used to calculate 10- 
90 % rise-times and decay time constants for each cell. The mean of several cells 
are displayed as a bar chart. Control recordings were made with normal patch pipette 
solution supplemented with the pre-activation buffer without a-CaMK-II.
(A) A bar chart showing the mean xl in the absence (Control, n = 8) and the 
presence (n = 8) of 85 nM a-CaMK-II of sIPSCs recorded from wt and (32 -/-
(Control, n = 7,CaMK, n = 7) mouse cultures.
(B) A bar chart showing the mean x2 in the absence (Control, n = 8) and the 
presence (n = 8) of 85 nM a-CaMK-II of sIPSCs recorded from wt and /32 -/-
(Control, n = 7, CaMK-II, n = 7) mouse cultures.
(C) A bar chart showing the relative contributions of the area of xl and t2  to the 
total area of decay in the absence (Control, n = 8) and presence (n = 8) of 85 nM 
a-CaMK-II of sIPSCs recorded from wt and /32 -/- (Control, n = 7, CaMK-II, n = 7) 
mouse cultures.
(D) A bar chart showing the mean 10-90 % rise-time of sIPSCs in the absence 
(Control, n = 8) and the presence (n = 8) of 85 nM a-CaMK-II recorded from wt and 
j32 -/- (Control, n = 7, CaMK-II, n = 7) mouse cultures.
(E) Representative average traces of 50-100 IPSCs from a single cell in the absence 
and the presence of 85 nM a-CaMK-II recorded from wt and /32 -/- mouse cultures 
re-scaled to the same amplitude.
Mean ± s.e. Significance is indicated by the symbol *, CaMK-II compared to 
Control and the symbol *, wt compared to /32 -/-.
P < 0.05, t-test.
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Table 8.1
Amplitude H-W x1 t2 A1
(PA) (ms) (m s) (ms) (%)
Wt
Control 44.9 ± 7.6 9.8 ± 1.4 16.1 ±2 55.2 ± 7 58.7 ±5.1
Wt * * * *
CaMK-II 95.4 ± 22.6 17.7 ±2.9 29.5 ± 5.3 109 ±15.9 69.5 ±1.8
(32 -/- 
Control
47.1 ±8 10.4 ± 1.3 11.7 ± 1.3 55.2 ± 4.3 45.5 ± 7.3
(32 -/- 
CaMK-II
46.7 ± 5.6
*
17.8 ±3
*
22.6 ± 2.2
*
78.8 ±5.1
*
59.5 ±3.1
Table 8.1: A table summarising sIPSC characteristics.
The mean values of peak amplitude, half-width (H-W), time constants xl and t2 and 
the proportional area of xl, in control conditions and in the presence of 85 nM a- 
CaMK-II from wt and (32 -/- cultures. Significance is indicated by the symbol *, 
CaMK-II compared to control and the symbol *, Wt compared to (32 -/- in the 
presence of CaMK-II. P < 0.05, t-test.
8.2.4 CaMK-II amplitude and decay time changes across the whole population 
of IPSCs.
As previously demonstrated, in rat cerebellar cultures the population of 
sIPSCs did not respond uniformly to a-CaMK-II (See Chapter 5) it was therefore 
possible that different changes in different sub-populations of events between wt and 
/32 -/- in control conditions or on application of a-CaMK-II, might mask or alter the 
apparent effect of a-CaMK-II. Therefore, a more beneficial approach would be to 
look at the whole population of IPSC events.
An IPSC half-width histogram was constructed for wt and /32 -/- cultures for 
control conditions and following the response to application of 85 nM a-CaMK-II.
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In wt cultures there did appear to be a slight shift in half-width values from under 15 
ms to over 15 ms (Control, n = 8, 6600 events, CaMK-II, n = 11, 6300 events, Fig 
8.5A). The histogram constructed from /32 -/- cultures also showed a shift to higher 
values of half-width (over 15 ms) but in this case it appeared much more pronounced 
(Control, n = 9, 5500 events, CaMK-II, n = 10, 5500 events, Fig 8.5B).
The more pronounced effect on addition of a-CaMK-II could indicate that the 
increase in half-width observed in wt cultures is partly masked by the presence of the 
132 subunits which are not affected by CaMK-II. There is also the indication that the 
loss of the j32 subunit also creates a small group of events with large half-widths of 
over 30 ms which are not present in the wild-type, under control conditions. It 
should be noted from the previous analysis though, that this slight shift in the 
population was not enough to alter the mean half-width. This population of IPSCs 
with increased half-widths in /32 -/- cultures could possibly be a result of a loss of a l 
(faster decaying) subunit-containing receptors alongside /32 in favour of c/213/6 
containing receptors which are slower decaying (Gingrich et al., 1995; Tia et al., 
1996; Ortinski et al., 2004). It is important to note that analysis of decay time 
constants and proportional area’s required selection of events with no deflections 
during the rise or decay phase. Slower decaying events are more likely to be 
superimposed by other events so these slower events may have been under­
represented in the group averages used to calculate x values and proportional areas.
Amplitude histograms were constructed of sIPSCs recorded from wt cultures 
in control conditions and after application of a-CaMK-II. In control conditions (n = 
8, 6500 events) there appeared to be two populations of events: one under 100 pA 
and the other of 100-300 pA. On application of a-CaMK-II (n = 11, 6300 events, Fig 
8.6A) both populations shifted slightly to the right with an increase in the number of
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events at around 100 pA and the appearance of events over 300 pA in amplitude (Fig 
8.6A, arrow). The amplitude histogram of sIPSCs constructed from events recorded 
from j82 -/- cultures showed a slightly different pattern. In control conditions (n = 9, 
5500 events) the distribution of amplitudes was similar to that seen in wild-type with 
two populations of under 100 pA and between 100-300 pA. On application of a- 
CaMK-II (n = 10, 5500 events, Fig 8.6B) there was an increase in the number of 
events around 100 pA; however, in this case, there was no appearance of larger 
IPSCs around 400pA. This suggested that a sub-population of events did increase in 
amplitude but that the removal of the /32 subunit prevented the appearance of another 
sub-population of much larger amplitude IPSCs. This is in contrast to the more 
pronounced effect of a-CaMK-II on half-widths observed in /32 -/- cultures. Despite 
the increase in the number of IPSCs around lOOpA in /32 -/- cultures this was not 
enough to significantly alter the mean peak amplitude. The loss of the larger 
amplitude events is probably responsible for the lack of apparent effect on the mean 
peak amplitude after a-CaMK-II application to /32 -/- cultures.
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Fig 8.5: Frequency histograms of sIPSC half-widths recorded from wt and #2 
-I- mouse cultures.
Continuous recordings were made from t = 5-10 min after achieving the whole-cell 
configuration in the presence of 10 pM CNQX, 20 pM AP-5 and 5 mM QX-314. 
All the half-widths of sIPSCs from 10-11 cells were grouped together and frequency 
histograms were constructed. Control recordings were made with normal patch 
pipette solution supplemented with the pre-activation buffer without a-CaMK-II.
(A) Half-width distribution histogram of sIPSCs in the absence (Control, n = 8, 6600 
events) and the presence (n = 11, 6300 events) of 85 nM a-CaMK-II recorded from 
wt mouse cultures.
(B) Half-width distribution histogram of sIPSCs in the absence (Control, n = 9, 5500 
events) and the presence (n = 10, 5500 events) of 85nM a-CaMK-II recorded from 
j82 -/- mouse cultures.
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.6: Frequency histograms of sIPSC amplitudes recorded from wt and 82 -/-
mouse cultures.
Continuous recordings were made from t =  5-10 min after achieving the w h ole-cell 
configuration in the presence o f  10 pM  CNQ X, 20 pM  AP-5 and 5 m M  Q X -314. A ll 
the peak amplitudes o f  sIPSCs from a series o f  cells were grouped together and 
frequency histograms were constructed. Control recordings were made with normal 
patch pipette solution supplemented with the pre-activation buffer without a-CaM K-II.
(A) Amplitude distribution histogram o f  sIPSCs in the absence (Control, n =  8, 6600  
events) and the presence (n =  11, 6300events) o f  85 nM a-CaM K-II recorded from wt 
m ouse cultures.
(B) Amplitude distribution histograms o f  sIPSCs in the absence (Control, n =  9, 5500  
events) and the presence (n = 10, 5500 events) o f  85 nM a-CaM K-II recorded from /32 
-/- m ouse cultures. The red arrow depicts large amplitude events o f  over 300 pA.
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8.2.5 Scatter-plots of sIPSC half-widths and amplitudes.
In order to try and reconcile these different responses when examining sIPSC 
half-widths and amplitudes separately, scatter-plots of half-width against amplitude 
were constructed similar to those constructed for the IPSCs measured in rat cultures 
(Fig 5.5A). The scatter plot of sIPSCs recorded from wt cultures in control 
conditions (n = 8, 6600 events, Fig 8.7A) reveals at least two populations of events. 
One population appears to consist of sIPSCs of under 100 pA with a broad range of 
decay times. There is another distinct population of sIPSCs of 100-300 pA 
amplitude (as seen in the amplitude histogram) with a half-width of 10-30 ms. In the 
scatter-plot of sIPSCs from /52 -/- cultures in control conditions (n = 9, 5500 events, 
Fig 8.7C) this larger amplitude population has dispersed with larger amplitude events 
occurring with varying half-widths mostly over 30 ms. This could be interpreted as a 
shift from subunit-containing events at these synapses to 02/3/33^2 subunit-
containing events with a slower decay.
On application of 85 nM a-CaMK-II to wt cultures (n = 11, 6300 events, Fig 
8.7B) there appears to be a shift of sIPSCs to greater half-widths and amplitudes. 
The population of sIPSCs of 100-300 pA shifts to even higher amplitudes with little 
effect on half-width. If these events can indeed be interpreted as /32 subunit- 
containing events this implies an a-CaMK-II dependent effect on /32 subunit- 
containing receptors that is only revealed in a native environment. The addition of a- 
CaMK-II to rat cerebellar granule cultures revealed a similar effect on the population 
of sIPSCs to that observed in wt mouse cultures (See Fig 5.5 A).
On addition of a-CaMK-II to /32 -/- cultures (n = 10, 5500 events, Fig 8.7D) 
there is a shift of events, or the appearance of another population of events, at 75-200 
pA amplitude and 15-35 ms that was not apparent in control conditions. There is,
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however, no shift in amplitude of the larger amplitude events and there are no sIPSCs 
of over 300 pA amplitude. Again this could be interpreted as a result of the loss of 
/32 subunit-containing events. It cannot be concluded with certainty that this is a 
specific /32 subunit dependent effect due to the possible changes in the expression 
levels of other subunits on removal of the /32 subunit however, it does appear that in 
this neuronal culture, synaptic /32 subunit-containing receptors may be modulated by 
a-CaMK-II which contrasts with the lack of response to a-CaMK-II of al/?2'y2S 
receptors expressed in NG108-15 cells.
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Fig 8.7: Scatter plots of sIPSC amplitude against half-width recorded from wt 
and R2 -/- mouse cultures.
Continuous recordings were made from t = 5-10 min after achieving the whole-cell 
configuration in the presence of 10 pM CNQX, 20 pM AP-5 and 5 mM QX-314. 
All the peak amplitudes and half-widths of sIPSCs from a series of cells were 
grouped together and scatter-plots of the amplitudes and half-widths for the IPSCs 
were constructed. Control recordings were made with normal patch pipette solution 
supplemented with the pre-activation buffer without a-CaMK-II.
(A) A scatter-plot of sIPSC amplitudes and half-widths in the absence (Control, 
n = 8, 6600 events) of 85 nM a-CaMK-II recorded from wt mouse cultures.
(B) A scatter-plot of sIPSC amplitudes and half-widths in the presence (n = 11, 6300 
events) of 85 nM a-CaMK-II recorded from wt mouse cultures.
(C) A scatter-plot of sIPSC amplitudes and half-widths in the absence (Control, 
n = 9, 5500 events) of 85 nM a-CaMK-II recorded from /32 -/- mouse cultures.
(D) A scatter-plot of sIPSC amplitudes and half-widths in the presence (n = 9, 5500 
events) of 85 nM a-CaMK-II recorded from /32 -/- mouse cultures.
IPSCs potentially mediated by /32 subunit-containing receptors are indicated by the 
dark blue line.
The green line indicates EPSCs potentially mediated by (33 subunit-containing 
receptors.
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8.3 DISCUSSION
Spontaneous IPSCs recorded from cerebellar granule cells lacking the /32 
subunit display slightly different properties compared to sIPSCs in wild-type cells. 
The population of sIPSCs from /32 -/- cultures has more events with slower decay 
times although this is not enough to significantly alter the mean half-width. There is 
however a significant difference in the relative contribution of x2 on application of a- 
CaMK-II between wt and j32 -/- cultures indicating a more pronounced effect on 
decay times which can be observed in the half-width distribution histogram.
On application of a-CaMK-II to wild-type cultures there appears to be two 
broad trends. An increase in decay time for one population of IPSCs and an increase 
in amplitude with little change in decay times for another set of IPSCs. By 
comparing populations of sIPSCs in control conditions for wild-type and /32 -/- cells 
it can be predicted that the larger amplitude sIPSCs with faster decay times that 
change in amplitude, but not decay, on a-CaMK-II application, may be /32 subunit- 
containing GABAa receptor mediated.
This raises an interesting possibility, that /32 subunit-containing GABAa 
receptors at the synapse can be modulated by a-CaMK-II in a native neuronal 
environment. It appeared that expression of recombinant receptors in a neuronal cell 
line or in native neurones was not sufficient to allow a-CaMK-II modulation of 
al/32'y2 receptors to occur. This may be because recombinant receptors expressed in 
neurones are not targeted to the correct subcellular location. For instance aft 
heteromers would not be expected to be targeted to the synapse without the 72 
subunit (Essrich et al., 1998). It is also possible that recombinant receptors do not 
bind to the relevant kinase anchoring proteins and this disrupts their modulation by 
phosphorylation. The current study seems to suggest that a.1^2^1 receptors need to
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be expressed in their native neuronal environment at the synapse in order for a- 
CaMK-II modulation of GABAa receptors to be observed. It should be noted that 
recombinant cd/32t2S receptors were transfected into cerebellar granule cells 
maintained in depolarising conditions, which display no synaptic activity and are 
thought to be representative of immature neurones (Ives et al., 2002a). It could 
therefore be that expression of a mature functional synapse and the associated 
scaffolding and kinase anchoring proteins is critical for modulation of alfil'il 
GABAa receptors by CaMK-II.
The functional effect of a-CaMK-II modulation appeared to be different for 
/32 and /33 subunit-containing receptors with the /33 subunit-containing receptors 
changing in decay time and /32 subunit-containing receptors increasing in amplitude 
with no change in decay time. It should be noted that a sub-population of IPSCs in 
/32 -/- cultures also increased in amplitude as can be seen from the amplitude 
distribution (Fig 8.6) but this shift was not enough to alter the mean IPSC amplitude 
(Fig 8.3). There was also a slight reduction in the number of large amplitude events 
on application of a-CaMK-II to /52 -/- cultures which may have acted to mask this 
change in amplitude.
It appeared from the study of recombinant receptors expressed in NG108-15 
cells and cerebellar granule cells that in looking at a-CaMK-II dependent modulation 
it is necessary to consider the whole receptor and all subunits together. For instance 
it appeared that /? and y  subunits interacted in different ways to modulate the 
response to CaMK-II. In a neuronal situation it appears that the loss of the /32 
subunit may alter a  subunit expression. A number of studies have suggested that a l 
may preferentially co-assemble with /32, over 02/3 (Benke et al., 1994; Ramadan et 
al., 2003; Ortinski et al., 2004). The loss of faster decaying large amplitude events
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in /32 -/- cultures may reflect not only the loss of /32 but also a concurrent loss of a l, 
so it is difficult to say with absolute certainty that the /32 subunit is modulated 
directly by CaMK-II as it is possible a l may be involved as well. Indeed, CaMK-II 
has been reported to phosphorylate a l subunits (Chum et al., 2002) although 
generally, they are thought to be poor substrates for phosphorylation (Moss et al., 
1992; Moss and Smart, 1996). The increase in the number of slower decaying events 
in control conditions in /32 -/- cultures may reflect a shift from a l to 02/3 after a loss 
of a l together with /32. In support of this, in /33 knockout mice, there is a decrease in 
02/3 subunit expression and a reduction in IPSC decay times (Ramadan et al., 2003).
It appears that (32 subunit-containing receptors predicted to consist of a lp l'fi 
subunits may be preferentially targeted to large synapses. The size of the amplitudes 
of these IPSCs suggests that they were produced by multi-quantal release of GABA. 
One other possibility is that at these large amplitude synapses, /32/3 subunits are co­
assembled in the same receptor complex and that /33 still mediates the CaMK-II 
effect. However if direct phosphorylation of /33 causes an increase in decay time this 
should have been observable in GABAa receptors containing both /52 and /33 
subunits. The lack of effect on decay time of the large amplitude IPSCs suggests this 
effect was not mediated by /33.
It is always difficult when interpreting data from knockout mice to say for 
certain if a loss or change in synaptic transmission is due to the loss of the subunit 
removed or unforeseen indirect compensatory mechanisms. Despite these potential 
problems the evidence does suggest that it is possible that /32 subunit-containing 
receptors may be modulated at the synapse by a-CaMK-II. Modulation of /32 
subunit-containing receptors by a-CaMK-II in a recombinant system is clearly not
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possible (See Chapter 6) suggesting the mechanisms for modulation of both subtypes 
could be dependent on cell type.
Evidence in the literature suggests that phosphorylation in neurones can have 
distinctly different functional effects depending on the receptor subtypes present in a 
cell (Nusser et al., 1999; Poisbeau et al., 1999). There is evidence for PKC 
dependent down-regulation of receptor function via phosphorylation of /32 Ser410 in a 
recombinant system (Kellenberger et al., 1992). A similar modulation by PKC has 
also been reported to be independent of phosphorylation of this subunit (Chapell et 
al., 1998). In this case the down-regulation observed was thought to be associated 
with a loss of receptors from the cell surface and phosphorylation of receptor 
associated proteins rather than the /32 subunit directly. PKC has also been reported to 
modulate receptor endocytosis in HEK293 cells and cortical neurones in culture. 
This process involved a dynamin endocytic pathway and was dependent on a 
dileucine motif present on the /32 subunit (Herring et al., 2005).
In a neuronal environment, PKA can modulate IPSCs recorded from 
cerebellar stellate, basket and Purkinje neurones that are thought to predominantly 
express the /32 subunit (Persohn et al., 1992; Kano and Konnerth, 1992; Nusser et al., 
1999). In addition, CaMK-II is thought to play a role in rebound potentiation (Kano 
et al., 1992; Kano et al., 1996; Kawaguchi and Hirano, 2002), a phenomenon that 
results in an increase in the amplitude of IPSCs without a change in decay times. 
This occurs in Purkinje cells of the cerebellum that are thought to express 
predominantly subunits (Persohn et al., 1992; Laurie et al., 1992a). Wang
and colleagues (2003) have demonstrated an increase in the number of receptors at 
the cell surface related to PKB phosphorylation of /52 Ser410 in HEK293 cells and in 
neurones using immunocytochemistry. Thus, functional changes due to
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phosphorylation of 02 by PKB can be detected in HEK293 cells, in contrast to the 
present study with CaMK-II, and in contrast to the lack of PKA dependent functional 
modulation of GABAa receptors in HEK293 cells (McDonald et al., 1998). 
Therefore, phosphorylation of receptors may not only be dependent on cell type and 
receptor subunit composition, but also on the kinase under investigation.
In neurones the effect of PKB induced an increase in the amplitude of IPSCs 
without a change in their decay, which was related to an increase in 02 subunit- 
containing receptors at the synapse (Wang et al., 2003). This is comparable to the 02 
subunit-containing population of sIPSCs in the current study increasing in amplitude 
without a change in decay time after exposure to a-CaMK-II. This raises the 
possibility that 02 subunit mediated effects may involve insertion of new receptors 
rather than a change in their single channel properties. It may be that a lack of 
functional effect on 02 subunit-containing receptors in recombinant systems is 
related to a lack of the appropriate cellular machinery needed to insert new receptors. 
Direct modification of channel properties by phosphorylation may be easier to 
observe and measure in a recombinant environment. However, insertion of receptors 
into the cell membrane has been observed in recombinant systems in response to 
phosphorylation (Wan et al., 1997; Wang et al., 2003).
It might simply be that 02 subunit phosphorylation is under much tighter 
control than that of 01/3, requiring multiple kinase anchoring proteins or GABAa 
receptor scaffolding proteins to occur. There is evidence for differences in 02 and 03 
binding to kinase anchoring proteins as well as differences in the trafficking and 
targeting of these receptors to the synapse. For example AKAP 79/150 has been 
shown to directly bind the 01/3 subunits but not 02 and is critical for PKA-mediated 
phosphorylation of the 03 subunit (Brandon et al., 2003) and RACK-1 has been
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associated with binding to and facilitation of phosphorylation of /31/3 subunits 
(Brandon et al., 2002; Jovanovic et al., 2004). The GABAa receptor-associated 
protein (GRTF-1) has been identified which binds to the /32 subunit but not 01/3, 
although the function of this protein is unknown, it has been proposed as another 
subunit trafficking factor (Beck et al., 2002).
There is some evidence that the trafficking and targeting of /32 and /33 
subunit-containing receptors to the cell surface are different (Connolly et al., 1996) 
and that these processes can be differentially affected by phosphorylation (Ives et al., 
2002b). The /32 and /33 subunits require different processes for correct assembly of a 
receptor and trafficking to the cell surface (Bollan et al., 2003). In addition, /33 
subunits alone can form functional homomeric channels, whereas j82 subunits cannot 
(Connolly et al., 1996; Wooltorton et al., 1997). Moreover, PKC phosphorylation 
can modulate receptor endocytosis of receptors in HEK293 cells and in
neurones (Connolly et al., 1999; Herring et al., 2005) as well as directly affecting the 
properties of the ion channel (Krishek et al., 1994; Lin et al., 1996).
The activity of CaMK-II itself is thought to be controlled through its 
localisation to targets where it exerts an effect on proteins (Bayer and Schulman, 
2001; Schulman, 2004; Colbran, 2004). For instance, it can bind to the NMDA 
receptor to maintain the activity of the kinase in a calcium-dependent manner (Bayer 
et al., 2001). A CaMK-II anchoring protein, formed by alternative splicing of the a- 
CaMK-II gene that is stably integrated into the CaMK-II holoenzyme and influences 
CaMK-II localisation and function, has been identified in skeletal muscle (Bayer et 
al., 1998; Bayer and Schulman, 2001) although not yet in neurones. Although a few 
potential CaMK-II anchoring proteins have been characterised (See Chapter 1) there 
are probably others that are yet to be found (Colbran, 2004). It is probable, therefore,
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that CaMK-II dependent modulation of GABAa receptors may also be dependent on, 
or altered by, appropriate anchoring proteins and that some of the differences seen in 
the present study between recombinant and neuronal cultures may be due to the 
presence or absence of critical CaMK-II anchoring proteins.
It is possible to interpret the effects of a-CaMK-II in the current study on 
sIPSCs as a direct /33 phosphorylation and possibly an indirect tyrosine kinase 
phosphorylation of i2S  (See Chapter 7) leading to a possible increase in IPSC 
amplitude and a change in decay time seen in both wt and /32 -/- cultures. This 
would also explain the strong effect of a-CaMK-II on whole-cell currents recorded 
from cerebellar granule cells cultured in depolarising conditions when cells are 
thought to express predominantly /?3 subunit-containing receptors (Ives et al., 2002a) 
and would also be in accord with the modulation of recombinant a l ^ ^ S  receptors 
seen in NG108-15 cells. The lack of a significant change in the extent of the effect 
of CaMK-II on /52 -/- cerebellar cultures, maintained in depolarising conditions, 
could indicate that there is little /32 in these cells (Ives et al., 2002a), or that j82 
modulation by a-CaMK-II is only possible at a functional synapse since these 
cultures generally display no synaptic activity (Mellor et al., 1998).
On application of exogenous GABA, the time to reach the peak amplitude of 
whole-cell current is relatively slow (See Chapter 2, 200-300ms). Direct changes on 
GABAa channel function altering probability of opening or the extent of 
desensitisation could increase the apparent amplitude of whole-cell currents. It has 
been demonstrated that phosphorylation of the *y2 subunit by tyrosine kinases alters 
the mean open time and probability of opening of the GABAa receptor (Moss et al., 
1995) and that this tyrosine kinase phosphorylation of *y2S can increase whole-cell 
currents recorded from HEK293 cells and neurones (Moss et al., 1995).
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Tyrosine kinase phosphorylation of has been reported to increase the 
amplitude of IPSCs, although not the decay time (Boxall, 2000; Ma et al., 2003). So 
it could be speculated that Ser phosphorylation of the /33 subunit and 
phosphorylation of *y2S by down-stream activation of a tyrosine kinase together, 
alters directly the properties of the channel in such a way as to lengthen the decay 
times and increase the amplitudes of a sub-population of IPSCs. The /52 subunit 
mediated effect may be related to increased numbers of functional receptors and 
therefore results in an increase in amplitude with no change in decay times. The /32 
subunit-containing receptors appear to be located at synapses responsible for much 
larger amplitude IPSCs in the present study (See Fig 8.7), possibly reflecting the fact 
that they are situated near to the soma or that they are located at specific, large, 
multi-quantal synapses.
There is evidence that the extent of receptor occupancy on release of GABA 
varies at different synapses within the same cell (Hajos et al., 2000). Changes in 
channel properties would be expected to increase decay times and amplitudes of 
sIPSCs if GABA is not saturating, but would have no effect on amplitude at synapses 
where GABA is saturating. This may mean that phosphorylation dependent changes 
in channel function have slightly different effects depending on the degree of 
receptor occupancy at a given synapse. This may explain why a-CaMK-II appears to 
increase the amplitude of some IPSCs in /32 -/- cultures (See Fig 8.6), but has little 
effect on the mean IPSC amplitude (See Fig 8.3), as some IPSCs increase in 
amplitude and decay time and others only increase in decay time dependent on the 
level of receptor occupancy by GABA. At synapses where GABA is saturating an 
increase in receptor number is predicted to be the most effective way of up- 
regulating inhibitory transmission (Otis et al., 1994; De Koninck and Mody, 1994;
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Nusser et al., 1998). It is possible therefore that different receptor subtypes are 
modulated by phosphorylation in different ways. This may allow the most 
appropriate form of modulation to occur at different synapses.
Changes in the decay times of IPSCs can be the result of changes in 
desensitisation of the receptor (Jones and Westbrook, 1996). The bi-exponential 
decay observed at many GABAergic synapses has been proposed to be related to 
desensitisation. The slower component of decay may relate to GABAa receptors that 
have bound GABA that are briefly desensitised before re-opening, prolonging the 
decay phase of the IPSC (Jones and Westbrook, 1996). The alteration in the 
apparent contribution of xl and t2 between wt and /32 -/- cultures on application of 
a-CaMK-II may suggest that CaMK-II dependent phosphorylation can alter the 
desensitisation of the receptor. In support of this, the calcium-dependent 
phosphatase calcineurin has been proposed to alter the desensitisation of the GABAa 
receptor (Jones and Westbrook, 1997).
The presence of perisynaptic receptors can alter the apparent rise-time and 
decay time of IPSCs (Mody and Pearce, 2004). Spillover-mediated transmission has 
been identified at golgi cell to granule cell synapses in brain slice preparations (Rossi 
and Hamann, 1998; Wall, 2002; Hamann et al., 2002). This is thought to be related 
to the presence of high affinity o6 subunits in these cells which have been identified 
at cerebellar granule cell synapses (Nusser et al., 1996; Ortinski et al., 2004). Within 
rat cultures, under physiological conditions, there was little evidence of a tonic 
current, however, in these mouse wild-type and /32 -/- cultures, a proportion of cells 
did express a tonic current indicating the likely presence of o6 subunit-containing 
receptors. Up-regulation of the function of perisynaptic receptors could alter the 
apparent decay times and rise-times of IPSCs. In the current study, a slight tendancy
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to change the rise-time was observed in cells from /32 -/- cultures on application of a- 
CaMK-II which could be related to an effect on perisynaptic receptors, however, this 
effect did not reach statistical significance (P < 0.1, Fig 8.4D).
In conclusion the analysis of knockout mouse data can be complicated by 
compensatory changes and any differences observed could potentially be non­
specific. But the evidence does indicate that an a-CaMK-II dependent effect occurs 
on a population of events that disappear in the /32 knockout mouse. The most 
parsimonious explanation is that a-CaMK-II can modulate /32 subunit-containing 
receptors, but only in the native neuronal synaptic environment. It is not clear why 
this does not occur in a recombinant system, but it could be because specific kinase 
anchoring proteins, synaptic scaffolding proteins and/or receptor trafficking 
machinery is needed for a-CaMK-II to modulate these receptors. This has important 
implications for the functional role of phosphorylation of different GABAa receptors 
at inhibitory synapses.
8.4 CONCLUSIONS:
• There was no significant difference in the modulation of whole-cell GABA 
currents by a-CaMK-II recorded from cerebellar granule cells maintained in 
depolarising conditions lacking the /32 subunit. Suggesting a lack of 02 in 
wild-type cultures or a lack of an a-CaMK-II dependent effect on 02 subunit- 
containing receptors under these culture conditions.
• Application of a-CaMK-II had a different effect on two populations of 
sIPSCs recorded from cerebellar granule cells from wt mice. One population 
of sIPSCs increased in decay time and another population of larger amplitude 
sIPSCs increased significantly in amplitude with no change in decay.
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• The larger amplitude population of sIPSCs was no longer present in /32 -/- 
cultures, suggesting that they were mediated by /32 subunit-containing 
receptors and that these sIPSCs could be modulated by a-CaMK-II in the 
wild-type cultures.
• The loss of the /32 subunit resulted in subtle changes to the population of 
sIPSCs observed in control conditions. There was an apparent loss of large 
amplitude fast decaying events which were replaced by large amplitude 
events with slower decay times. This may coincide with a loss of a l subunit- 
containing receptors alongside the loss of /32.
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Chapter Nine:
Physiological significance of CaMK-II modulation of
GABAa receptors
9.1 INTRODUCTION
Modulation of GABAa receptor mediated currents through activation of 
CaMK-II has been reported in a number of neuronal cell types (Kano et al., 1992; 
Wang et al., 1995; Kano et al., 1996; Kawaguchi and Hirano, 2002; Wei et al., 
2004). The current study provides evidence for the potential mechanisms behind this 
modulation. Use of NG108-15 cells allowed sites of CaMK-II dependent 
phosphorylation to be determined revealing that Ser383 on the /53 subunit is likely to 
be a direct site of CaMK-II phosphorylation on the GABAa receptor. In addition, a 
CaMK-II dependent phosphorylation of tyrosine residues 357 and 359 on the t2S 
subunit was also observed (See Fig 9.1). The evidence suggested that CaMK-II can 
activate a down-stream tyrosine kinase which goes on to phosphorylate /31 and /33 
subunit-containing GABAa receptors. However, /32 subunit-containing receptors are 
not modulated at all by CaMK-II suggesting a specific kinase anchoring protein may 
be required for any effect on /52 subunit-containing receptors to be observed (See 
Chapters 6 and 7). In addition, in the HEK293 cell line, it was not possible to 
identify any functional modulation of GABAa receptors by CaMK-II (See Chapter 
3), again suggesting kinase anchoring proteins may be important in regulating 
CaMK-II dependent phosphorylation of GABAa receptors. The importance of these 
sites of phosphorylation was confirmed by expression of recombinant receptors in 
cerebellar granule cells maintained in depolarising conditions. However it was still 
not possible to observe any a-CaMK-II dependent modulation of al(32'fl.S receptors.
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CaMK-II is capable of increasing whole-cell current amplitudes in a neuronal 
culture preparation (cerebellar granule cells in depolarising conditions) that is 
predicted to express predominantly /33 subunit-containing receptors (See Chapter 4). 
Analysis of synaptic currents recorded from cerebellar granule cell cultures predicted 
to express both /32 and /33 subunits (physiological conditions) confirms that CaMK-II 
can significantly increase the amplitude and decay times of IPSCs. However, these 
effects are not uniform across the whole population of IPSCs recorded. One 
population of IPSCs significantly increased in decay time and another population of 
IPSCs significantly increased in amplitude with no affect on decay time (See Chapter 
5).
Analysis of synaptic currents in a culture preparation lacking /32 subunit- 
containing receptors inferred that CaMK-II can indeed modulate /52 subunit- 
containing GABAa receptor mediated IPSCs. The effect of CaMK-II on /32 subunit- 
containing receptors involves an increase in IPSC peak amplitudes with no change in 
decay times (See Chapter 8). It is proposed that the mechanism of CaMK-II action 
on /32 subunit-containing receptors may involve insertion of receptors into the 
plasma membrane rather than a direct effect on channel properties, consistent with 
other evidence in the literature regarding /32 subunit phosphorylation. Whereas, 
CaMK-II dependent effects on /53 subunit-containing receptors may involve direct 
phosphorylation and alteration of channel properties which is consistent with the 
lengthened decay times of IPSCs.
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Src
CaMK-
Fig 9.1: Summary of the proposed action of CaMK-II on different GABAa 
receptor subtypes.
CaMK-II can modulate GABAa receptor function through direct phosphorylation of 
the (33 subunit at Ser and through activation of a tyrosine kinase that can 
phosphorylate the 72s subunit at Tyr357,359. PYK2 and Src tyrosine kinase (the most
1
likely candidates) have been proposed to be activated by Ca dependent signalling 
pathways and in some cases CaMK-II in other cell types.
CaMK-II modulation of the /32 subunit-containing receptors could occur through 
direct phosphorylation of the subunit or through an indirect mechanism. It is 
proposed that CaMK-II modulation of /32 subunit-containing receptors may occur 
through insertion of receptors into the plasma membrane.
Arrows in black indicate potential sites of direct phosphorylation. Block arrows 
indicate sites of phosphorylation mediated by a downstream kinase. Dashed line 
arrows indicate pathways involving changes to receptor trafficking.
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9.2 Limitations in studying phosphorylation.
9.2.1 Discrepancies in the literature.
The investigation of phosphorylation-dependent modulation of GABAa 
receptors in both recombinant and neuronal preparations has revealed a considerable 
amount of diversity in the functional response observed (Moss and Smart, 1996; 
Brandon et al., 2002a; Liischer and Keller, 2004). In some cases this may be due to 
differential effects of phosphorylation by the same kinase on different GABAa 
receptor subtypes (McDonald et al., 1998; Nusser et al., 1999). However, this 
cannot explain all of the differences in the functional effects observed. The 
importance of kinase anchoring proteins has been revealed by a number of 
experiments in recent years, and differential effects of phosphorylation may be, in 
part, explained by the presence of different kinase anchoring proteins in different cell 
types, which may localise the kinase in question to different sites or enable binding 
to different GABAa receptor subtypes (Brandon et al., 2002b; Brandon et al., 2003; 
Terunuma et al., 2004).
The mechanisms of functional modification by phosphorylation may also 
vary depending on the kinase involved or again the target GABAa receptor subtype. 
Covalent modification of receptor structure and alteration of channel properties, such 
as desensitisation (Jones and Westbrook, 1997) or probability of channel opening 
(Moss et al., 1995), have been shown to modulate GABAa receptor function. In 
addition, phosphorylation can alter the trafficking of GABAa receptors to the 
synapse and dynamic modulation of receptor number has been shown to be an 
important mechanism in synaptic plasticity (Nusser et al., 1998; Wang et al., 2003b; 
Kittler and Moss, 2003).
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When interpreting data relating to phosphorylation dependent changes in 
GABAa receptor function it is important to note that different experimental 
approaches can reveal different functional effects (See Chapter 1). For instance, the 
mechanism of activation of a particular kinase or the time-scale of activation can 
have a significant influence on the effect observed (Angelotti et al., 1993; Krishek et 
al., 1994; Lin et al., 1996; McDonald et al., 1998). When activating any kinase 
signalling pathway it is very difficult to discount downstream activation of other 
kinases, as has been demonstrated in the current study (See Chapter 7). In addition, 
phosphorylation must be considered in the context of a dynamically changing 
balance of activity between different kinases and phosphatases. The background 
basal phosphorylation state of the GABAa receptor in a given cell type may also alter 
the response observed in any given experiment (Brandon et al., 2000; Brandon et al., 
2001).
The method of analysis also has significant implications in that measurement 
of whole-cell current amplitudes per se, may not identify subtle changes or 
differences in channel behaviour which could have a significant effect on synaptic 
currents (Hinkle and Macdonald, 2003). When analysing the effects of 
phosphorylation on a heterogeneous population of GABAa receptor mediated IPSCs 
within a neuronal population, it is possible a significant effect on different 
subpopulations of events may be missed if  only mean values are measured (See 
Chapters 5 and 8).
9.2.2 CaMK-II
When looking at CaMK-II dependent modification of receptor function these 
problems are pronounced by the complexity of the processes that modulate the
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kinase activity itself (Griffith et al., 2003; Colbran, 2004). The current study 
indicates that pre-activated recombinant a-CaMK-II is capable of modulating 
GABAa receptor function. However, in cerebellar granule cells maintained in 
depolarising conditions, endogenous /3-CaMK-II may also be capable of basal 
phosphorylation of GABAa receptors (See Chapter 4) as this is the predominant 
isoform in this cell type (Miller and Kennedy, 1985; Burgin et al., 1990). It is 
currently not known what the role of different ratios of a  to /3 CaMK-II subunits 
and/or translocation of CaMK-II to inhibitory as opposed to excitatory synapses 
might be in relation to GABAa receptor modification.
The recombinant a-CaMK-II used in the current study can phosphorylate the 
same substrates as the full-length form of this subunit (Suzuki-Takeuchi et al., 1992) 
but cannot form a holoenzyme (Shen and Meyer, 1998). Pre-activation of this 
recombinant form of a-CaMK-II and inclusion within the patch pipette has been used 
successfully to reveal CaMK-II dependent effects on the function of AMPA 
receptors (Lledo et al., 1995; Barria et al., 1997). Application of a pre-activated 
recombinant form of /3-CaMK-II would be expected to have a similar effect using 
this protocol because of the similarity in substrate specificity between the two 
isoforms (Miller and Kennedy, 1985). The a  and /3 subunits differ in their sensitivity 
to activation by Ca2+/CaM (Miller and Kennedy, 1985; Brocke et al., 1999) which in 
this case is not relevant as CaMK-II was pre-activated in vitro.
It should be considered though, that localisation and targeting of recombinant 
constructs of CaMK-II may not be the same as that under physiological conditions 
after activation of an endogenous CaMK-II holoenzyme by Ca2+ signalling which, in 
itself, is a complex and highly regulated process (Meldolesi, 2001; Franks and 
Sejnowski, 2002; Augustine et al., 2003). Pre-activated recombinant a-CaMK-II can
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be expected to phosphoiylate CaMK-II substrates within the cell but the role of oaf.3 
subunits within an endogenous heteromer cannot be determined using this protocol.
9.3 The roles of specific GABAa receptor subtypes.
9.3.1 Specific synapses express discrete GABAa receptor subtypes.
The current study has revealed a difference in the response to CaMK-II 
dependent phosphorylation of different GABAa receptor subtypes (See Chapter 6 
and Chapter 8). This finding is similar to the observed differences in response of 
different GABAa receptor subtypes to PKA dependent phosphorylation (McDonald 
et al., 1998). Such differences have been proposed to partly explain some of the cell 
type dependent differences in functional response to phosphorylation by PKA and 
PKC (Nusser et al., 1999; Poisbeau et al., 1999).
Recent evidence also suggests that different GABAa receptor subtypes could 
be targeted to different locations within the same cell (Connolly et al., 1996; Koulen 
et al., 1996; Briinig et al., 2002). Specific synapses within the same neurone may 
express specific GABAa receptor subtypes (See Fig 9.2). Within rat or rabbit 
retinae, a l ,  02 and 03 subunits were shown to not be co-localised within the same 
clusters. Individual neurones could express several isoforms of GABAa receptor and 
these were targeted to specific postsynaptic sites (Koulen et al., 1996; Briinig et al., 
2002). In dissociated cultures of hippocampal neurones, specific a  subunits were 
targeted to discrete cellular regions in a different way depending on the cell type 
(Briinig et al., 2002). Although these studies focused on a  subunit expression it is 
known that certain a  and (3 subunits preferentially assemble suggesting that the 
subcellular location of /3 subunits may also be tightly controlled (Benke et al., 1994; 
Whiting, 2003). In support of this, in a recombinant system /? subunits have been
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shown to target to different subcellular locations (Connolly et al., 1996). 
Furthermore, specific targeting of GABAa receptor subtypes to particular synapses 
appears to occur in the current study, in that 132 subunit-containing receptors are 
targeted to form large IPSC amplitude synapses whereas the other subunits, 
presumed to be predominantly /33 in cerebellar granule cells, are targeted to smaller 
amplitude IPSC synapses (See Chapter 8).
Intemeurones are able to form synapses at precise locations on the target cell 
(McBain and Fisahn, 2001; Di Cristo et al., 2004; Farrant and Nusser, 2005; 
Somogyi, 2005). Different intemeurones can form discrete synapses onto 
hippocampal pyramidal cells with different GABAa receptor subtypes located 
postsynaptically (See Fig 9.2), even within a similar domain of the pyramidal cell. 
Pyramidal cells clearly have mechanisms to target GABAa receptor subtypes to 
distinct synapses depending on the presynaptic cell type (Nylri et al., 2001).
The targeting of specific GABAa receptor subtypes to specific sites is 
important because the channel properties of GABAa receptors can differ according 
to the subunits within the receptor (See Fig 9.2). For example, the presence of 
different a  subunits has been shown to alter the kinetics of a given receptor (Gingrich 
et al., 1995). Different receptor subtypes may be targeted to specific locations so 
that the functional properties of a GABAa receptor may be tailored to suit the 
specific synapse and functional role(s) that they play. In addition, these functional 
properties can be differentially modulated by phosphorylation depending on the 
GABAa receptor subtype present (See Fig 9.2).
In the current study, /32 subunit-containing receptors could not be modulated 
by CaMK-II in a recombinant system, whereas it was possible to observe modulation 
by CaMK-II of /33 subunit-containing GABAa receptors (Chapter 6). This suggests a
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possible difference in the way GABAa receptor subtypes are modulated by CaMK-II. 
CaMK-II dependent effects on /53 subunit-containing receptors were thought to 
involve a change in decay time of IPSCs consistent with a change in the single 
channel properties of the receptor, whereas effects on 02 subunit-containing 
receptors appeared to involve an increase in amplitude with no change in decay 
consistent with alterations in receptor number (See Chapter 8). The heterogeneity of 
response of different 0 subunits to phosphorylation may provide a mechanism to alter 
the function of specific synapses in precise ways according to their location and 
physiological role.
9.3.2 The physiological roles of 02 and 03 subunit-containing receptors.
Evidence suggests that certain a  and 0 subunits preferentially assemble 
together (Benke et al., 1994). It is thought that O'102/y2 and oi2/303^2 receptors 
comprise the majority of receptors in the brain (Benke et al., 1994; Whiting, 2003; 
Vicini and Ortinski, 2004). Although the cd02/y2 receptor is the most widely 
expressed recent evidence suggests both 02 and 03 subunit-containing receptors have 
important physiological roles. The use of knock-in mice with mutations that render 
specific subtypes of receptor insensitive to selected drugs has enabled their 
contribution to the effects of these drugs to be ascertained (Vicini and Ortinski, 2004; 
Rudolph and Mohler, 2004; Wafford et al., 2004; Wafford, 2005). Knock-in 
mutation of the 02 and 03 subunits, with mutations known to be critical for the action 
of general anaesthetics in vitro, has revealed that 02 and 03 subunit-containing 
receptors mediate different physiological effects of anaesthetics (Rudolph and 
Mohler, 2004). The 02 subunit appears to be involved in mediating the sedative
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properties of anaesthetics whereas the /33 subunit appears to mediate a loss of 
consciousness (Jurd et al., 2003; Reynolds et al., 2003).
The /52 subunit also appears to mediate a significant proportion of the 
hypothermic effect of the general anaesthetic etomidate (Cirone et al., 2004). The 
drug oleamide has sleep promoting effects in rodents but administration of this drug 
to j(33 knockout mice fails to have any affect suggesting that the action of this drug is 
solely mediated through actions on /33 subunit-containing receptors (Laposky et al., 
2001). The use of a l subunit and /32 subunit knockout mice has also revealed that 
the behavioural effects of ethanol may be mediated by distinct GABAa receptor 
subtypes (Blednov et al., 2003).
9.3.3 Network oscillations.
Inhibitory synaptic transmission plays a critical role in the generation of 
network oscillations which are associated with behaviour (Gaiarsa et al., 2002). 
During active exploration rat hippocampal neurones exhibit rhythmic theta and 
gamma frequency activity (McBain and Fisahn, 2001). Simulations involving 
intemeuronal networks with fast and slow GABAa receptor kinetics (fast and slow 
decaying IPSCs) have been shown to produce theta-gamma rhythmic activity (White 
et al., 2000; McBain and Fisahn, 2001). The kinetics of GABAa receptors have been 
shown to be important in shaping network oscillations in the cortex (Whittington et 
al., 1995). Alteration of the decay times of IPSCs through phosphorylation may 
therefore be important in generating or modulating this rhythmic activity.
Subunit specific effects of phosphorylation on different subtypes may 
modulate receptor properties changing the decay times of IPSCs and therefore 
altering oscillations in the network. In addition mutations that affect the decay times
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of IPSCs have been linked to pathological conditions such as epilepsy (Bianchi et al., 
2002; Fisher, 2004; Macdonald et al., 2004) and have been shown to alter behaviour 
(Homanics et al., 2005).
Specific GABAa receptor subunits have been shown to play precise roles in 
the generation of oscillatory activity. The role of the j83 subunit in network 
oscillations of the olfactory bulb has been investigated using the /33 subunit knockout 
mouse. Alteration of normal synaptic inhibition resulted in a significant increase in 
the amplitude of theta and gamma oscillations recorded from this region in freely 
moving mice resulting in an alteration of normal olfactory discrimination (Nusser et 
al., 2001). This implied an important role for /33 subunit-containing receptors in 
modulating theta and gamma oscillations. In addition use of a knock-in mouse with 
a /33 mutation rendering this subunit insensitive to the anaesthetic etomidate revealed 
that j82 and /?3 subunit-containing receptors could exert opposing actions on theta 
activity in neocortical slice cultures (Drexler et al., 2005).
It appears specific synapses formed at particular locations by specific 
intemeurones may play precise roles in shaping network activity and oscillations 
(McBain and Fisahn, 2001; Klausberger et al., 2004; Farrant and Nusser, 2005; 
Somogyi, 2005). It is becoming clear that the function of GABAa receptors is not 
simply to provide “blanket” inhibition. If different inhibitory synapses play precise 
roles then modification of these synapses by phosphorylation may also differ in 
mechanism and functional effect. Phosphorylation dependent effects may occur 
through several different mechanisms with the functional effect on GABAa receptor 
subtypes varying according to the subtype present in order to modulate and control 
the function of specific synapses and therefore patterns of activity related to 
behaviour.
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Fig 9.2: Specific GABAa receptor subtypes are targeted to discrete subcellular 
locations.
Different classes of intemeurone have been shown to form synapses at particular 
locations on the target cell. In addition there is evidence that specific GABAa 
receptor subtypes are expressed at different synapses.
Different GABAa receptor subtypes have different kinetic properties which shape 
the profile of an IPSC. Phosphorylation can have a differential effect on different 
GABAa receptor subtypes.
Network oscillations relevant to behaviour are differentially affected by changes in 
activity at these different synapses.
IN = Intemeurones. PC = Principal cell
9.4 Physiological role of GABAa receptor modulation by 
CaMK-II.
In summary, evidence now suggests that GABAa receptors can be composed 
of discrete sets of subunits which may be targeted to distinct subcellular locations 
(Koulen et al., 1996; Briinig et al., 2002). The different subtypes can be shown to 
play different physiological roles in that the different effects of certain drugs can be 
ascribed to specific GABAa receptor subtypes (Rudolph and Mohler, 2004; Wafford 
et al., 2004). In the current study phosphorylation appears able to affect the function 
of different GABAa receptor subtypes in different ways (See Chapters 6 and 8). 
There are different mechanisms of phosphorylation-dependent modulation of 
function involving changes in receptor targeting and trafficking and also direct 
changes to channel properties. These phosphorylation-dependent changes are 
thought to be crucial for the functional role of GABAa receptors at synapses. As a 
result CaMK-II dependent modulation of GABAa receptors may play important roles 
in neurodevelopment, inhibitory plasticity and certain disease states.
9.4.1 Development.
The role of the (33 subunit in neurodevelopment was highlighted by the severe 
behavioural deficits of the /33 subunit knockout mouse (Homanics et al., 1997; 
DeLorey et al., 1998). In contrast, the /32 subunit knockout mouse phenotype was 
relatively normal given the comparable loss of receptor number found in these mice 
(Sur et al., 2001) suggesting each /3 subunit plays very different physiological roles 
in neurodevelopment. In support of this the /33 subunit is the predominant subunit 
expressed early on in development (Laurie et al., 1992).
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The current study indicated that /33 subunit-containing receptors can be 
phosphorylated by CaMK-II resulting in a potentiation of function (See Chapters 6 
and 7). In support of this electrophysiological evidence, biochemical studies have 
revealed a CaMK-II dependent phosphorylation of the /33 subunit in embryonic 
cortical neurones. Application of muscimol in these cultures activates GABAa 
receptors which, at this point in development, are excitatory. As a result of GABAa 
receptor activation, there is a depolarisation and Ca2+ influx which results in 
phosphorylation of the /33 subunit of the GABAa receptor that can be blocked by 
KN-93. Further biochemical evidence suggests CaMK-II can bind to the /3 subunits 
of GABAa receptors in vitro at a region within the first 30 amino acids of the TM3-4 
loop (McAinsh K, Jovanovic JN and Moss SJ, personal communication). 
Application of pre-activated CaMK-II to the same embryonic cortical neuronal 
cultures resulted in a significant potentiation of the whole-cell current (See Chapter 
4).
It appears from the biochemical evidence that CaMK-II dependent 
modulation of /33 subunit-containing receptors may play a role in strengthening 
GABAa receptor synaptic transmission early on in development possibly playing a 
role in activity dependent strengthening of inhibitory synaptic transmission. Certain 
Ca2+-dependent forms of inhibitory plasticity have been suggested to be dependent 
on the stage of development of a particular cell-type and may play a role in the 
functional maturation of GABAergic synaptic transmission (Komatsu and Iwakiri, 
1993; Komatsu, 1994; Gubellini et al., 2001). It could be speculated that CaMK-II 
dependent potentiation of GABAa receptor function could provide a mechanism for
9 -4-these Ca -dependent forms of inhibitory plasticity.
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9.4.2 Homeostatic plasticity and metaplasticity.
The role of excitatory synaptic plasticity, in particular LTP, in learning and 
memory has been extensively studied in recent years. However, it is now becoming 
apparent that inhibitory synapses are also capable of long-lasting synaptic plasticity 
and that changes in inhibition can modulate excitatory plasticity. Activity-dependent 
changes in synaptic plasticity altering the threshold of excitatory LTP induction has 
been termed metaplasticity (Abraham and Tate, 1997; Elgersma et al., 2004). For 
example in CA1 pyramidal neurones induction of excitatory LTP activated a 
calcineurin-dependent LTD of GABAa receptor-mediated synaptic transmission 
which was found to enhance the LTP of EPSPs (Lu et al., 2000).
Inhibitory synapses have been demonstrated to change in strength in such a way 
as to enhance changes in excitatory transmission, but they have also been shown to 
adjust in opposition to changes in excitatory transmission in homeostatic forms of 
plasticity (Turrigiano and Nelson, 2004). Certain forms of inhibitory plasticity have 
been shown to be Ca2+-dependent and bidirectional (Aizenman et al., 1998) in a 
manner similar to excitatory LTP. CaMK-II has been shown to be critical in the 
potentiation of AMPA receptor-mediated synaptic transmission. It has also been 
shown that CaMK-II may play a role in inhibitory synaptic plasticity. CaMK-II 
modulation of GABAa receptors may represent a possible mechanism of 
postsynaptic inhibitory plasticity that could be involved in homeostatic or 
metaplasticity.
Rebound potentiation is a form of CaMK-II dependent long-term synaptic 
plasticity that occurs in Purkinje cells in response to a strong stimulation of 
excitatory inputs onto the same cell. In this way it could be thought of as a 
homeostatic form of plasticity acting to increase GABAergic synaptic transmission
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after strong excitation. Purkinje cells are thought to express pre-dominantly /32 
subunits over /33 and /31 (Persohn et al., 1992). Depolarisation and Ca2+ entry after 
strong excitation activates CaMK-II which goes on to modify IPSCs by increasing 
their amplitude with no change in decay times (Kano et al., 1992; Kano et al., 1996; 
Kawaguchi and Hirano, 2002). This is consistent with the current studies 
observation of /32 subunit-containing receptor mediated IPSCs increasing in 
amplitude with no change in decay times (See Chapter 8). It has been shown that 
rebound potentiation does not occur in the /32 knockout mouse supporting the role of 
this subunit in this kind of plasticity (Duguid and Smart, personal communication).
9.5 The role of CaMK-II dependent modulation of GABAa 
receptors in disease states.
9.5.1 Angelman syndrome and Autism.
The /?3 knockout mouse displays epilepsy and behavioural deficits that are 
similar to the phenotype of Angelman syndrome (DeLorey et al., 1998) a 
neurodevelopmental disorder affecting humans that results from a maternal 
deletion/mutation of chromosome 15ql 1-13. In this region, there are two candidate 
genes thought to be potentially responsible for the neurodevelopmental deficits seen. 
The UBE3A gene which encodes a ubiquitin ligase, a protein involved in protein 
degradation (Weeber et al., 2003) and the GABRB3 gene encoding the /33 subunit of 
the GABAa receptor. Both of these genes have been demonstrated to have reduced 
expression in Angelman syndrome patients (Samaco et al., 2005) and disruption of 
both genes in mice has generated models of Angelman syndrome with many of the 
same behavioural deficits as that seen in humans (DeLorey et al., 1998; Weeber et 
al., 2003; Sinkkonen et al., 2003).
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The role of the /33 subunit early on in development suggested that Angelman 
syndrome was caused by dysfunction in the normal development of inhibitory 
synaptic transmission. However, in another mouse model of Angelman syndrome 
involving maternal deletion of UBE3A, a reduction in CaMK-II activity and the total 
amount of CaMK-II associated with the postsynaptic density has been proposed to 
underlie the deficits in normal function associated with Angelman syndrome 
(Weeber et al., 2003). It is interesting to speculate that disruption of an interaction 
between CaMK-II and the /33 subunit of the GABAa receptor may be involved in the 
neurodevelopmental deficits seen in this syndrome. This implies an interaction 
between CaMK-II and the /33 subunit may be important in the development of 
inhibitory synaptic transmission.
Other conditions such as Rett syndrome, an X-linked dominant disorder 
caused by MECP2 (a transcriptional repressor protein) gene mutation and autism 
have also been demonstrated to involve a reduction in UPE3A and GABRB3 gene 
expression (Samaco et al., 2005). If CaMK-II modulation of /33 subunit-containing 
GABAa receptors in the early stages of development plays a role in 
neurodevelopement this signalling pathway may be a potentially important target for 
future drug therapies.
9.5.2 Epilepsy
A number of mutations in GABAa receptor subunit genes have been 
identified in humans that have been associated with epilepsy (Jones-Davis and 
Macdonald, 2003; Macdonald et al., 2004). Some of these mutations alter the 
properties of the channel itself and are proposed to alter the decay times of IPSCs 
(Bianchi et al., 2002; Fisher, 2004). In addition, epilepsy has been associated with
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up and/or down-regulation of specific GABAa receptor subunit mRNAs (Brooks- 
Kayal et al., 1998; Meguro et al., 2004) and increases in the number of GABAa 
receptors at specific synapses (Nusser et al., 1998).
^  I
During periods of enhanced neural activity the intracellular Ca load would 
be expected to increase and subsequently CaMK-II activity may also be increased. 
Observed compensatory increases in GABAa receptor function (Brooks-Kayal et al., 
1998; Nusser et al., 1998) could be related to CaMK-II dependent modification of 
receptor function. The decay times of IPSCs and the number of GABAa receptors at 
the synapse could both potentially be modulated by CaMK-II dependent 
phosphorylation.
In support of this epilepsy has also been linked to a decrease in the expression 
of a-CaMK-II. In human tissue of patients undergoing surgery who suffer from 
severe seizures immunocytochemical staining revealed a decrease in the expression 
of a-CaMK-II and a-CaMK-II autophosphorylated at Thr286 (Battaglia et al., 2002). 
In hippocampal neuronal cultures, complimentary oligonucleotides for a-CaMK-II 
were used to decrease the expression of this subunit. Reduction in a-CaMK-II 
expression resulted in increased neuronal excitability and epileptiform discharges. 
The magnitude of the reduced a-CaMK-II expression could be correlated with 
increased neuronal excitability (Chum et al., 2000). In addition, in a pilocarpine- 
induced rat model of epilepsy it has been demonstrated that there is a decrease in the 
activity of cortical and hippocampal CaMK-II (Singleton et al., 2005). These results 
are in contrast to the fact that increased a-CaMK-II activity and expression is 
associated with increases in excitatory synaptic transmission (Ouyang et al., 1997; 
Colbran and Brown, 2004; Collingridge et al., 2004). It could be speculated that
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CaMK-II dependent effects on GABAa receptor mediated inhibitory synaptic 
transmission might be involved in epilepsy in a causative or compensatory manner.
9.6 CONCLUSIONS
The evidence presented in this study suggests that CaMK-II can have a different 
effect on the function of specific GABAa receptor subtypes and that these effects 
may be mediated by different mechanisms. Although CaMK-II dependent effects on 
/31/3 subunit-containing receptors appear to be related to direct phosphorylation of 
the receptor it is not yet known if CaMK-II modulation of /32 subunit-containing 
receptors occurs through direct phosphorylation or another indirect process (See Fig 
9.1). The different effects on IPSCs may be tailored to form specific roles. As /32 
and (33 subunit-containing receptors appear to cluster at specific sets of synapses with 
specific physiological roles, phosphorylation may alter GABAa receptor function of 
different subtypes according to the function they perform.
Modulation of GABAa receptors by CaMK-II may represent a mechanism of 
synaptic plasticity that is involved in activity-dependent formation of inhibitory 
synapses during development. It may also represent a way of altering the decay of 
IPSCs in order to alter network oscillations crucial to behaviour. Alteration in IPSC 
decay times appears to form an important part of development and alteration of IPSC 
decay times has important pathological and physiological consequences (Macdonald 
et al., 2004; Homanics et al., 2005).
Long-term changes in the amplitude of IPSCs, as seen in rebound potentiation, 
may have important implications in the processes of learning and memory. 
Understanding the role of different GABAa receptor subtypes and their modulation 
by phosphorylation is crucial to understanding many physiological and pathological
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forms of inhibitory plasticity. In addition, understanding these processes may 
highlight important potential therapeutic targets for a number of diseases linked to 
alterations in the normal behaviour of GABAa receptors and inhibitory synapses.
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Appendix 1:
A l.l Oligonucleotide design for site-directed mutagenesis and knockout 
mouse genotyping.
Carried out in collaboration with Dr. A.M Hosie and Ms. H.M.A da Silva as follows: 
Two complimentary oligonucleotides were designed containing the desired 
mutation for use as mutagenic primers in a PCR reaction. The design of the 5’-3’ 
primer is shown in Table A l. Primers were synthesised by Invitrogen Life 
Technologies. The T2ST357F’ t359f cDNA was a gift from Prof. SJ. Moss. As 
required some subunits were tagged with the 9E10 epitope (EQKLISEEDL) from c- 
myc, inserted between the fourth and fifth amino acid of the mature protein by site- 
directed mutagenesis (Connolly et al., 1996).
Subunit
mutation
Sequence of primer #1:
5’ - 3 ’
Primer #2:
gtataggaaacaggccatgcccaaggaag cttccttgggcatggcctgtttcctatac
1^2 S408A,S409A ctacggaggagggctgcacagctcaaaatc gattttgagctgtgcagccctcctccgtag
/y2gT348A,T350A gatattcgtcccagagcagcagccattcaaatgaac gttcatttgaatggctgctgctctgggacgaatatc
^2gY357F,Y359F gagggatgaagaatttggctttgagtgtttggatg catccaaacactcaaagccaaattcttcatccctc
Table Al: Primers designed for the construction of GABAa receptor subunit 
cDNAs containing the desired single point mutations.
Primers were designed by by Dr A Hosie. Letters indicate: a = adenine, g = guanine, 
c = cytosine, t = thymine.
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A1.2 Transformation of competent E-Coli cells using TOPIO one shot Kit 
(Invitrogen).
Carried out by Ms. H.M.A da Silva as follows:
• An aliquot of cDNA PCR product was centrifuged and placed on ice.
• An aliquot of frozen competent cells was thawed and kept on ice.
• 0.5-1 pi of cDNA PCR product was mixed with the competent cells (25 pi) in 
a sterile microcentrifuge tube and this was left on ice for 30 min.
• The tube was then transferred to a 42°C water bath for 30 s and then placed 
back on ice.
• 80 pi of pre-warmed SOC media (Sigma, 0.5 % w/v yeast extract, 2.0 % w/v 
tryptone, 8.6  mM NaCl, 2.5 mM KC1, 20 mM MgSC>4, 20 mM glucose) was 
added to the cells and they were incubated for 60-90 min at 37°C shaking at 
-900 rpm.
• 100 pl/transformation was then plated out on LB-agar plates containing 
50 pg/ml ampicillin (Sigma) and left overnight for colonies to develop.
• At least 2 colonies per mutant were selected from the agar plates and grown 
overnight in 2ml LB Broth base media (Sigma) with 10 % w/v ampicillin, the 
plasmid from these E. Coli cultures was purified before sequencing.
A1.3 Purification of plasmid DNA using the QLAPrep Spin Miniprep kit 
(Qiagen).
Carried out by Ms H.M.A da Silva as follows:
• 2 ml of bacterial suspension were transferred to a microcentrifuge tube and 
centrifuged for 1-2 min at 13,200 rpm and the supernatant discarded.
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• The pellet of bacterial cells was then re-suspended in 250 pi of Buffer PI (as 
supplied).
• 250 pi of buffer P2 (as supplied) was added and again inverted 4-6 times to 
mix.
• 350 pi of buffer N3 (as supplied) was added and inverted 4-6 times.
• The mixture was then centrifuged at 16,000 rpm for 10 min, and the 
supernatant decanted into a spin column.
• The column was centrifuged at 13,200 rpm for 30-60 s.
• The flow through the column was discarded and 750 pi buffer PE was added 
and centrifuged for 30-60 s for an additional 2 min, to remove any residual 
washing buffer.
• The QIAprep column was placed into a clean microcentrifuge tube. To elute 
the DNA, 50 pi buffer EB (10 mM Tris-Cl @ pH 8.5) or water was added to 
the centre of the QIAprep column, allowed to stand for 1 min, centrifuged for 
1 min.
• The concentration of purified cNDA was measured using a BioPhotometer 
(Eppendorf).
A1.4 Preparation of mouse tail DNA.
Carried out by Ms H.M.A da Silva as follows:
• Tails were placed into a 1.5 ml microcentrifuge tube and 700 pi of NTES (50 
mM Tris HC1 @ pH 8 , 50 mM EDTA, 100 mM NaCl2 and 1 % w/v SDS) 
was added along with 7.5 pi of 20 mg/ml Proteinase K (Sigma) per tube.
• This was incubated overnight at 55°C on a thermomixer at 300 rpm.
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• The following day 600 pi of phenol/chloroform/isoamyl alcohol (25:24:1) 
was added and the tubes were left to shake for 10-15 min. They were then 
spun at 11,400 rpm in a microcentrifuge. The top phase (DNA) was 
transferred into a fresh tube avoiding the interface.
• Then 2.5 pi of 20 mg/ml RNase was added and incubated for 1 hr at 37°C.
• Phenol/chloroform/iosamyl alcohol (25:24:1) was added for 5-10 min and 
then the tubes were microfuged again for 5 min.
• The top phase was transferred to a fresh tube and this was filled with 1 ml 
isopropanol. This was inverted a few times until a precipitate had formed and 
centrifuged for a further 10 min.
• The supernatant was aspirated and 100 pi 70 % v/v ethanol was added, 
followed by centrifugation for 5 min (12,000 rpm). The supernatant was 
aspirated again and the pellet left to air dry.
• 300 pi of TE buffer was added and left at 37°C at 300 rpm on a thermomixer 
overnight. The next day the solution could be transferred to the fridge until 
required.
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